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Abstract 
Engineering resistance against pathogens is often frustrated by the lack of suitable genes. 
This problem can be overcome by in planta expression of antibodies (plantibodies) able to 
inactivate pathogen specific proteins. Since antibodies can be generated against almost any 
molecular structure, this strategy should be feasible for various diseases and pests. 
Antibodies have several desirable features with regard to protein engineering. Using 
molecular techniques the relatively large antibody molecule (150 kDa), consisting of two 
heavy and two light chain molecules, can be trimmed to a single-chain antibody fragment 
(scFv) of 30 kDa, which consists of a variable heavy and light domain connected by a linker 
peptide. 
This thesis describes the expression and subcellular targeting of functional full size 
antibodies and various types of scFv fragments in tobacco plants. The light and heavy chain 
coding genes of a full size model antibody were efficiently introduced in tobacco plants. A 
large number of the transformants expressed and secreted relatively high levels of the 
functional antibody. 
From the model antibody an scFv fragment was derived and expressed in tobacco. The scFv 
was poorly secreted. However, the scFv fragments could be expressed intracellularly to high 
protein levels in the endoplasmic reticulum (ER) by adding the KDEL retention signal, and in 
the ectopic environment of the cytosol by omitting the ER translocation signal. Remarkably, 
the cytosolic scFv could only be expressed at detectable levels when the KDEL sequence 
was present. Immunoelectron microscopy and biochemical markers confirmed the proper 
subcellular locations of these intracellularly expressed scFv fragments. The KDEL extension 
also improved cytosolic expression levels of several other scFv fragments. 
The in vivo redox state of these intracellularly expressed scFvs was determined. Both the 
variable heavy and light domains contain a disulfide bridge, which is considered crucial for 
stability and functionality of the scFv. As expected, these disulfide bridges were present in 
the oxidizing environment of the ER. Remarkably, in stable transformants the intramolecular 
disulfide bridges were also found in the scFvs present in the reducing environment of the 
plant cytosol, resulting in a functional antibody fragment. Like in the ER, the formation of 
intermolecular disulfide bridges was also observed, which resulted in functional dimers. 
When transiently expressed in the cytosol, the scFv was present in a reduced and non-
functional form, confirming that the intramolecular disulfide bridges are necessary for the 
functionality. 
In an attempt to improve scFv secretion levels, the model scFv was modified without 
changing the variable domains. The linker peptide was changed and modified, and 
expression levels were compared in transient expression assays. This only influenced the 
intracellular accumulation indicating that the secretory scFv was probably degraded 
somewhere in the secretory pathway. Various novel types of dimerized scFvs, by adding an 
extra domain derived from camel or IgM antibodies, were expressed transiently and in stable 
transformants. The addition of the camel lgG2 'long hinge' in combination with the IgM CH4 
domain did significantly improve secretion. 
It can be concluded that scFvs, unlike full size antibodies, can be targeted to various 
subcellular compartments. This allows direction of scFv fragments to locations where the 
pathogen specific protein is present. This thesis demonstrates that antibodies are versatile 
molecules and that engineering resistance through plantibody technology against 
nematodes, fungi and insects seems within reach. 
'Voir plus loin que le bout de son nez. 
VoorSaskia, Thomas 
en mijn ouders. 
Contents 
1 General Introduction 1 
2 Coordinate expression of antibody subunit genes yields high levels of functional 
antibodies in roots of transgenic tobacco 9 
3 The C-terminal KDEL sequence increases the expression level of a single chain 
antibody designed to be targeted to both the cytosol and the secretory pathway in 
transgenic tobacco 23 
4 Improving scFv antibody expression levels in the plant cytosol 39 
5 Disulfide bridge formation within and between single-chain Fv antibodies in the 
reducing ectopic environment of the plant cytosol 53 
6 ScFv stability in the secretory pathway of plant cells: Influence of linker peptides, 
the scFv architecture, CH1 residues and the addition of camel hinges and IgM CH4 
domains 67 
7 Summary and concluding remarks 95 
References 103 
Samenvatting 115 
Dankwoord/ Acknowledgements 121 
Curriculum vitae 123 
CHAPTER 1 
General Introduction 
Advances in gene technology and plant transformation systems offer novel routes to 
engineer resistance. An appealing approach to obtain host plant resistance is to introduce 
genes encoding antibodies inhibiting specific factors (e.g. enzymes) essential for the 
pathogenesis. These factors can be present extracellularly, like cell wall degrading enzymes 
of fungi and nematodes (Smant et al., 1998), or intracellular^, like viral proteins or factors 
involved in the induction of feeding sites by sedentary nematodes (Globodera, Heterodera, 
and Meloidogyne species). Consequently, antibody mediated resistance demands the 
expression of functional antibodies in the appropriate subcellular location. The aim of this 
thesis is to determine whether functional antibodies or antibody fragments can be efficiently 
expressed in various subcellular compartments of plants. 
Function, origin and structure of antibodies. 
Antibodies, or immunoglobulins, perform an essential role in the humoral immune response 
of vertebrates. Their unique function is to bind with high affinity to an apparently limitless 
variety of foreign invaders to neutralize and eliminate them from the body. Antibodies are 
synthesized by and initially displayed on the cell membrane of virgin B-lymphocytes. When 
triggered by an antibody inducing agent, or antigen, the organism reacts by B-lymphocyte 
proliferation resulting in antibody secreting plasma cells and memory cells, which reside in 
the spleen. 
An antibody is a Y-shaped protein and is composed out of four subunits, two identical light 
chains and two identical heavy chains (Fig. 1A), both with a distinct domain structure. Each 
Fab 
Constant 
domain 
B 
Fig. 1. A. Schematic representation of an IgG antibody molecule. The individual domains and the 
different fragments are indicated. Abbreviations used: CH1- CH3, heavy chain constant domains; CL, 
light chain constant domain; VL and VH variable light and heavy chain, respectively; h, hinge region; 
Fv, variable fragment; Fab, antigen binding fragment; Fc, constant fragment. B. Ribbon model of the 
light chain variable and constant domains (Lodish ef al., 1995). The arrows represent the (3-pleated 
sheet. The three complementarity-determining regions (CDRs) and intramolecular disulfide bridges 
are indicated. 
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chain contains a variable domain (VL and VH) at the N-terminal end of the peptide, which 
together form the variable fragment (Fv), followed by the constant domain(s), CL of the light 
chain and CH1, CH2 and CH3 of the heavy chain. Intermolecular disulfide bridges and non-
covalent interactions hold the four subunits together as depicted in Fig. 1A. All domains are 
structurally similar and consist of three or four anti-parallel (3 strands, connected by loops of 
varying length (Fig. 1B). Three hypervariable loops, within each VL and VH domain mediate 
binding to a certain site (epitope) on the antigen. These complementarity-determining 
regions (CDRs) are formed during an ingenious recombination procedure during B cell 
maturation and determine the antibody specificity. Since each antibody contains two Fv 
fragments, it can bind two identical epitopes. For example, a mouse comprises initially about 
108 different B-lymphocytes, each displaying an antibody with different specificity. This 
illustrates the vast number of different determinants that can be bound by antibodies. The 
constant domains serve different purposes. The CH1 plays a crucial role during antibody 
assembly in the endoplasmic reticulum (ER). The interaction with the heavy-chain 
chaperoning protein (BIP) (Hendershot ef a/., 1987) prevents the heavy chain from being 
secreted prior to pairing with the light chain. Next to holding the individual chains together by 
covalent and non-covalent interactions, the CL and CH1 domains extend the distance 
between the two antigen binding sites, facilitating cross-linking and agglutination (Dangl ef 
a/., 1988; Schneider ef a/., 1988). Antigen binding is further facilitated by a flexible hinge 
region, which increases the maximum rotation of the Fab arms (Fig. 1A). Since antibodies 
can bind with high specificity and affinity to an antigen they are potentially suitable for 
various scientific and medical applications. However, since the serum of an animal contains 
a wide variety of antibodies with different specificities, which can not be separated, the use 
of these polyclonal antibodies is limited. 
Monoclonal antibodies. 
The hybridoma technology (Kohler and Milstein, 1975) made it possible to immortalize 
individual antibody secreting B cells by fusing them to myeloma cells. The resulting hybrid 
myeloma cell, or hybridoma, has the characteristics of both cells: it secretes one type of 
antibody (monoclonal antibody) and grows indefinitely in vitro. 
The hybridoma technology solves the problems encountered with polyclonal antibodies. 
Nowadays a wide variety of monoclonal antibodies are used as tools in diagnosis, therapy 
and research. A major drawback of the hybridoma technology is that it is only suited for the 
generation of murine antibodies, which are immunogenic in human therapy. 
Inhibiting antibodies. 
The high specificity and affinity of monoclonal antibodies has often also an another important 
impact on the antigen, which makes them even more valuable as tools for science and 
medicine. Some antibodies have the ability to inhibit the activity of the antigen upon binding 
(Fig. 2). This feature has been used to determine the topography of the active site of protein 
antigens. It has been well documented (Table 1) that monoclonal antibodies generated 
against an enzyme can inhibit the activity. 
It was demonstrated by Carlson (1988) that antibodies can also be exploited to inhibit the in 
vivo activity of an antigen. Yeast (Saccharomyces cervisiae) cells expressing cDNAs 
encoding the heavy and light chain of an inhibitory anti-ADH (alcohol dehydrogenase) 
antibody displayed significantly reduced in vivo activity of this enzyme in the cytosol. This 
result indicates that antibodies may also have the potential to provide resistance against 
pathogens or to alter metabolic pathways in plants. 
enzyme (antigen) V IX. 
"substrate &. product 
V T antibody 
Fig. 2. Schematic representation of an inhibiting antibody. Binding of the antibody makes the active 
site of the enzyme inaccessible for the substrate and therefore prevents processing into a product. 
Table 1. Examples of inhibition of enzyme activity by monoclonal antibodies (MAbs). For each of 
the protein antigens the number of raised MAbs and the number of inhibiting MAbs are shown. 
Antigen 
Asparagine synthase 
Human pancreatic elastase 2 
Terminal deoxynucleotidyl transferase 
RNA polymerase II 
p-lactamase 
Taq polymerase 
Number of 
MAbs 
raised 
11 
3 
4 
5 
9 
9 
Number of 
inhibiting 
MAbs 
4 
1 
3 
3 
5 
8 
References 
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Antibody engineering. 
In medicine inhibiting antibodies can be used for therapy, like treatment against cancer. To 
reduce the immunogenicity of murine antibodies, 'humanization' through antibody 
engineering was necessary. This was facilitated by the domain structure of antibodies (Fig. 
3). Initially, antibodies were humanized by replacing murine constant domains with those 
from human origin (Neuberger et a/., 1984 and 1985). These antibodies were still 
immunogenic. Human antibodies were then 'reshaped' by grafting the CDRs from a murine 
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on a human antibody (Jones et al., 1986). Alternatively, to reduce antigenicity murine 
antibodies can be trimmed to functional F(ab')2 and Fab fragments (Horwitz, et al., 1988) 
(Fig. 3). Expression of only the VH and VL encoding genes in bacteria resulted in functional 
Fv fragments (Skerra and Pluckthun, 1988). However, since the Fv fragment relies only on 
non-covalent interactions the stability is relatively low. This problem was overcome by 
constructing a single-chain Fv (scFv) gene in which the VH and VL domains were covalently 
coupled by a flexible linker peptide (Bird et al., 1988; Huston et al., 1988, Glockshuber et al., 
1990). In addition, this made cloning and expression less complicated since only one gene 
had to be expressed instead of two. 
Fig. 3. The domain structure of antibodies facilitates engineering. Possibilities leading to a functional 
antibody fragment are indicated. For medical applications antibodies can be humanized by swapping 
the murine variable domains to human constant domains, or by grafting the complentairity-determining 
regions (CDRs; depicted as black boxes) on a human antibody. Fab and F(ab')2 fragments can be 
obtained through proteolytic cleavage or gene technology. Fv and scFv fragments, in which the two 
variable Fv domains are connected by a peptide linker, can only be obtained through gene technology. 
Antibody expression in heterologous systems. 
Various heterologous expression systems for antibodies have been developed developed. 
Genes coding for full size antibodies and antibody fragments have been expressed, in yeast 
(Wood et al., 1985; Horwitz et al., 1988), myeloma cell lines (Orlandi et al., 1989; Shin and 
Morisson, 1990), plants (Hiatt, era/., 1989; During era/., 1990), algae (Stieger era/., 1991), 
insect cells (zu Putlitz et al., 1990) and bacteria (Pluckthun, 1991). The systems showed 
differences in expression level and the synthesis of functional antibodies. 
Compared to eukaryotic expression systems bacterial expression is considered relatively 
simple and cheap to realize. However, in bacteria complete antibodies cannot be produced. 
Fab and scFv fragments can be expressed, although with limited success. The assembly 
into functional fragments proved to be the rate-limiting step in E. coli. Even when targeted to 
the periplasmic space, Fab and scFv fragments tend to aggregate in most cases as 
incorrectly folded proteins, forming insoluble 'inclusion bodies'. Only low yields of properly 
folded and functional fragments are observed. From the inclusion bodies functional antibody 
fragments can only be recovered after time-consuming renaturation protocols. 
In contrast, the eukaryotic expression systems do not show inclusion body formation. 
Although yields may be lower, these systems are capable of synthesizing full size antibodies 
and antibody fragments. The functional expression of these antibody genes may be caused 
by the presence of the proper molecular chaperones, which mediate the assembly of 
proteins, and prevent aggregation and misfolding of complete antibodies and antibody 
fragments. 
Expression of antibodies in plants. 
Expression of antibodies or antibody fragments in plants (plantibodies) can serve different 
purposes. Plants allow the production of antibodies on a large scale. It has been estimated 
that this production process is cheap when compared to expression in animal cells (Hiatt, 
1990). The only concern is the potential cost of antibody purification from plants. 
An interesting application is the use of antibodies to modulate traits of plants or to engineer 
resistance against pathogens. In this approach it is of paramount importance that the 
antibodies or antibody fragments can be expressed at sufficient levels at the proper 
subcellular location, i.e. the compartment where the antigen is present. So far, insufficient 
and confusing data were presented with respect to the expression levels of antibody and 
antibody fragments and the targeting of antibodies to different subcellular locations. 
Apparently, full size antibodies can not be expressed in the cytosol of plant cells (Hiatt et a/., 
1989). The absence of suitable chaperones in the cytosol may prevent proper folding, 
leading to rapid protein degradation. Furthermore, the reducing environment may prevent 
intra- and intermolecular disulfide bridge formation, necessary for the assembly into stable 
and functional antibodies. IgG antibodies have been efficiently expressed in tobacco by 
targeting them into the secretory pathway using an immunoglobulin ER translocation signal 
(Hiatt, et a/., 1989, Hein, ef a/., 1991). However, During ef a/., (1990) expressed low levels of 
an IgM antibody in tobacco, which was localized in the ER and chloroplasts when the a-
amylase signal sequence for translocation into the ER was used. No secretion was 
observed. De Neve ef a/., 1993 reported that expression of antibodies or Fab fragments 
differed significantly between transgenic tobacco and Arabidopsis, being very inefficient in 
the first and efficient in the latter (De Neve ef a/., 1993). In addition only few plants showed 
high expression levels. 
Data on the expression of scFv fragments are also scarce and confusing. ScFvs were 
efficiently expressed and secreted in transgenic tobacco plants (Firek et a/., 1993). Owen ef 
a/. (1992) had to analyze over one hundred transgenic tobacco plants to find one expressing 
an scFv fragment, which was expected to be located in the cytosol, at the relatively low level 
of 0.1%. In contrast, Tavladoraki ef a/. (1993) reported efficient expression of an scFv, 
targeted to the cytosol, which mediated resistance against artichoke mottled crinkle virus. 
Altogether, this suggests that expression of plantibodies in plants is feasible, making them 
suitable molecules to obtain intracellular resistance and to modulate metabolic pathways. 
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Outline of this thesis. 
This thesis presents results on the expression and subcellular targeting of complete 
antibodies and scFv fragments in plants. In chapter 2 an anti-cutinase antibody was 
efficiently expressed in tobacco plants by introducing one T-DNA carrying the coding genes 
of both the light and heavy chain, each containing the same ER translocation signal 
sequence and under control of a different promoter. As anticipated, the assembled 
antibodies were efficiently secreted. 
In Chapter 3 tobacco transformants were obtained synthesizing scFv fragments, derived 
from the same anti-cutinase antibody, which were designed for secretion, retention in the 
ER, and expression in the cytosol. The four amino acid ER retention signal (KDEL) proves to 
retain the secretory protein in protoplasts. Surprisingly, this KDEL extension had also an 
effect on an scFv designed for expression in the cytosol. The KDEL sequence significantly 
improved the expression in the cytosol. 
In Chapter 4 we confirm that the scFv antibodies targeted to the cytosol and ER are 
translocated to the expected subcellular locations. Furthermore, the beneficial effect of the 
KDEL retention signal was verified by adding this signal to other scFv fragments designed 
for expression in the cytosol. 
In Chapter 5 the influence of the intra- and intermolecular disulfide bridges on the affinity for 
the antigen is determined for an scFv fragment present in the ER and the cytosol. The scFv 
fragment can form disulfide bridges in stable transformants and this is remarkable since the 
cytosol is considered a reducing environment in which disulfide bridge formation is supposed 
to be a rare event. These disulfide bridges prove to be crucial for scFv functionality. 
In contrast to intracellular expression, low scFv protein levels were obtained in transgenic 
tobacco carrying the anti-cutinase scFv gene designed for secretion (see: Chapter 3). 
Chapter 6 describes the intracellular accumulation and degradation of scFv fragments during 
transit through the secretory pathway. Elements in the scFv fragments that may destabilize 
the protein, like the linker peptide and the C-terminus are modified in various ways to 
improve secretion levels. Also, it is determined whether the scFv secretion can be improved 
by adding an extra domain, responsible for multimerization. Addition of a camel hinge 
combined with an IgM CH4 domain indeed improve secretion levels. 
CHAPTER 2 
Coordinate expression of antibody subunit genes yields high 
levels of functional antibodies in roots of transgenic tobacco. 
This chapter was published in Plant Molecular Biology 26 (1994), 1701-1710, by the authors FA. van 
Engelen, A. Schouten, J.W. Molthoff, J. Roosien, J. Salinas, W.G. Dirkse, A. Schots, J. Bakker, F.J. 
Gommers, MA. Jongsma, D.Bosch and W.J. Stiekema. 
Abstract 
To explore the feasibility of employing antibodies to obtain disease resistance against 
plant root pathogens, we have studied the expression of genes encoding antibodies 
in roots of transgenic plants. A model monoclonal antibody was used that binds to a 
fungal cutinase. Heavy and light chain cDNAs were amplified by PCR, fused to a 
signal sequence for secretion and cloned behind CaMV 35S and TR2' promoters in a 
single T-DNA. The chimeric genes were cloned both in tandem and in a divergent 
orientation. The roots of tobacco plants transformed with these constructs produced 
antibodies that were able to bind antigen in an ELISA. Immunoblotting showed 
assembly to a full-size antibody. In addition, a F(ab')2-like fragment was observed, 
which is probably formed by proteolytic processing. Both antibody species were 
properly targeted to the apoplast, but the full-size antibody was partially retained by 
the wall of suspension cells. The construct with divergent promoters showed a better 
performance than the construct with promoters in tandem. It directed the 
accumulation of functional antibodies to a maximum of 1.1% of total soluble protein, 
with half of the plants having levels higher than 0.35%. The high efficiency of this 
construct probably results from coordinated and balanced expression of light and 
heavy chain genes, as evidenced by RNA blot hybridization. 
Introduction 
Since its initial demonstration (Hiatt et a/., 1989; During et a/., 1990), the expression of 
functional antibodies in transgenic plants has been considered highly promising for plant 
disease control and manipulation of metabolic pathways (Hiatt, 1990). This promise has 
been redeemed with reports of protection against virus infection (Tavladoraki et a/., 1993) 
and aberrant phytochrome-dependent germination (Owen et a/., 1992) obtained through 
expression of antibody derivatives against viral coat protein or phytochrome, respectively. 
Antibodies are heteromultimeric proteins composed of two heavy chains and two light chains 
connected by disulfide bridges. Thus, the production of functional antibodies requires the 
proper oligomerization of subunits in addition to gene expression. To promote antibody 
assembly and reduce the size of the molecule, antibodies have been engineered to form a 
single-chain Fv, in which the variable, antigen-binding domains of the light and the heavy 
chain are connected by a linker polypeptide (Bird and Walker, 1991). However, the affinity of 
the single-chain Fv for the antigen is often lower than the parent antibody (Bird and Walker, 
1991; Tavladoraki era/., 1993), which may be a serious drawback in applications requiring a 
high affinity. 
In case of expression of complete antibodies, the synthesis of light and heavy chains should 
be balanced for antibody assembly. To obtain transgenic plants producing antibodies, light 
and heavy chain genes have initially been expressed in separate plants, which were 
subsequently crossed (Hiatt ef a/., 1989). However, this procedure is time-consuming. Co-
transformation is faster than crossing, but suffers from a large proportion of low antibody 
expressors (De Neve et a/., 1993). This may be due to independent variability of the 
expression of light and heavy chain genes. In addition, in both these approaches 
segregation will occur in the progeny if the two T-DNAs are not linked. Introduction of light 
and heavy chain genes on a single T-DNA circumvents the aforementioned disadvantages, 
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but puts additional demands on the promoter and terminator sequences employed. These 
sequences should preferably be different to avoid a potential lack of coordination of 
expression of the two transgenes (An, 1986; Dean ef a/., 1988) or silencing of transgene 
expression in the progeny (Assaad ef a/., 1993). 
Because we aim for resistance against root pathogens, our research has been focussed on 
the expression of antibodies in plant roots, which have hardly been studied for antibody 
expression so far. On the basis of the above considerations, we have chosen to transfer the 
antibody genes on a single T-DNA under the control of the cauliflower mosaic virus 35S 
promoter (heavy chain) and the TR2' promoter (light chain), which both have a high activity 
in roots (Benfey ef a/., 1989; Langridge ef a/., 1989; Teeri ef a/., 1989). As a model, we have 
employed the monoclonal antibody 21C5 that was raised against a cutinase produced by the 
fungus Botrytis cinerea (Salinas, 1992). The analysis reported here shows coordinate and 
balanced expression of light and heavy chain genes giving rise to a large proportion of 
tobacco plants with a high level of antibodies (up to 1.1% of total soluble protein) in the 
roots. These antibodies are targeted to the apoplast and bind to the target enzyme. Thus, we 
have created an efficient system for high-level expression of antibodies in roots that has the 
potential to interfere with pathogenesis. 
Materials and methods 
cDNA amplification and vector construction 
Messenger-RNA was isolated from the 21C5 hybridoma (Salinas, 1992) by 
oligo(dT)cellulose chromatography using the QuickPrep Micro mRNA Purification Kit from 
Pharmacia. First strand cDNA was synthesized using the First Strand cDNA Synthesis Kit 
from Pharmacia. The antibody cDNAs were amplified from this material using the following 
primers: light chain: 5'-GGTGTCGACGGTGATGTTGTGATGACCCAATCTCC-3'(VL) and 5'-CGT-
CAGATCTTTAACACTCATTCCTGTTGAAGCTC-3'(CL); heavy chain: 5'-GGTGTCGACTGTGAGG-
TCCAGCTGCAACAATCTG-3' (VH) and 5'-GAGGTTAACTTATTTACCAGGAGAGTGGGAGAGGCT-
CTT-3' (CH3). 0.5 (il of the first strand cDNA synthesis reaction was amplified with 12.5 pmol 
of each primer in 20 mM Tris pH 8.8, 10 mM KCL, 6 mM (NH4)2S04, 1.5 mM MgCI2, 0.1% 
Triton X-100, in a total volume of 50 \i\. After 5 min denaturation at 94°C and 3 min 
annealing at 50°C 1.25 units Pfu DNA polymerase (Stratagene) was added, followed by 34 
cycles consisting of 3 min 72°C, 1 min 94°C and 2 min 50°C. A polymerisation step of 5 min 
72°C concluded the amplification. PCR products of the correct size were excised from 
agarose gels and purified by adsorption to Prep-a-Gene (Bio-Rad) glass beads. The 
fragment ends were made blunt with Klenow DNA polymerase (Sambrook ef a/., 1989) and 
cloned into the Smal site of pBluescript SK+ (Stratagene). After sequence analysis (see 
below) the inserts were cut from the plasmids with Sa/I/Hpal (heavy chain) or Sa/l/BamHI 
(light chain). An DNA fragment encoding a signal peptide for secretion was constructed by 
annealing and ligation of four oligonucleotides. This sequence was derived form the signal 
sequence of the kappa light chain of antibody CEA 66-E3 (Kabat ef a/., 1991) by changing 
the codons at positions -3 and -2 from GTTGAA to GTCGAC, which converted the glutamic 
acid residue at -2 to aspartic acid. This Ncol/Sall fragment was ligated to the heavy chain 
and cloned between the CaMV 35S promoter with a duplicated enhancer (Kay ef a/., 1987) 
and the nopaline synthase (NOS) terminator of the binary vector pCP031. This vector is 
identical to the previously described pCP05 vector (Florack ef a/., 1994) except for an 
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additional A/col site downstream of the 35S promoter. To introduce the light chain cDNA into 
this vector, a HindlH fragment containing the TR 2'-1' dual promoter and 35S terminator was 
first cloned into the /-//ndlll site of pBluescript (Stratagene) from which the BamHI site had 
been deleted. This plasmid was cut between the TR2' promoter and 35S terminator with 
A/col and BamHI and ligated to the light chain fragment and signal sequence. Then the 
/-//ndlll fragment was transferred to pCP031. 
DNA sequences were determined on an Applied Biosystems 370A automated DNA 
sequencer by PCR cycle dideoxy chain termination sequencing using fluorescently labeled 
dideoxynucleotides. The obtained sequences were analyzed with the gcg DNA sequence 
analysis software package (Devereux et a/., 1984). The nucleotide sequence data were 
deposited in the GSDB, EMBL, Genbank and DDBJ databases under the accession 
numbers L35037 and L35138. 
Plant transformation 
Constructs were first transferred to E. coli strain S17.1 and subsequently to Agrobacterium 
tumefaciens strain GV3101 (pMP90RK) (Koncz and Schell, 1986) by biparental mating. 
Tobacco (Nicotiana tabacum cv. Samsun NN) leaf discs were transformed essentially 
according to the method of Horsch et al. (Horsch et al., 1985). Minor modifications included 
incubation of the leaf discs with Agrobacterium culture for three days in liquid medium 
containing 1 mg/l NAA and 0.2 mg/l BAP and the use of cefotaxime (Duchefa, Haarlem, The 
Netherlands) to control bacterial growth after transformation. Stably transformed plants were 
maintained under sterile conditions on MS agar medium (Duchefa) containing 3% (w/v) 
sucrose and subsequently transferred to soil in the greenhouse. For protein and RNA 
analyses, plants were dissected, frozen in liquid nitrogen and stored at -80°C. Roots taken 
from agar were rinsed with water to remove most of the attached agar prior to freezing. 
Protein extraction and analysis 
Plant tissues were ground with mortar and pestle in liquid nitrogen. The fine powder was 
added to an equal volume of 2xPBS (phosphate-buffered saline) and thawed. After mixing, 
samples were centrifuged twice to remove insoluble material. Protein levels were determined 
with the Coomassie Brilliant Blue assay from Bio-Rad, using bovine serum albumin (fraction 
V, Sigma) as standard. For immunoblot analysis proteins were separated by standard SDS-
PAGE and blotted onto nitrocellulose membranes (Sambrook et al., 1989). These were 
blocked with PBS containing 4% (w/v) nonfat dry milk and 0.2% (v/v) tween-20, incubated 
with sheep-anti-mouse IgG or rat-anti-mouse IgG antibodies (Jackson ImmunoResearch 
Laboratories) conjugated to alkaline phosphatase and developed with NBT and BCIP as 
substrates (Sambrook et al., 1989). 
To assay for antigen binding, microtiter plates were coated overnight with 250 ng per well of 
a partially purified cutinase preparation in 50 mM sodium carbonate, pH 9.6 at 4°C. Wells 
were washed twice with PBS, blocked for four hours at room temperature with 5% (w/v) 
nonfat dry milk in PBS and washed twice with PBS containing 1% (w/v) nonfat dry milk 
(PBSM). Either one to five (ig of plant proteins or a known concentration range of 21C5 
standard monoclonal antibody, both in PBSM, were added to the wells and incubated 
overnight. The plates were washed four times with PBSM. To determine the antigen binding 
capacity of full-size and processed antibodies qualitatively the wells were subsequently 
washed with PBS, eluted with SDS-PAGE sample buffer and analyzed by immunoblotting. 
Alternatively, for quantitative ELISA, wells were incubated for two hours with alkaline 
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phosphatase-conjugated sheep-anti-mouse IgG antibodies (F(ab')2-specific, Jackson 
ImmunoResearch Laboratories). After four washes with PBSM and two with PBS, the plates 
were developed with 0.75 mg/ml 4-nitrophenylphosphate in 100 mM Tris-HCI pH 9.5, 100 
mM NaCI, 5 mM MgCI2. 
Protoplast and cell suspension culture methods 
Prior to plant transformation, constructs were tested by transient expression in tobacco 
(Nicotiana tabacum cv. Samsun NN) leaf protoplasts using polyethylene glycol as described 
by Denecke et al. (1989). The same protoplast isolation and culture method was employed 
to study secretion. Proteins secreted into the culture medium in these experiments were 
precipitated with ethanol. Protein pellets and protoplasts were dissolved in SDS-PAGE 
sample buffer. A cell suspension culture was initiated from transgenic stem slices. Callus 
formation was induced on MS agar plates containing 3% sucrose, 2 mg/l IAA, 0.5 mg/l 
kinetin and 2 g/l casein hydrolysate. Friable callus was transferred to liquid MS medium 
containing 2 mg/l 2,4-D, 0.1 mg/l kinetin and 1 g/l casein hydrolysate and subcultured every 
10 to 14 days. Cells were separated from culture medium by sieving, washed with fresh 
culture medium and ground in protein sample buffer. Culture medium was filtered through a 
0.22 urn filter and treated as described above for protoplast culture medium. 
RNA and DNA isolation, blotting and hybridization 
RNA was isolated as described by De Vries et al. (1991). Five ng of each RNA preparation 
was denatured with DMSO and glyoxal (Sambrook et al., 1989), separated on a 1% agarose 
gel, blotted onto Gene Screen Plus membrane (New England Nuclear) and hybridized to 
32P-labeled DNA probes in formamide-containing buffer at 42 °C according to the 
manufacturer's instructions. The stringency of the final washing was 2xSSC at 65°C. The 
blot was successively hybridized with the complete light chain cDNA, with a subclone of the 
heavy chain cDNA comprising the variable domain and the first constant domain and with an 
rDNA probe. Probes were labeled with [a-32P]-dATP by random primed labeling (U.S. 
Biochemical corp.). 
Results 
Cloning of21C5 antibody cDNA and transformation of tobacco 
The 21C5 monoclonal antibody employed in this study is an lgG1, kappa isotype antibody 
that binds to a cutinase produced by Botrytis cinerea (Salinas, 1992). The cDNA sequences 
encoding the heavy and light chain of 21C5 were amplified using cDNA prepared from total 
21C5 hybridoma mRNA. To increase the fidelity of 5'-end amplification, eight different 
primers based on the 5'-end of variable domain sequences of both heavy and light chains, 
as found in the Kabat database (Kabat ef al., 1991), were tried. The PCR reaction with the 
highest yield was considered to contain the best matching primer set and the product was 
used for cloning and sequence analysis. Comparison of the sequences obtained with 
sequences in an immunoglobulin database (Kabat et al., 1991) confirmed that the heavy 
chain was an lgG1 and the light chain was of the kappa type. The 21C5 cDNAs were fused 
to a fragment encoding a slightly modified antibody signal sequence (Fig. 1A; Kabat ef al., 
1991) and cloned into the plant expression vector pCP031 (Fig. 1B). In the resulting 
construct a 35S promoter with duplicated enhancer (Kay et al., 1987) drives the expression 
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Fig 1. A. Secretory signal sequence cloned in front of heavy and light chain cDNA. Restriction enzyme 
cleavage sites are shown above the sequence and the amino acid translation below the sequence. 
B. T-DNA constructs. LB, left border; RB, right border; L, light chain gene; H, heavy chain gene; S, 
secretory signal sequence; NPTII, neomycin phosphotransferase gene; Pnos, nopaline synthase 
promoter; Tg4, T-DNA gene 4 terminator; P2', T-DNA gene 2 promoter; T35S, CaMV 35S terminator; 
P35S, CaMV 35S promoter with doubled enhancer; Tnos, nopaline synthase terminator; CbR, 
carbenicillin resistance gene. The T-DNA gene 1 promoter (PV) and the octopine synthase terminator 
(Toes) were not used in this study. 
of the heavy chain (type "M" construct), while the light chain expression is under the control 
of the TR2' promoter. The cloning procedure generated two different orientations of the 
TR2'-light chain cassette with respect to the 35S-heavy chain cassette (Fig. 1B). In the MA 
construct the distance between the transcription initiation sites of the 35S and the TR2' 
promoter was 1730 bp and the genes were transcribed in tandem. In the MB construct this 
distance was 1340 bp and transcription was divergent. ELISA analysis of transient 
expression products from tobacco protoplasts confirmed that the heavy and light chains 
encoded by these constructs could form functional antibodies (data not shown). Both 
constructs were transferred to tobacco by Agrobacterium tumefaciens-med\aled leaf-disc 
transformation. 
21C5 antibodies are functional and partly processed in tobacco roots 
The production of antibodies in roots of transgenic tobacco plants was analyzed by 
immunoblotting of root extracts from a randomly selected set of axenically grown plants. 
Under non-reducing conditions, a protein of the size of a fully assembled antibody could be 
specifically detected in most samples with an anti-mouse-IgG secondary antibody (Fig. 2A). 
In addition, another prominent protein band with an estimated size of about 110kDa and two 
other, faint bands were visible on the blot. Upon reduction with DTT none of these bands 
could be detected (results not shown), showing intermolecular disulfide bonds to be present 
in these proteins. 
To identify the nature of the 110 kDa protein, immunoblotting was performed with secondary 
antibodies that recognize different domains of immunoglobulins (Fig. 2B). Whereas the band 
running at the position of a full-size antibody reacted with antisera specific for either light 
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Fig 2. A. Immunoblot of root extracts from different MA and MB plants, developed with an anti-mouse 
IgG secondary antibody. The lane marked "Samsun" is from an untransformed control plant. "IgG" is 
an immunoglobulin G standard purified from hybridoma culture supernatant. "Mr" is a prestained 
molecular weight marker set. B. Immunoreactivity of antibodies in a root extract (lanes marked "root") 
or a standard hybridoma IgG (lanes marked "standard") with secondary antisera specific for light chain 
(L), heavy chain (H), Fab fragment (Fab) or Fc fragment (Fc). 
chain, heavy chain, Fab or Fc fragments, the 110 kDa protein could be detected with all 
antisera except for the anti-Fc reagent. Thus, it is most likely that the 110 kDa protein has a 
structure similar to an F(ab')2 fragment, a dimer of two Fab fragments held together by 
disulfide bridges. 
To determine if both these forms of plant-produced antibodies were functional, the binding of 
the antibodies to immobilized cutinase was assayed (Fig. 3). This revealed that both the full-
size and the 110 kDa antibody specifically bind to the cutinase antigen, which further 
supports the F(abVNke structure of the 110 kDa fragment. 
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Fig 3. Binding of antibodies from a transgenic plant to cutinase. Immunoblot of proteins eluted from 
wells coated with (+) or without (-) cutinase after incubation with root extract from untransformed 
control plant ("Samsun"), 21C5 antibody from hybridoma culture supernatant ("hybridoma") or root 
extract from plant transformed with MB construct ("MB57"). The right lane shows the antibodies 
present in the MB57 extract before addition to the wells. 
Secretion of antibodies 
To study secretion of antibodies to the apoplast, we isolated protoplasts from leaves of an 
MB plant with a high antibody expression. The protoplasts were cultured in fresh medium for 
0.2 to 20 hours and the culture medium and cells were analyzed by immunoblotting (Fig. 4, 
left panel). Antibodies accumulated in the culture medium with time, while in the cells, of 
which more than 90% remained viable, antibodies were not detectable at any time point. 
Thus, the antibodies are secreted by the plant cells. Furthermore, mainly full-size (150 kDa) 
antibodies were detected, suggesting that the formation of the 110 kDa F(ab')2-Nke fragment 
in planta occurs only after secretion and is most likely due to proteolytic processing in the 
apoplast. 
The fate of the antibodies after secretion was investigated in a cell suspension culture of the 
same plant (Fig. 4, right panel). Only the 150 kDa full-size antibody was associated with the 
cells in this culture, whereas both the 150 kDa antibody and the F(ab')2-like fragment were 
observed in the culture medium. This suggests that the 110 kDa F(ab')2-like fragment can 
freely diffuse through the cell walls of suspension cells, while the full-size antibody is partially 
retained by these walls. 
Promoter configuration affects expression level 
To compare the efficacy of the two constructs used, the level of functional antibodies was 
determined in root extracts by ELISA. Since different root extracts contained full-size and 
F(ab')2-like antibody molecules in different ratios (Fig. 2a), expression levels could only be 
properly quantified with Fab-specific secondary antibodies. The data obtained are 
summarized in Figure 5 and Table 1. They show functional antibody expression for both 
constructs, the highest levels being 0.6% and 1.1% of total soluble protein for the MA and 
MB constructs, respectively. The between-transformant variability of expression levels was 
large, a phenomenon commonly observed with primary transgenic plants. Because the MB 
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Fig 4. Secretion of antibodies by plant cells. Left panel. Immunoblot detection of antibodies in total 
cellular or culture medium proteins from a transgenic protoplast culture grown for 0.2, 2, 6 or 20 hours, 
as indicated on top of the lanes. Right panel. Immunoblot detection of antibodies in total cellular or 
culture medium from a transgenic cell suspension culture grown for four days. 
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Fig 5. Frequency distribution of antibody expression level in roots of MA and MB primary transgenic 
plants. The expression level is given as percentage of total soluble root protein. 
population was not normally distributed, the non-parametric Wilcoxon-Mann-Whitney test 
was used to evaluate the differences between the populations (Neave and Worthington, 
1988). This demonstrated that the MB construct gave significantly higher expression levels 
than the MA construct. Comparison of the mean values suggested that the difference was 2-
fold. However, in the case of non-normality the significance of means is uncertain and 
median values are more informative (Nap et a/., 1993). The medians indicated a 1.5-fold 
17 
higher expression for the MB construct. The difference between the two constructs was 
further underlined by the fact that 35% of the MB plants showed an expression level above 
0.6%, while this figure was 0% for the MA plants. 
Stems, leaves and flowers from plants with a high antibody expression in roots were also 
found to contain antibodies, with levels ranging from 0.05% to 0.4% (data not shown). 
Table 1. Expression level statistics. 
number of plants 
mean 
highest 
median 
MA 
22 
0.24% 
0.58% 
0.24%* 
MB 
50 
0.45% 
1.1% 
0.36%* 
' significantly different (p < 0.0006) according to Wilcoxon-
Mann-Whitney test 
Coordinated and balanced expression of heavy and light chain genes 
The expression levels of two genes on a single T-DNA have been found to exhibit 
independent between-transformant variability in a number of cases (An, 1986; Jones ef a/., 
1987; Dean era/., 1988; Peach and Velten, 1991). In addition, the use of different promoters 
may lead to unequal expression of these two genes. In the case of antibodies, unbalanced 
expression would be highly undesirable, since functional antibodies will only be produced to 
high levels when expression of both heavy and light chain genes is high. To evaluate the 
behaviour of our expression system in this respect, we determined the relative expression 
levels of light and heavy chain genes in roots by RNA blot hybridization. Plants from three 
different expression categories, low (0.005%-0.01%), medium (0.05%-0.1%) and high (0.5%-
<-? low medium high 
Ribosomal 
Heavy 
m H l l i Light 
Fig 6. RNA gel blots containing total RNA from plants with a low, medium or high level of antibodies 
(see text) hybridized with probes specific for ribosomal RNA (upper panel), heavy chain (middle panel) 
or light chain (lower panel) sequences. In the rightmost lane an amount of DNA encoding the mature 
heavy or light chain was applied corresponding to 0.1% of mRNA. In the leftmost lane RNA was 
applied from a plant transformed with an empty vector. 
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1%), were chosen for this analysis. This experiment showed that the expression of light and 
heavy chain genes covaries between different independent transformants (Fig. 6). 
Comparison of the signal intensities of the root mRNA bands with the intensity of 
hybridization to a known amount of light chain or heavy chain cDNA revealed that the 
absolute heavy and light chain mRNA levels in individual transformants were similar. 
Furthermore, a correlation was observed between the amount of mRNA and the level of 
assembled antibody as determined by ELISA. Overall, the construct employed directs both 
coordinate and balanced expression of antibody subunit genes, explaining the large 
proportion of plants accumulating a high level of assembled, functional antibody in roots 
(Table 1). 
Discussion 
Antibody-mediated inactivation of antigens provides new possibilities for resistance breeding 
in plants. This was recently demonstrated by the inhibition of AMCV infection by expression 
of an scFv antibody in the leaves of Nicotiana benthamiana (Teeri ef a/., 1989). In this paper 
we describe an efficient transformation vector that directs high level expression of functional 
antibodies in roots of transgenic tobacco. Controlled by the CaMV 35S and TR2'promoters 
on a single T-DNA, expression of the heavy and light chain genes is coordinated and 
balanced with this construct, giving rise to expression levels exceeding 0.35% of total 
soluble root protein in more than half of the transgenic plants obtained. Obviously, this 
expression system could be employed for the simultaneous high level expression of other 
proteins in roots of transgenic plants. 
Transgene expression level variability between independent transformants is commonly 
observed in plant transformation experiments. When two transgenes have to be expressed 
simultaneously, independent variability of these genes may be limited by transferring them 
on one T-DNA. However, from a number of studies it has become clear that even this 
approach does not warrant concurrent expression of the two genes (An, 1986; Jones ef a/., 
1987; Dean ef a/., 1988; Gidoni ef a/., 1988; Peach and Velten, 1991). In one study the 
expression from two different and two identical promoters was directly compared in the same 
T-DNA background (Dean ef a/., 1988). In this case coordinated expression was only 
observed when different promoters were used. We used the 35S and TR2' promoters to 
direct the expression of the heavy and light chain, respectively, and observed covariation of 
light and heavy chain mRNA levels, which is in line with those observations. In other studies, 
however, the use of different promoters was not sufficient to achieve coordinated expression 
(Jones ef a/., 1987; Peach and Velten, 1991). 
In addition to covariation, the absolute expression levels of light and heavy chain genes must 
be similar and the subunits must be produced in the same cell types to achieve a high level 
of assembled antibody. The combination of 35S and TR2' promoters seemed particularly 
useful in this respect, since these promoters show a similar tissue-specific pattern and level 
of reporter gene expression in roots (Benfey ef a/., 1989; Langridge et at., 1989; Leung ef a/., 
1991; Teeri ef a/., 1989). The high antibody expression we observe in roots demonstrates 
that the spatial expression patterns of these promoters indeed coincide. 
We have shown that construct MB with divergent promoters has a better performance than 
construct MA with promoters in tandem. It could be argued that this difference is due to 
different susceptibility of the two constructs to influences of neighbouring plant DNA (Breyne 
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et a/., 1992). However, a similar difference was observed in transient expression assays in 
protoplasts (data not shown), which do not involve integration in the plant genome and, 
therefore, cannot be susceptible to position effects. Therefore, we consider it more likely that 
the effect is caused by the enhancer action that has been described for the doubled 35S 
promoter (Kay ef a/., 1987). This enhancer activity is influenced by distance, orientation and 
up- or downstream location (Odell ef a/., 1988). In the MB construct the 35S enhancer is 400 
base pairs closer to the TR2' promoter, located upstream (downstream in MA) in a divergent 
orientation (tandem in MA). This configuration could stimulate transcription from the TR2' 
promoter more than the A-configuration, thus significantly increasing the amount of 
antibodies produced. 
The proper targeting of antibodies will be crucial for their effectiveness against pathogens. 
Therefore, we studied the secretion of antibodies in transgenic plants. Murine secretory 
signal sequences appear to be well-suited to direct antibodies to the apoplast of plant cells. 
This was previously shown (Hein ef a/., 1991) and is confirmed here by the accumulation of 
fully assembled immunoglobulins in protoplast culture medium. Once in the apoplast, 
antibodies appear to be subject to proteolytic processing, as indicated by the occurrence of a 
110 kDa F(ab')2-like antibody fragment in a cell suspension and in root tissue. Similar results 
were obtained by other authors (Hiatt ef a/., 1989; De Neve ef a/., 1993), but not further 
investigated. If the formation of this fragment is indeed due to proteolytic cleavage, it is not 
surprising that cleavage occurs in the so-called "hinge" region between the Fab and Fc 
domains, since this is a highly flexible and accessible domain that is cleaved by the 
proteases pepsin and papain as well (Amzel and Poljak, 1979). The formation of 110 kDa 
antibody fragments apparently influences the fate of antibodies after secretion: full-size 
antibodies are somewhat retained by the walls of suspension cells, but the F(ab')2-like 
fragments can freely diffuse. However, since the cell wall porosity of suspension cells and 
cells in planta may differ, care must be taken in extrapolating these results to cells in intact 
plant tissues. 
Although antibodies are susceptible to proteolytic processing, the products are functional 
and stable in plant roots, as suggested by the high level of functional antibody accumulation. 
This provides a basis for the application of antibody technology in resistance breeding. 
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CHAPTER 3 
The C-terminal KDEL sequence increases the expression level 
of a single chain antibody designed to be targeted to both the 
cytosol and the secretory pathway in transgenic tobacco 
This chapter was published in Plant Molecular Biology 30 (1996), 781-793, by the authors A. 
Schouten, J. Roosien, FA. van Engelen, G A M . de Jong, A.W.M. Borst-Vrenssen, J.F. Zilverentant, 
D. Bosch, W.J. Stiekema, F.J. Gommers, A. Schots and J. Bakker. 
Abstract 
The effects of subcellular localization on single chain antibody (scFv) expression 
levels in transgenic tobacco was evaluated using an scFv construct of a model 
antibody possessing different targeting signals. For translocation into the secretory 
pathway a secretory signal sequence preceded the scFv gene (scFv-S). For cytosolic 
expression the scFv antibody gene lacked such a signal sequence (scFv-C). Also, 
both constructs were provided with the endoplasmic reticulum (ER) retention signal 
KDEL (scFv-SK and scFv-CK, respectively). The expression of the different scFv 
constructs in transgenic tobacco plants was controlled by a CaMV 35S promoter with 
double enhancer. The scFv-S and ScFv-SK antibody genes reached expression levels 
of 0.01% and 1% of the total soluble protein, respectively. Surprisingly, scFv-CK 
transformants showed considerable expression of up to 0.2% whereas scFv-C 
transformants did not show any accumulation of the scFv antibody. The differences in 
protein expression levels could not be explained by the steady-state levels of the 
mRNAs. 
Transient expression assays with leaf protoplasts confirmed these expression levels 
observed in transgenic plants, although the expression level of the scFv-S construct 
was higher. Furthermore, these assays showed that both the secretory signal and the 
ER retention signal were recognized in the plant cells. The scFv-CK protein was 
located intracellularly, presumably in the cytosol. The increase in scFv protein 
stability in the presence of the KDEL retention signal is discussed. 
Introduction 
Recent advances in antibody engineering offer various perspectives to endow plants with 
new properties. Antibodies and antibody fragments can be used to engineer disease 
resistance, to alter or design metabolic routes with catalytic antibodies, and to study plant 
growth and development by antisense-like approaches (Schots ef al., 1992). For these 
applications it is crucial to have functional antibodies located in the proper subcellular 
compartment. This can be accomplished by providing the antibody with suitable targeting 
and sorting signals (Biocca et al., 1990). 
The engineering of antibodies is facilitated by their domain structure. The domains carrying 
the antigen-binding loops can be manipulated in different ways to create various biologically 
active fragments (Winter and Milstein, 1991). An interesting and valuable antibody fragment 
is the single chain antibody (scFv), in which the variable domains of light and heavy chain 
are connected by a flexible peptide linker. Through expression of scFvs, several problems 
inherent to the post translational processing of full size antibodies, like assembly of the four 
subunits, formation of intermolecular disulfide bonds, and glycosylation, can be 
circumvented (Hiatt et al., 1989; Hein et al., 1991). 
Single chain antibodies have been successfully expressed in plants. Constitutive cytosolic 
expression of an scFv antibody in tobacco mediated resistance against artichoke mottled 
crinkle virus (Tavladoraki ef al., 1993). Owen et al. (1992) and Firek ef al. (1993) reported 
cytosolic expression and secretion of an anti-phytochrome scFv antibody. 
Cytosolic expression of functional scFv antibodies in plants and other eukaryotes (Biocca ef 
al., 1993 & 1994; Werge ef al., 1994) is remarkable. The two intramolecular disulphide 
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bridges (one in VH and one in VL) which are assumed to be necessary for folding into a 
stable and functional scFv (Glochkshuber et al., 1992) are expected not to be formed in the 
reducing environment of the cytosol because of the absence of the enzyme protein 
disulphide isomerase (Freedman, 1989), which catalyzes the formation of such bonds. 
Despite the reported successes, intracellular expression of scFv antibodies in plants may not 
be that straightforward. Owen et al. (1992) reported that only after screening more than 100 
transgenic plants, transformed with 'leaderless' scFv constructs, a plant showing an 
expression level of 0.1% of the total soluble protein fraction was obtained, while 
transformants expressing the secretory version of the scFv gene produced ten times more 
scFv protein (Firek et al., 1993). 
The objective of our study was to compare functional expression of scFv proteins in 
transgenic tobacco plants if targeted to different subcellular compartments. The scFv gene 
was derived from the heavy and light chain genes of an antibody raised against a cutinase 
(21C5) of Botrytis cinerea (Salinas, 1992). Both with and without signal peptide the 
expression of this scFv gene greatly improved when the C-terminal endoplasmic reticulum 
(ER) retention signal peptide, KDEL (Pelham, 1989) was added. Possible causes for this 
strong enhancement of expression and the implications for antibody expression in plants are 
discussed. 
Materials and methods 
Bacterial vectors and strains. 
For cloning of the scFv inserts the bacterial expression vector pHEN1 (Hoogenboom et al., 
1991) was modified by substituting the multiple cloning site and deleting the g3p gene 
(pNEM5). Addition of the KDEL (Lys-Asp-Glu-Leu) coding sequence behind the c-myc tag 
sequence resulted in pNEM5K. The Escherichia coli strains DH5oc and TG1 were used for 
routine cloning and scFv protein expression, respectively. 
Plant vectors. 
The vectors pCP033, pCP033T and pCP035 were used for plant transformations and 
transient assays. These vectors are closely related to pCP05 (Florack et al., 1994) and only 
differ between the T-DNA borders (Fig. 1). The vector pCP033 contains a promoter-
terminator cassette composed of a truncated cauliflower mosaic virus (CaMV) Cabb B-D 
35S promoter (-343/-1) with duplicated enhancer sequence (-343/-90) together with the 38 
base pair alfalfa mosaic virus (AIMV) RNA4 untranslated leader (Sijmons et al., 1990), a 
polylinker with unique Wcol, Ssfl, Smal, and BglW cloning sites, and the nopaline synthase 
terminator, respectively. Furthermore, the ft-lactamase gene for prokaryotic selection 
(ampicillin in E. coli, carbenicillin in Agrobacterium tumefaciens) and the APH(3')II gene 
under the control of the nopaline synthase promoter for kanamycin resistance selection at 
the plant level were located between the T-DNA borders. pCP033T contains a c-myc tag 
sequence (Munro and Pelham, 1986) between the multiple cloning site and nopaline 
synthase terminator. pCP035 contains a mouse kappa light chain signal sequence as A/col-
Sa/I fragment between the 35S promoter and the Kpnl site. The mouse signal sequence for 
ER translocation is derived from the kappa light chain, CEA 66E3 (Kabat et al., 1987, van 
Engelen et al., 1994) and was chosen because minor changes could create a Sail site, 
which is rare in antibody genes (Kabat et al., 1987; Chaudhary et al., 1990). The signal 
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sequence was made synthetically with an Nco\ site at the 5'-end (triplet position -24) and a 
Sa/I site at the 3'-end (triplet position -3). 
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Fig. 1. T-DNA of pCP033, pCP033T and pCP035. LB, left border; RB, right border; A, alfalfa 
untranslated leader; S, secretory signal sequence; T, c-myc tag; NPTII, neomycin phosphotransferase 
gene; Pnos, nopaline synthase promoer; Tg4, T-DNA gene 4 terminator; P35S, CaMV 35S promoter 
with doubled enhancer; Tnos, nopaline synthase terminator; CbR, carbenicillin resistance gene. 
Isolation, amplification, and cloning of antibody 21C5 variable domains. 
Isolation of poly(A*) RNA from 21C5 hybridoma cells (Salinas, 1992) was performed by 
using the QuickPrep Micro mRNA purification kit (Pharmacia). First strand cDNA was 
synthesized using the Pharmacia First Strand cDNA Kit. The variable heavy (VH) and light 
domains (VL) of the 21C5 antibody were amplified through PCR using the following primers: 
5'-end primer (H53) 5'-GGTCTCGAGTGTGAGGTCCAGCTGCAACAATCTG-3' and 3'-end primer 
(VH33) 5'-ATGCGTTAACCCCGGGTGTTGTTTTGGCTGMRGAGACDGTGAS-3' for the heavy 
chain, and 5'-end primer (L5d) 5'-GGTGTCGACGGTGATGTTKTGATGACCCAAA-3' and 3'-end 
primer (VK1) 5'-GGCTCGAGTTTGGATTCGGAGCCGGATCCTGAGGATTTACCCTCCCGTTTTAT-
TTCCAGSTTGGTSCCYCC-3' for the light chain. Primers L5d and H53 contained a Sa/I and 
Xho\ site at their 5'-end, respectively. Primer VH33 was chosen such that, after PCR 
amplification and digestion with Smal, the VH domain still contained the initial five triplets of 
the CH1 domain, encoding Ala-Lys-Thr-Thr-Pro. The primer VK1 carried an Xho\ site at the 
5'-end. Primer VK1 also encodes a sequence for a synthetic linker peptide, adapted with 
some modifications from Chaudhary et al. (1990). For amplification first strand cDNA was 
denatured at 94°C for 4 minutes and subjected to 35 cycles of PCR using Vent DNA 
Polymerase (New England Biolabs). Each PCR cycle consisted of denaturation at 94°C for 1 
min, annealing at 60°C for 2 min, and primer extension at 72°C for 3 min. The amplified 
fragments were purified from agarose gel, digested with the appropriate restriction enzymes, 
and ligated simultaneously into Sa/I/Smal digested pNEM5 and pNEM5K, resulting in the 
vectors pNEM-scFv and pNEM-scFv-K, respectively. 
The nucleotide sequences of the scFv inserts were verified by the dideoxy chain termination 
sequencing method (Sanger et al., 1977) on an A.L.F. DNA sequencer (Pharmacia). The 
sequence encoding the 21C5 scFv was subjected to computer analysis with the Wisconsin 
GCG software package (Devereux ef a/., 1984). From the derived protein sequence the 
molecular weight was calculated and the algorithm for predicting processing sites for 
eukaryotic signal sequences was used (von Heijne, 1986). 
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Bacterial expression ofscFv cassettes. 
E. coli strain HB 2151 was transformed with pNEM-scFv and pNEM-scFv-K. For the scFv 
expression assay 5 ml 2xTY, 1% (w/v) glucose and 100 ng/ml ampicillin was inoculated with 
a colony containing the appropriate plasmid, and incubated at 30°C for 16 hours. Fresh 
medium containing 2xTY, 0.075% (w/v) glucose and 1 ng/ml ampicillin was inoculated with 
1/50 volume of the bacterial culture and incubated at 30°C for 3 hours. Then the scFv 
synthesis was induced by adding isopropyl (3-D-thiogalactoside (IPTG) to a final 
concentration of 1mM and the incubation was continued for another 4 hours. The 
periplasmic proteins were extracted by osmotic shock (Neu and Heppel, 1965). Borate buffer 
was added to the periplasmic fraction to a final concentration of 0.2 M sodium borate, pH 
8.0, and 0.16 M NaCI. The scFvs were purified by affinity chromatography with activated 
protein A Sepharose (Pharmacia) to which the anti c-myc tag 9E10 monoclonal antibody 
(Munro and Pelham, 1986) was covalently attached. 
Cloning in plant vectors and tobacco transformation. 
To generate constructs suitable for cloning in plant vectors without the signal sequence the 
pNEM-scFv and pNEM-scFv-K vectors were digested with A/col and the ends were filled in 
with Klenow. After digestion with HincU at the Sail site the fragments were purified and blunt 
end ligated resulting in the vectors pNEM-scFv-C and pNEM-scFv-CK, respectively. Thus, 
the A/col site was restored providing the ATG start codon in the proper reading frame. 
Furthermore, the ATG start codon was placed at position -3 of the mature scFv sequence. 
The constructs lacking the KDEL sequence were cloned as Sall/Smal (pNEM-scFv) or 
Nco\ISma\ (pNEM-scFv-C) fragments into the A/col/Smal digested plant vector pCP033T. 
For construction of the scFv-S the A/col/Sa/l signal sequence fragment was also included in 
the ligation mixture. The resulting vectors, pCPO-scFv-S and pCPO-scFv-C, had the single 
chain construct in frame with the c-myc tag sequence. The scFv-K and scFv-CK constructs 
were cloned as Sa/l/6c/l (pNEM-scFv-K) and Nco\IBcl\ (pNEM-scFv-CK) fragments and 
transferred to the SaMBglU digested pCP035 and NcoUBgM digested pCP033, respectively. 
The resulting vectors were designated as pCPO-scFv-SK and pCPO-scFv-CK. All vector-
scFv junctions were verified by sequencing. 
Tobacco transformation was conducted according to van Engelen ef al. (1994). 
Protoplasts. 
Transient expression assays in tobacco (N. tabacum cv. Samsun NN) leaf protoplasts were 
performed according to the polyethylene glycol procedure as described by Denecke ef al. 
(1989). The same protoplasts isolation and culture method was employed to study secretion 
and retention in transgenic plants. Protoplasts and culture medium were separated by 
centrifugation and analyzed by Western blotting experiments and ELISA. For Western 
analysis the proteins present in the culture medium were precipitated with 3 volumes of 
ethanol. Both protein pellet and protoplasts were dissolved in SDS-PAGE sample buffer 
(see: protein extraction and analysis). For ELISA the culture medium was diluted 1:1 with 
PBS-0.1% Tween-1% skimmed milk powder and 1 mM 4-(2-aminoethyl)-benzenesulfonyl 
fluoride hydrochloride (Pefabloc SC, Boehringer) and the protoplasts were lysed in the same 
buffer. All samples were further treated as described in protein extraction and analysis. 
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RNA extraction and analysis. 
For extracting total RNA from plant tissues the guanidine hydrochloride procedure of 
Logemann ef al. (1987) was used. The RNA concentration was measured 
spectrophotometrically and Northern analysis was carried out according to Sambrook et al. 
(1989). 
Briefly, 9 |ig RNA was separated on a 1.2% (w/v) agarose (Pharmacia) formaldehyde gel. As 
size marker 1 ng denatured 21C5 scFv DNA and 1 (xg of the 0.16-1.77 kb RNA ladder (Life 
Technologies) were used. After electrophoresis the gel was incubated twice for 15 minutes 
in DEPC treated double distilled water and the RNA was transferred to a Hybond-N+ 
membrane (Amersham) by vacuum blotting, using 20xSSC as transfer buffer, and cross-
linked to the membrane under UV light at 1.5 J/cm2. The blot was hybridized with [a-
32P]dATP-labeled probes at 65°C for 48 hours and further treated as described by Church 
and Gilbert (1984). The stringency of the final washing was 0.2xSSC at 65°C. The blot was 
first hybridized with a labeled scFv DNA fragment, isolated as Sall-Smal fragment from 
pNem-scFv. To establish the differences in the amount of total RNA the blot was hybridized 
with a ribosomal probe. To estimate the molecular sizes the blot was hybridized to labeled 
cDNA of the RNA ladder. All probes were obtained by random prime labeling (Feinberg and 
Fogelstein, 1983). 
Protein extraction and analysis. 
Proteins were extracted by grinding tobacco leaves in liquid nitrogen to a fine powder. The 
powder was transferred to an eppendorf tube and mixed 1:1 (w/v) with SDS-PAGE sample 
buffer, containing 61 mM Tris-HCI, pH 6.8, 2% (w/v) SDS, 12.5% (w/v) glycerol, 1 mM 
Pefabloc SC (Boehringer). Insoluble plant material was pelleted by centrifugation for 5 
minutes at 13,000 rpm. The protein concentration in the supernatant was determined using 
the BCA method (Smith et al., 1985). To the supernatant DTT and bromophenolblue were 
added to final concentrations of 40 mM and 0.008% (w/v), respectively, and the samples 
were boiled at 100°C for 5 minutes. For non-reducing gel electrophoresis DTT was omitted 
during sample preparation. Thirty ng of total protein was loaded on a 13% SDS-
polyacrylamide gel Laemmli, 1970) (Bio-Rad mini protean system). After electrophoresis the 
proteins were transferred to a PVDF membrane (Millipore) by electroblotting. For 
immunodetection the membranes were incubated with 1:1000 diluted 9E10 monoclonal 
antibody, followed by a 1:5000 diluted rat-anti-mouse alkaline phosphatase conjugate 
(Jackson Immuno Research). Alternatively a rabbit polyclonal anti-21C5 serum, precleared 
from antibodies reacting to the constant domains, was used in conjunction with a 1:2500 
diluted goat-anti-rabbit alkaline phosphate conjugate (Jackson Immuno Research). The blots 
were stained in 0.1 M ethanolamine-HCI pH 9.6, supplemented with 4 mM MgCI2, 5-bromo-
4chloro-3-indolyl phosphate (0.06 mg/ml) and nitro blue tetrazolium (0.1 mg/ml). The relative 
molecular weights of the proteins were estimated with pre-stained low range molecular 
weight markers (Bio-Rad). 
Purification of native scFv 21C5 antibody from plant extracts was carried out by polytron 
homogenization of 4 g tobacco leaves in 4 ml 0.2 M sodium borate, pH 8.0, containing 0.16 
M NaCI and 1mM Pefabloc SC (Boehringer), in the presence of 200 mg insoluble 
polyvinylpyrrolidone (Serva). The soluble protein fraction was isolated by centrifugation and 
filtered through a 0.45 (xm filter (Millipore). The scFvs were purified by affinity 
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SCFV-S DWMTQ== (VL) ==IKREGKSSGSGSESKLECEV== (VH) ==AAKTTPGRSE£KLISEEDLN 
SCFV-C DGDWMTQ== (VL) ==IKREGKSSGSGSESKLECEV== (VH) ==AAKTTPGRSEOKLISEEDLN 
SCFV-SK DWMTQ== (VL) ==IKREGKSSGSGSESKLECEV== (VH) = =AAKTTPGAAAEOKLISEEDLNDIKDEL 
SCFV-CK MDGDWMTQ== (VL) ==IKKEGKSSGSGSESKLECEV== (VH) ==AAKTTPGAAAEOKLISEEDLNDIKDEL 
Ec-scFv QVDGDWMTQ== (VL) ==IKREGKSSGSGSESKLECEV== (VH) = =AAKTTPGAAAEOKLISEEDLNDI 
Ec-scFv-K QVDGDWMTQ== (VL) ==IKREGKSSGSGSESKLECEV== (VH) ==AAKTTPGAAAEOKLISEEDLNDIKDEL 
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Fig. 2. A. Predicted amino acid sequence of the different mature scFv antibody constructs expressed 
in plants and bacteria. The VL and VH domains are connected by a 16 amino acid linker peptide (bold). 
The c-myc tag (underlined) is located at the C-terminal end of the peptide. B. Antigen-binding activity 
of scFv antibodies, isolated from E. coli, assayed by ELISA using the anti c-myc antibody. Serial 
dilutions of purified Ec-scFv and Ec-scFv-K antibodies were incubated in wells coated with 100 ng 
cutinase. Individual points represent mean values of triplicate trials with standard deviations (error 
bars). 
chromatography with the 9E10 monoclonal antibody coupled to activated protein A 
Sepharose (Pharmacia) as described previously. 
For use in ELISA assays the proteins were extracted by grinding 0.2-0.4 g tobacco leaves in 
liquid nitrogen to a fine powder. The powder was transferred to an eppendorf tube and mixed 
1:2 (w/v) with PBS-0.1% (v/v) Tween (PBST) and 1 mM Pefabloc SC (Boehringer), and 
incubated on ice for 5 minutes. Insoluble material was removed by centrifugation at 
13.000xg. The supernatant was stored at -80°C until further use. 
The cutinase binding activity of the crude supernatant or purified scFv was determined by 
ELISA. A 96-well plate was coated overnight with 1 ug/ml cutinase in 50 mM sodium 
carbonate, pH 9.6 (100 ul/well). After blocking for 30 minutes with 200 ul PBST-5% skimmed 
milk powder per well the plates were washed and 100 ul protein extract per well was added. 
The plate was incubated for 2 hours. To determine the antigen binding capacity of the scFv 
antibody preparations, the wells were subsequently washed with PBST, eluted with SDS-
PAGE sample buffer, and analyzed by immunoblotting under non reducing conditions. 
Alternatively, for quantitative ELISA, after washing with PBST each well was incubated for 
another two hours with 100 ul anti c-myc tag antibody 9E10 (1 ng/ul) in PBST-1% skimmed 
milk powder. Then, after washing three times with PBST, the wells were incubated for 1 hour 
with alkaline phosphatase conjugated rat-anti-mouse antibody (Jackson Immuno Research), 
diluted 1:5000 in PBST-1% skimmed milk powder. Finally the wells were washed five times 
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with PBST and 100 ^l substrate (0.75 mg/ml p-nitrophenylphosphate in 1M diethanolamine, 
pH 9.8) was added and the OD405 was monitored. All incubations were carried out at 37°C. 
Results 
Construction of the scFv expression cassettes. 
An scFv gene was constructed containing the variable domains of the 21C5 antibody heavy 
(VH) and light chain (VL) genes (van Engelen et al., 1994) in the 5'-VL-linker-VH-3' orientation. 
The end of the VH region was fused to the c-myc tag coding sequence for detection and 
purification purposes. To enable translocation of the 21C5 scFv to the lumen of the ER it 
was preceded by a murine K light chain signal peptide (scFv-S; Fig. 2A). This signal peptide 
has shown previously to export full-size antibodies efficiently to the plant apoplast (van 
Engelen et al., 1994). To retain the scFv-S antibody in the ER a C-terminal ER retention 
signal KDEL was added (scFv-SK; Fig. 2A). In addition two cytosolic versions of the 21C5 
scFv (scFv-C and scFv-CK; Fig. 2A) were constructed, which both lacked the ER 
translocation signal. 
To determine if the presence of the KDEL retention signal had any effect on either antigen 
binding capacity or detection with the anti-c-myc tag antibody, the scFv genes, with and 
without KDEL sequence, were expressed in £. coli (Ec-scFv-K and Ec-scFv, respectively; 
Fig. 2A). Both scFv genes were preceded by the pelB signal peptide. After affinity 
purification the Ec-scFv and Ec-scFv-K antibodies showed similar binding properties to the 
cutinase antigen in an ELISA assay (Fig. 2B). Western blotting followed by 
immunodetection using the anti c-myc tag antibody revealed proteins of 31 kDa (Fig. 3). 
Apparently, addition of the KDEL retention signal had no effect on the binding properties of 
the anti c-myc tag antibody 9E10. 
Expression ofscFv antibodies in transgenic tobacco leaves. 
The scFv cassettes were introduced into tobacco by Agrobacterium mediated 
transformation. As a control, transformation also was conducted using the empty vector 
pCP033T. Independent kanamycin resistant transformants were screened by 
immunoblotting of total protein extracts from leaves. All 43 plants containing the scFv-S 
constructs showed poor expression. By comparison of the staining intensity on Western blot 
of the plant produced scFv protein with known amounts of bacterially produced scFv, it was 
estimated that the maximum expression level reached was 0.01% of total protein. No scFv 
protein was detected in 23 plants containing the scFv-C construct. However, 9 out of 15 
scFv-CK transformants showed scFv antibody expression with a maximum level of 0.2% (Fig 
3). From the 15 scFv-SK transformants 13 were expressing scFv protein, the highest 
expression level being 1.0% (Fig. 3). 
In plants expressing the scFv-SK protein an additional minor product of approximately 65 
kDa was detected. To gain more insight in the nature of this 65 kDa band, protein samples 
were prepared from leaves and analyzed under non-reducing conditions. Western blotting 
showed that under these circumstances the fraction of the 65 kDa protein increased 
considerably for both scFv-SK and scFv-CK protein preparations (Fig. 4A). This could 
indicate that in plant cells the cysteine residue present in the linker peptide (Fig. 2A) may 
have been involved in dimer formation. To determine if both scFv protein and the presumed 
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Fig. 3. Western blot analysis of leaf tissue from two independent tobacco transformants (a and b) 
containing the scFv-S, scFv-C, scFv-SK and scFv-CK cassettes. The lanes marked 'Control' are from 
a transgenic tobacco plant transformed with the vector pCP033T. The scFv antibodies were detected 
using the anti-c-myc antibody (9E10). The arrows marked T indicate the scFv-S antibody and the 
arrow marked 'II' indicates the 65 kDa protein band. 
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Fig. 4. A) Western blot of proteins from scFv-SK and scFv-CK transgenic tobacco after non-reducing 
electrophoresis. The scFv antibodies were detected using the anti-c-myc antibody (9E10). Arrow 
indicates the 65 kDa protein band. B) Binding of scFv antibodies to cutinase. Immunoblot of proteins 
eluted from wells coated with (+) or without (-) cutinase after incubation with scFv-SK and scFV-CK 
antibodies purified from plants and the scFv-K antibody purified from E. coli. The antibodies were 
detected with the anti-c-myc antibody (9E10). Asterisk and arrow indicate the scFv antibodies and 65 
kDa protein bands, respectively. 
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scFv-dimer had antigen binding capabilities, purified scFv-CK and scFv-SK antibodies were 
incubated with immobilized cutinase and analyzed after elution under non-reducing 
conditions (Fig. 4B). Purified bacterially expressed Ec-scFv-K was used as a control. 
Western blotting of the eluents showed that not only scFv-CK and scFv-SK monomers, but 
also the 65 kDa proteins bound specifically to the cutinase antigen. 
Accumulation ofscFv mRNA and protein in transgenic tobacco leaves. 
Since the KDEL retention signal is thought to function only in the secretory pathway the 
difference in expression level between the scFv-C and scFv-CK was a surprise. Therefore, 
we investigated whether the differences in protein accumulation between the various 
constructs could be explained by differences in the steady state mRNA levels. For a number 
of plants both total RNA and protein was isolated from the same leaf and analyzed (Fig. 3 
and 5). 
Northern blot analysis showed that the scFv transgenic plants accumulated scFv mRNA of 
the expected size of 1000-1200 bases, albeit in different quantities (Fig. 5A). In addition, a 
much less abundant mRNA of 1400 bases was detected. The origin of this mRNA is not 
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Fig. 5. RNA and protein analysis of leaf tissue from the same independent tobacco transformants as 
depicted in Fig. 3. A. RNA blot containing total RNA hybridized with a specific scFv probe. Arrow 
indicates position of scFv transcripts. B. ScFv antibodies detected on Western blot using the 
polyclonal rabbit antiserum against the 21C5 antibody. 
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clear. It was not detected in control plants and therefore may be a read-through product of 
the scFv messenger RNA. The difference in protein expression level between the different 
scFv genes could not be explained by various levels of scFv mRNA. The scFv-C mRNA 
level (Fig. 5A: lane a) was comparable with the scFv-CK mRNA level (Fig. 5A: lane b) but no 
scFv-C protein was present whereas scFv-CK protein was detected (Fig. 3 and 5B: lanes a 
and b). Furthermore, a low scFv-SK mRNA level (Fig. 5A: lane a) resulted in a higher scFv 
protein accumulation than the relative high scFv-S mRNA level (Fig. 5A: lanes a and b). 
To exclude the possibility that the c-myc tag had been removed by plant proteases, thereby 
affecting our detection procedure, we used both anti-tag antibodies (Fig. 3) and an anti-
21C5-Fv rabbit polyclonal antiserum (Fig. 5B) for scFv detection in a number of transgenic 
plants. Essentially the same results were obtained, indicating that the presence of the 
complete scFv antibody correlated with the presence of the tag. 
The addition of the KDEL retention signal elevated the steady state levels of the 21C5 scFv 
antibody, both with and without signal peptide. 
Expression of the scFv antibodies in tobacco leaf protoplasts. 
The four different mature scFv proteins varied slightly in their number of amino acids (Fig. 
2A). The calculated sizes of the mature scFv proteins ranged from 30 kDa for the scFv-S to 
31 kDa for the scFv-CK. An uncleaved signal peptide would increase the calculated size for 
the scFv-S and scFv-SK antibodies by 2.5 kDa. On Western blot the protein bands showed 
only minor size differences, the smallest molecule being the scFv-S protein (Fig. 3). This 
might indicate that the signal peptides of both scFv-S and scFv-SK proteins were recognized 
and cleaved off during translocation into the ER. 
To determine whether the signal peptide and the KDEL retention signal had the predicted 
effects on scFv protein translocation, transient expression assays were carried out in 
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Fig. 6. Western blot analysis of a transient expression assay in tobacco protoplasts transformed with 
plant vectors containing the scFv-S, scFv-C, scFv-SK and scFv-CK gene cassettes. The 'Control' lane 
represents the transformation of tobacco protoplasts with the vector pCP033T. The scFv antibodies 
present in the cells and incubation medium were detected by the anti-c-myc antibody (9E10). Arrow 
indicates the 65 kDa protein band. 
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tobacco protoplasts. Western blot analysis showed differences in the location of the scFv 
proteins (Fig. 6). As expected the scFv-S protein was secreted into the incubation medium 
indicating that the signal peptide was indeed functional. The scFv-SK and scFv-CK proteins 
were predominantly found inside the protoplasts. The residual presence of scFv-CK and 
scFv-SK protein in the incubation medium was probably due to cell disruption during the 
assay, since in a control experiment expressing a p-glucoronidase (GUS) construct lacking a 
signal peptide some GUS activity was detected in the medium. From the data obtained with 
the scFv-SK expression we concluded that the KDEL retention signal was able to retain the 
scFv-SK antibody inside the protoplasts. This was confirmed by using protoplasts, prepared 
from the transgenics with a high scFv mRNA level, which showed only intracellular 
accumulation of the scFv-SK. However, in this case we could not detect the scFv-S 
antibody, neither in the protoplasts nor in the medium (results not shown). 
Discussion 
Successful applications for scFv antibodies expressed in plants, including creating 
resistance against pathogens (Tavladoraki et al., 1993) or altering metabolic pathways (e.g. 
catalytic antibodies), will to a large degree depend on the ability to target the scFvs to a 
particular subcellular compartment and to optimize their expression level. Tavladoraki et al. 
(1993) described the successful expression of an scFv antibody directed to the cytosol. Firek 
et al. (1993) reported a significant increase in the expression level of an scFv antibody 
against phytochrome when secreted instead of expressed in the cytosol (Owen et al. 1992). 
They suggested that this difference in expression levels was not the result of a difference in 
subcellular location but was caused by a destabilizing effect of the phytochrome on the 
cytosolic scFv (Firek et al., 1993). 
Since no further data on the expression of scFv antibodies in different subcellular 
compartments of plant cells were available we decided to explore the possibilities of 
intracellular targeting of scFv antibodies and assess the effect on stability and accumulation. 
To improve intracellular stability we targeted an scFv antibody away from the cytosol to the 
potentially more favourable environment of the endoplasmic reticulum (ER) by adding a 
signal peptide and the tetrapeptide KDEL (Herman et al., 1990; Denecke ef al., 1992; 
Wandelt ef al., 1992) (scFv-SK). For comparison a secretory version (scFv-S) of this 
molecule was used, as well as two cytosolic counterparts, one with and one without the 
KDEL retention signal (scFv-CK and scFv-C, respectively). The expression level and 
localization of this scFv-SK antibody were compared with those of the scFv-C, scFv-CK, 
and scFv-S antibodies. 
Of the tobacco transformants expressing the scFv-SK cassette, 85% showed a high 
accumulation of the protein in leaves. In some plants the scFv protein comprised up to 1% of 
the total soluble protein. Protoplasts prepared from these transgenic plants showed total 
retention of scFv-SK in the cells. This was confirmed by transient expression assays in 
tobacco protoplasts. The ScFv-SK antibody was retained intracellularly while a large 
proportion of the scFv-S antibody was secreted into the culture medium. These results 
indicated that the signal peptide was functional. Furthermore, they showed that the KDEL 
retention signal was probably well exposed, recognized by a salvage receptor (Vaux ef al., 
1989; Tang ef al., 1994), thereby enabling the scFv antibody to be retained in the ER. When 
compared with the plants expressing the secreted scFv (scFv-S) the retention in the ER 
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resulted in a 100-fold increase in the amount of detectable scFv antibody. These high 
accumulation levels cannot be explained by differences in the mRNA levels. It therefore 
seems that the high level of scFv antibody accumulation is due to its strict localization in the 
ER and consequently is protected from proteolytic activity further down the secretory 
pathway, either intra- or extracellularly. Similar results have been obtained with the vacuolar 
protein vicilin, which also accumulated to a much higher level when retained in the ER 
(Wandeltefa/., 1992). 
Most striking were the differences in expression levels obtained with the scFv-C and scFv-
CK constructs. No transgenic tobacco plants could be found with detectable levels of scFv-C 
antibody. In contrast to this finding, among the scFv-CK transformants 60% of the plants 
showed detectable antibody levels. In one plant the scFv-CK protein level reached 0.2% of 
the total soluble protein, which is comparable with previously reported cytosolic expression 
levels (Owen et ai, 1992; Tavladoraki ef ai, 1993). This difference in expression between 
the two constructs (scFv-C and scFv-CK) was also found in the transient expression assay. 
The steady state levels of scFv mRNA indicated that the difference in protein accumulation 
most likely depended on differences in stability of the protein. This phenomenon is not 
unique for the anti-cutinase scFv, since we have recently obtained similar results with 
another scFv antibody (unpublished results). 
Presently we can only speculate on the factors that cause these KDEL correlated differences 
in expression in plants. Assuming that both scFv-C and scFv-CK antibodies are located in 
the cytosol, it might be possible that the C-terminal extension of the scFv-CK antibody, which 
is in fact six amino acids long (DIKDEL), protects the scFv from C-terminal degradation by 
exo-proteinases. This then would suggest that particular exo-proteinases are involved in the 
breakdown of scFvs. Alternatively, the DIKDEL sequence may indirectly protect the scFv 
from proteolytic attack via a KDEL mediated interaction with the cytosolic side of the ER 
salvage receptor (Tang et ai, 1994). 
Another explanation for the observed differences could be that expression levels of the scFv 
are correlated to a different subcellular location. It has been well documented that the 
expression of normally secreted proteins, particularly those with disulphide bridges, in the 
cytosol of plant cells is very low (Sijmons ef a/., 1990; Bosch ef a/., 1994; Florack et a/., 
1994). It is therefore not surprising that the scFv-C transformants failed to produce 
detectable amounts of scFv antibodies. Protein analysis using the algorithm for predicting 
signal peptidase cleavage sites (von Heijne, 1986) within the GCG Wisconsin program 
revealed that both mature scFv-C and scFv-CK proteins did not contain a signal peptide-like 
sequence in the amino-terminal region. Possibly, the KDEL containing scFvs, even when no 
signal peptides are added, are directed away from the cytosol to a more favourable location, 
presumably the ER. The presence of substantial amounts of the 65 kDa protein in the scFv-
CK transgenic plants along with its functionality might indicate an ER location. Noteworthy in 
this respect is the recent suggestion that scFv antibodies targeted to the cytosol of animal 
cells were actually "mistranslocated" to the ER (Jiang ef a/., 1995). In addition, alternative 
pathways for secretory proteins, lacking signal peptides, have been put forward (Muesch et 
ai, 1990). 
The very low expression from the scFv-S construct in transgenic plants and transgenic 
protoplasts contrasts with the result obtained in transient expression experiments where we 
could detect the scFv-S extracellularly. Possibly the protoplasts used for the transient assay 
were physiologically different from the transgenic scFv-S protoplasts and produced less 
proteases into the incubation medium. Firek et ai (1993) reported high expression levels in 
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plants when an anti-phytochrome scFv antibody was being secreted. This difference in 
stability between different scFv antibodies is not clear but may depend on the amino acid 
constitution in the variable domains of the scFv antibodies or the linkerpeptide. 
Efficient expression of scFv antibodies in different subcellular sites seems feasible. 
However, it should be kept in mind that successful expression of functional scFvs in the 
cytosol may only be found under certain conditions, like an scFv amino acid sequence which 
remains relatively stable (Tavladoraki ef a/., 1993) or at least can be stabilized by the 
presence of the antigen (Biocca er a/., 1990; Firek ef a/., 1993). The C-terminal addition of 
the retention sequence KDEL as a contributing factor for scFv stabilization opens additional 
opportunities for expressing scFv antibodies in plants. 
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Improving scFv antibody expression levels in the plant cytosol 
This chapter was published in FEBS Letters 415 (1997), 235-241, by the authors A. Schouten, J. 
Roosien, J.M. de Boer, A. Wilmink, M.-N. Rosso, D. Bosch, W.J. Stiekema, F,J. Gommers, J, Bakker 
and A. Schots. 
Abstract 
Expression of single-chain antibody fragments (scFvs) in the plant cytosol is often 
cumbersome. It was unexpectedly shown that addition at the C-terminus of the ER-
retention signal KDEL resulted in significantly improved expression levels. In this 
report the cytosolic location of the scFv-CK was confirmed, excluding possible 
mistranslocation to other subcellular compartments. It was shown that expression of 
several other scFvs was also improved in tobacco protoplasts. In addition expression 
was improved in transgenic potato. Changing from KDEL into KDEI did not affect the 
enhanced protein expression level. Addition of the KDEL motif is a simple and 
straightforward tool to stabilize in planta cytosolic expression of many scFvs. 
Introduction 
The expression of specific antibodies or antibody fragments in plant cells to obtain 
phenotypic mutants, like resistance against pathogens (Tavladoraki ef al., 1993; Voss et al., 
1995) or altered metabolic pathways (Owen ef al., 1992; Artsaenko ef al., 1995), has proven 
its potential. The use of single-chain Fv fragments (scFvs), consisting of the variable heavy 
and light chain domains coupled by a linker peptide, is of particular interest since these 
molecules were functionally expressed in both the secretory pathway and ectopic 
environments. Even in the reducing environment of the plant cytosol scFvs can fold into 
functional molecules. This folding capability has also been demonstrated in Xenopus 
oocytes, COS cells and human cells (Biocca and Cattaneo, 1995; Duan et al., 1994). 
Despite these successes, cytosolic expression of scFv antibodies in plants is often low or 
absent (Fiedler ef al., 1995; Bruyns ef al., 1996; Schouten ef al., 1996; Whitelam and 
Cockburn, 1996; Fecker et al., 1997). If the stability in the cytosol is an intrinsic property of 
the variable domains it will be a tedious job to improve expression levels for each individual 
scFv antibody without loosing affinity. It would therefore be more convenient to search for a 
general approach to stabilize cytosolic scFv molecules without modifying the variable 
domains. 
Recently, we obtained a significantly improved stability in tobacco when the tetrapeptide 
KDEL was added at the C-terminal end of an anti-cutinase scFv (scFv-CK) designed to be 
located in the cytosol (Schouten ef al., 1996). This tetrapeptide is the signal for retaining 
proteins in the endoplasmic reticulum (ER) when translocated into the secretory pathway 
(Pelham, 1989; Denecke ef al., 1992; Wandelt ef al., 1992; Artsaenko ef al., 1995). The 
addition of a four amino acid extension may be a valuable approach to stabilize cytosolic 
scFvs without modifying the variable domains. 
In this report we first established that scFv-CK was present in the cytosol of tobacco, to 
exclude possible mistranslocation to the ER, reported by (Jiang ef al., 1995), as a cause for 
improved scFv protein expression levels. We then investigated if the tetrapeptide KDEL 
could also be beneficial for the cytosolic expression level of several other scFv antibodies 
and be successfully applied for the expression of scFvs in another plant species, potato. 
Finally, to study whether or not the tetrapeptide could be slightly modified without loosing its 
positive effect on protein stability in the cytosol, the leucine of the tetrapeptide KDEL of one 
of the scFvs was changed into isoleucine and this antibody fragment was expressed in 
potato. 
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Materials and methods 
Cell lines, vectors and strains. 
Single chain antibodies were constructed starting from the hybridoma cell lines MGR48, 
MGR49 and MGR59 (de Boer et al., 1996), all producing monoclonal antibodies reacting 
with p-1,4-endoglucanase, and from the hybridoma line anti-GUS, which produces an anti-fS-
glucuronidase monoclonal antibody. 
For construction of the various 21C5 anti-cutinase scFv genes the vectors pNEM-scFv, 
pNEM-scFv-K and pCPO-scFv-CK (Schouten ef al., 1996) were used. 
For transient expression assays scFv antibodies were cloned in pRAP-scFv-SK, pTR2-scFv-
SK or pTR2-scFv-S. To obtain pRAP-scFv-SK the vector pUCAP35S (van Engelen et al., 
1995) was provided with a kappa signal peptide (van Engelen et al., 1994) and the scFv 
cassette with carboxy terminal KDEL extensions, obtained from the vector pNEM-scFv-K 
(Schouten et al., 1996). The thus obtained vector pRAP-scFv-SK can accept other scFv 
encoding genes as Sal\INot\ fragments between the kappa signal peptide and the c-myc tag 
plus C-terminal KDEL extension. To obtain pTR2-scFv-SK and pTR2-scFv-S we first cloned 
the 1.4 kb Hind\\\ fragment from pCP05 (Florack et al., 1994) containing the 35S terminator 
(T35S), the TR2'-1' dual promoter and octopine synthase terminator (Toes) into the Hind\\\ 
site of pAP (van Engelen et al., 1995). Then the original Sa/I site, present between the TR1' 
promoter and Toes was removed by filling in, creating the vector pTR2. The anti-cutinase 
scFv cassettes with the coding sequence for signal peptide and C-terminal c-myc tag, with 
and without KDEL retention signal, were isolated from pNEM-scFv-K and pNEM-scFv as 
Wcol/Bc/I fragments and inserted into A/col/BamHI digested pTR2, resulting in the vectors 
pTR2-scFv-SK and pTR2-scFv-S, respectively. 
Construction ofscFv genes with coding sequence for glycosylation in the linker. 
To modify the 202' derived peptide linker (Pantoliano et al., 1991) of the 21C5 anti-cutinase 
scFv the VL domain was reamplified using the primers L5d (5'-GGTGTCGACGGTGATGTTK-
TGATGACCCAAA-3') and Vkglyc (5'-AGCCGGATCCGTTGGATTTACCCTCGAGTTTTATTTCCAR-
CTTKGTSCC-3'). Restriction sites in the primers, used in the cloning procedure, are 
underlined. PCR conditions were used as described by Schouten et al. (1996). The amplified 
fragment was inserted into the Sa/l/BamHI restricted vector pNEM-scFv. The resulting 
pNEM-scFv9lyo contained a linker flanked by Xho\ sites. With respect to the original scFv the 
Arg at position 1 of the peptide linker was replaced by Leu (Fig. 1). The Serat position 6 was 
replaced by Asn, thereby creating a consensus site for N-linked glycosylation (Kornfeld and 
Kornfeld, 1985). A control scFv construct in which the Asn was replaced by Ser, but the Leu 
at position 1 retained, was obtained by inserting an Xho\IBamH\ adapter fragment (5'-
TCGAGGGTAAATCCTCCG-3' and 5'-GATCCGGAGGATTTACCC-3') into Xho\IBamH\ digested 
pNEM-scFvglyc, creating pNEM-scFvA°lyc. The modified scFv constructs were cloned as 
Sa/l/A/ofl fragments from pNEM-scFvglyo and pNEM-scFvAglyc into pRAP-scFv-SK, creating 
pRAP-scFvglyc-SK and pNEM-scFvAglyc-SK, respectively (Fig. 1). 
The scFv gene insert from the vector pRAP-scFv-SK was replaced by the Nco\/Not\ scFv 
insert from pCPO-scFv-CK, resulting in the vector pRAP-scFv-CK. To obtain scFv-CK 
constructs with identical linker peptide coding sequences with and without glycosylation 
signal the Pst\ fragment in this vector was replaced with the same insert from the vectors 
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pRAP-scFvglyc-SK and pRAP-scFvAglyc-SK. The resulting constructs were verified on proper 
orientation and subsequently called pRAP-scFvglyc-CK and pRAP-scFvAglyc-CK, respectively 
(Fig. 1). 
scFv-SK 
s c F w g l y o _ S K 
scFv^o'yo-SK 
scFv-CK 
scFv» l y 0-CK 
s c F v 4 o i y o _ C K 
SP 8oFw tag KDEL 
REGKSSGSGSESKLEC 
L .NGS.... 
L._ SGS 
scFv tag KDEL 
REGKSSGSGSESKLEC 
L NGS 
L SGS 
Fig. 1. Diagram of the scFv-SK and scFv-CK constructs with modifications in the linker peptide. The 
signal for N-linked glycosylation, Asn-X-Ser, was introduced by changing the Ser of both scFvA°lyc-SK 
and scFvAglyc-CK into Asn, resulting in the sequence Asn-Gly-Ser in the constructs scFvglyc-SK and 
scFvglyc-CK, respectively. The N-terminal signal peptide (SP), the single chain antibody construct 
(scFv) with the variable the variable light (VL) and heavy (VH) chain domain connected by the linker 
peptide, the C-terminal c-myc tag (tag) followed by the KDEL peptide sequence are indicated. 
Immunocytolocalization. 
Young leaves (length approximately 3 cm) of in vitro grown transgenic tobacco plants, 
expressing the anti-cutinase scFv-CK and scFv-SK antibodies, were submersed in a solution 
of 4% formaldehyde, 0.1 M HEPES-NaOH pH 7.5 and 1.5 mM CaCI2. The leaf tissue was 
cut into strips of approximately 1 x 5 mm, which were degassed briefly in vacuo and left to fix 
overnight at room temperature. Following washing in water, the leaf strips were dehydrated 
in ethanol and embedded in LR-Gold resin following standard low-temperature procedures 
(Vandenbosch, 1991). Immunogold labeling of thin sections was performed essentially as 
described by de Boer ef al. (1996), using monoclonal antibody 9E10 to the c-myc tag at a 
concentration of 1 u.g/ml as the primary antibody, and a 10 nm goat-anti-mouse gold 
conjugate (Aurion, Wageningen, The Netherlands) for detection. Control labeling 
experiments were performed with leaf tissue from untransformed plants, and by omitting the 
primary antibody in the labeling procedure. 
Construction ofscFv antibody genes. 
Isolation of poly(A)+ RNA from hybridoma cells was performed using the QuickPrep Micro 
mRNA purification kit (Pharmacia). cDNA was synthesized using the Pharmacia First Strand 
cDNA Kit. 
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To create the scFv48 gene the MGR48 cDNA was amplified by PCR using the primer 
combination L5d-Nco (5'-CGTGCCATGGATGnKTGATGACCCAAACTC-3') and 202VL3 (5'-GG-
ATTCAGATCCGGATCCTGAGGACTTACCCTCGAGCTTTATTTCCAGCTTGGTCCC-3') for the VL 
domain and 202VH5 (5'-TCAGGAJCCGGATCTGAATCCAAGCTCGAGTCTCAGGTCCAGTTGGT-
ACAGTCTG-3') and VH33b (5'-GCACGTJAACCCCGGGTGTTGTTTTGGCTGCAGAGACAG-3') for 
the VH domain. The Wcol/BamHI digested VL and BamH\IHpa\ digested VH fragments were 
ligated together in the Nco\ISma\ digested pTR2-scFv-S and pTR2-scFv-SK. 
For the scFv49 construction we amplified MGR49 cDNA using primer combination L5h (5'-
GGTGTCGACGGTGACATCCAGATGACMCAGWCTMCM-3') and 3KGS to obtain VL and 5HGS 
(5'-GGTGGAGGATCCGGTGGAGGAGGTTCTGAGGTYCAGCTGCARSA-3') and VH34 (5'-ATGC-
GTTAACCGTTGTTTTGGCTGMRGAGACDGTGAS-3') to obtain VH. The VL and VH domains 
were fused using splicing by overlap extension (SOE) (Horton ef a/., 1990) and initially 
ligated as a Sa/I/Hpal fragment into pNEM6 (Rosso ef a/., 1996). Finally the scFv49 fragment 
was cloned as NcoUNoti fragment into Nco\INot\ digested pTR2-scFv-S and pTR2-scFv-SK. 
To create scFv59 MGR59 cDNA was amplified with the primers L5d-Nco and 3Kgs2 (5'-CG-
CCTCCGGAGCCTCCACCACCGGAACCACCACCACCGGATCCCCCTTTTATTTCCARCTTKTGTC-
3') for the VL domain and gsH5c (S'-GGTGGAGGCTCCGGAGGCGGAGGATCCGAGGTCCAGC-
TGCAACARTC-3') and VH33a (5'-GCACGTTACCCCGGGTGTTGTTTTGGCTGAGGAGACKG-3') 
for the VH domain. After Ncol/BspEI and BspE\ISma\ digestion the domains were ligated 
together in the Nco\ISma\ digested pTR2-scFv-S and pTR2-scFv-SK. 
To create SCFVGUS anti-GUS cDNA was amplified using the primer combination L5h and 
VLK2 (5'-GACTCGAGTTTGGATTCGGAGCCGGATCCTGAGGATTTACCCTCCCGTTTTATTTCCA-
RCTTKGTCCCMG-3') to obtain VL and primer combination FVH3 (5'-TCAGGATCTGGCTC-
CGAATCCAAACTCGAGTCTGAGGTGAAGCTGGTGGARTCTG-3') and VH33 to obtain VH. The 
VL and VH domains were fused by SOE and initially ligated as a Sa/I/Smal fragment into 
pNEM5 (Schouten ef a/., 1996). Then the SCFVGUS gene was ligated as Nco\INot\ fragment 
into NcoVNott digested pRAP-scFv-S and pRAP-scFv-SK. 
Cloning procedures were according to Sambrook et al. (1989). All constructs were checked 
by sequencing (Sanger et al., 1977). The sequence data were deposited in the GenBank 
database under the accession numbers AF004403; AF004404, AF00440, AF004406 and 
AF004407. 
Transient expression and protein analysis. 
Transient expression assays in tobacco (N. tabacum cv. Samsun NN) leaf protoplasts were 
performed essentially according to the polyethylene glycol procedure as described by 
(Denecke ef al., 1989). In case of tunicamycin treatment the transfected protoplast were 
incubated in TEX medium supplemented with 10 ^g/rnl tunicamycin (Iturriaga ef al., 1989). 
The protoplasts were separated from the incubation medium and lysed by adding an equal 
volume of 10 mM Tris-HCI, pH 8.0, 1 mM EDTA and 1 mM Pefabloc SC (Boehringer), and 
subsequent vortexing. The chloroplasts were pelleted by centrifugation at 13000xg for 2 min 
and the supernatant was used for further analysis. For western analysis one third volume of 
4xSDS-PAGE sample buffer, containing 244 mM Tris-HCI, pH 6.8, 8% (w/v) SDS, 50% (w/v) 
glycerol and 1 mM Pefabloc SC (Boehringer), was added to an aliquot of the supernatant, 
equaling 3x104 protoplasts. The samples were incubated at 100°C for 5 min and 
bromophenolblue was added to a final concentration of 0.008% (w/v). 
For deglycosylation proteins isolated from 8x104 protoplasts in a final volume of 20 yi\, were 
denatured by adding 2.2 nl 5% (w/v) SDS, 2% (v/v) p-mercaptoethanol and incubation at 
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100°C for 5 minutes. The sample was split into two portions. Both aliquots received 2 \x\ 0.5 
M sodium phosphate, pH 7.5, 3 |xl water and 2 |il 10% (v/v) NP-40. To the first aliquot 2 ^l 
PNGase F (500 units/^l, New England Biolabs) was added. As a control, 2 jxl water was 
added to the second aliquot. The samples were incubated at 37°C for 1 hr and 
bromophenolblue was added to a final concentration of 0.008% (w/v). . 
Protein samples were loaded on a 13% SDS-polyacrylamide gel (Laemmli, 1970) (Bio-Rad 
mini protean system). After electrophoresis the proteins were transferred to a PVDF 
membrane (Millipore) by electroblotting. For immunodetection the membranes were 
incubated with 1:1000 diluted 9E10 monoclonal antibody (Munro and Pelham, 1986), 
followed by a 1:5000 diluted rat-anti-mouse alkaline phosphatase conjugate (Jackson 
Immuno Research). The blots were stained in 0.1 M ethanolamine-HCI pH 9.6, 
supplemented with 4 mM MgCI2, 5-bromo-4-chloro-3-indolyl phosphate (0.06 mg/ml) and 
nitro blue tetrazolium (0.1 mg/ml). The relative molecular weights of the proteins were 
estimated with pre-stained low range molecular weight markers (Bio-Rad). 
Potato transformation and protein analysis. 
The scFv48 expression cassettes cloned in the transient expression vector pTR2 were 
isolated as Pac\-Asc\ fragments and transferred to the binary vector pBINPLUS as described 
by (van Engelen et a/., 1995). The resulting plasmids were introduced into Agrobacterium 
tumefaciens strain AGL0 (Lazo et a/., 1991). This strain was used for the transformation of 
internodal stem sections of Solanum tuberosum, dihaploid genotype 6487-9 (2n=2x=24), as 
described by (Flipse et a/., 1994). Genotype 6487-9 resulted from a crossing between 
genotype 1024-2 (Kuipers er a/., 1995) and genotype 91-6222-40, a self-incompatible Gg-
clone selected in 1992 from the material of (Olsder and Hermsen, 1976). Kanamycin 
resistant transformants were regenerated and total soluble proteins were extracted by 
grinding roots essentially as described by (van Engelen et al., 1994). The proteins were 
analyzed by loading 30 ng total soluble protein homogenate on an SDS-polyacrylamide gel 
followed by electroblotting and immundetection as described. 
Results 
Subcellular location of the scFv antibodies in plant cells. 
To study possible 'mistranslocation' of scFv-CK to the ER we used N-linked glycosylation as 
a biochemical marker. A mutant, scFv9lyc-CK (Fig. 1), having a consensus glycosylation site 
(Asn-Gly-Ser) in the linker peptide was engineered. Both this construct and the construct 
having the original Ser-Gly-Ser peptide coding sequence in the linker (scFva9lyc-CK, Fig. 1) 
were expressed transiently in tobacco protoplasts. As controls we took the scFvglyc-SK and 
scFvAglyc-SK constructs which carry both the ER translocation signal sequence and an ER 
retention signal KDEL (Fig. 1). Glycosylation was determined by the relative migration of 
these proteins on western blot (Fig. 2). ScFv°ly0-SK expression resulted in proteins migrating 
at 32, 33 and 67 kDa (Fig. 2, lane 1). The 67 kDa protein is thought to be an scFv dimer due 
to disulfide bridge formation caused by the cysteine present in the linker peptide (Fig. 1) 
(Schouten et al., 1996). Due to the presence of p-mercaptoethanol in the reaction buffer this 
dimer was absent after glycosidase F treatment. When the transfected protoplasts were 
incubated in the presence of the glycosylation inhibitor tunicamycin or after glycosidase F 
treatment of the total protein homogenate, the 33 kDa band disappeared and the 67 kDa 
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Fig. 2. Determining the glycosylation state of scFv°lyc-SK and scFvglyc-CK proteins. Top panel: Western 
blot of total protein from tobacco protoplasts, transfected with the vectors containing the scFvglyc-SK, 
scFvAglyc-SK, scFvglyc-CK and scFv4glyc-CK gene cassettes, were incubated in the absence (-) or 
presence (+) of tunicamycin and analyzed on westernblot. Arrow indicates the 67/65 kDa protein 
bands. Bottom panel: Western blot of total protein from protoplasts, transfected with the vectors 
containing the scFvglyc-SK, scFvAglyc-SK, scFvglyc-CK and scFvAglyc-CK gene cassettes, which had been 
incubated in the absence of tunicamycin and were either mock treated (-) or treated (+) with the 
endoglycosidase glycoF. As a negative control (Control) a vector without scFv gene cassette was 
used. 
band slightly shifted to 65 kDa (Fig. 2, lane 2). Expression of scFvAglyc-SK resulted in 32 and 
65 kDa bands which were unaffected by glycosidase F treatment of the total protein 
homogenate or tunicamycin treatment of the transfected protoplasts (Fig. 2, lanes 3 and 4). 
This indicates that the 33 kDa and 67 kDa proteins are glycosylated forms of the 32 kDa 
scFv monomer and 65 kDa scFv dimer. The band intensities of the 33 and 32 kDa bands 
indicate that approximately 70% of the scFv9lyc-SK protein became glycosylated. Because of 
a three amino acid extension at the N-terminus the apparent molecular weight of the 
expressed scFv9lyc-CK and scFvAglyc-CK proteins is slightly higher than the scFvAglyc-SK and 
unglycosylated scFvglyc-SK proteins and was estimated at 33kDa (Fig. 2, lanes 5 and 7). For 
both scFv9'yc-CK and scFvAglyc-CK the mobility was unaffected by glycosidase F treatment of 
the total protein homogenate or tunicamycin treatment of the transfected protoplasts (Fig. 2, 
lanes 6 and 8). Therefore, we conclude that the scFvglyc-CK protein is not glycosylated, 
indicating that the scFv-CK antibody, in contrast to the scFv-SK antibody, is not translocated 
into the ER. 
To obtain 'visual' proof for the presence of the scFv-CK antibodies in the cytosol, we 
examined leaf sections of transgenic plants expressing the anti-cutinase scFv-CK and scFv-
SK antibodies with immunoelectron microscopy (Fig. 3). We had obtained transgenic plants 
with maximum expression levels of 0.2% and 1% of total soluble protein for scFv-CK and 
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Fig. 3. Localization of scFv-CK and scFv-SK in transgenic tobacco by immunogold labeling and 
transmission electron microscopy. Leaf sections from plants expressing scFv-CK at a level of 0.2% (A 
and B) and scFv-SK at a level of 0.2% (C) and 1% (D) of total soluble protein. E: Leaf sections from 
untransformed plants, chl, chloroplast; cw, cell wall; cy, cytoplasm; rER, rough endoplasmic reticulum; 
r, ribosome. Bars = 1 |im. 
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scFv-SK, respectively (Schouten ef a/., 1996). Leaf sections were prepared from transgenic 
plants expressing the scFv-CK at a level of 0.2% and the scFv-SK at the levels of 0.2% and 
1% of total soluble protein. The ultrathin sections of leaves expressing the scFv-CK showed 
gold particles evenly distributed in the cytosol (Fig. 3, A and B), indicating the presence of 
scFvs in that compartment. No gold particles were found in other subcellular compartments. 
The sections of the leaves expressing the ER-targeted scFv-SK showed gold particles 
localized in the membranous elements coated with electron dense ribosomes, the rough ER 
(rER) (Fig. 3, C and D). The number of gold particles correlated with the scFv-SK expression 
level. In several plant cells the structure of some of the rER was not elongated but 
vacuolated as has been described (Rodriguez-Garcia ef a/., 1995). No significant labeling 
was found in untransformed leaf sections (Fig. 3E). We therefore conclude that, as intended, 
the scFv-SK and scFv-CK were located in the ER and the cytosol, respectively. 
Expression of different scFv antibodies in the cytosol of tobacco protoplasts. 
To determine if the C-terminal KDEL extension could also improve cytosolic expression 
levels of other scFv antibodies the variable light (VL) and heavy (VH) domains of four other 
antibodies were amplified by PCR and coupled by a synthetic linker sequence in a 5'-VL-
linker-VH-3' orientation. These antibodies were MGR48, MGR49 and MGR59, all reacting 
with (3-1,4-endoglucanase, and anti-GUS, reacting with p-glucuronidase. The linker 
sequences coded for 202' (Pantoliano et a/., 1991) and (Gly4Ser)3 peptides or derivatives 
(Table 1). The scFv sequences were directly preceded by the ATG translational start codon 
and fused in frame with the c-myc tag coding sequence, enabling detection ('C constructs). 
The 'CK' constructs carried the additional KDEL coding sequence at the 3'-end. 
Table 1. Amino acid sequences of the linker peptides 
present in the various scFv antibodies. 
Single-chain Linker peptide 
ScFv48 
ScFv49 
ScFv59 
ScFvGUS 
-LEGKSSGSGSESKLES-
-(GGGGS)3 
-G2S-(GGGGS)3 
-REGKSSGSGSESKLES-
These scFv constructs were transiently expressed in tobacco protoplasts. The 21C5 anti-
cutinase scFv-C and scFv-CK constructs were used as reference. Western blot analysis 
showed that cytosolic expression of the scFv48 and scFv59 constructs was improved when 
the KDEL tetrapeptide was present (Fig. 4). The estimated expression levels of scFv48-C 
and scFv48-CK were 0.02% and 0.06% of total soluble protein, respectively (Fig. 4, lane 1 
and 2). The estimated expression levels of scFv59-C and scFv59-CK were 0.02% and 0.1% 
of total soluble protein, respectively (Fig. 4, lane 3 and 4). Poor expression was found with 
scFv49 for both the C and CK versions. Transient expression of both SCFVGUS versions gave 
no detectable expression (not shown). Apparently, the KDEL tetrapeptide is not capable of 
improving cytosolic expression of every scFv antibody. 
Cytosolic expression of scFv48 gene cassettes in transformed potato. 
To determine whether the KDEL extension could improve scFv protein expression in the 
cytosol of another plant species we transformed C and CK gene constructs of scFv48 to 
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Fig. 4. Western blot analysis of a transient expression assay in tobacco protoplasts transformed with 
the scFv48, scFv59 and scFv49 constructs without (C) and with (CK) the tetrapeptide KDEL extension. 
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Fig. 5. Western blot analysis of transgenic potato plants expressing scFv48 without (C) and with (-CK) 
tetrapeptide KDEL extension or with tetrapeptide KDEI extension (CI). 
potato by Agrobacterium mediated transformation. Independent kanamycin-resistant 
transformants were screened by immunoblotting of total protein extracts (Fig. 5). Only 20% 
of the scFv48-C transgenics screened showed expression, at an estimated level of 0.03% of 
total soluble protein (Fig. 5, lane 1). In contrast, 60% of the scFv48-CK transgenics screened 
showed an expression level estimated at 0.15-0.3% of total soluble protein (Fig. 5, lane 2). 
This demonstrates that the stabilizing effect of the tetrapeptide in cytosolic expression is not 
restricted to tobacco. 
To study the influence of a modification in the KDEL extension on protein expression levels, 
an scFv48-CI gene construct, carrying the KDEI instead of KDEL coding sequence, was 
introduced into potato. This single amino acid substitution in the tetrapeptide is known to 
disrupt the retention signal and the protein is no longer retained in the ER (Denecke et al., 
1992). In 80% of the transgenics screened the scFv48-CI protein expression level was 
estimated at 0.3% of total protein (Fig. 5, lane 3), indicating that the isoleucine replacement 
did not result in a loss of the stabilizing effect. 
48 
Chapter 4 
Discussion. 
The expression of antibodies in plants is a promising approach for obtaining pathogen 
resistance or altering metabolic pathways. Success depends on proper targeting to the 
desired subcellular compartment combined with proper folding and sufficient stability in order 
to obtain functional antibodies. The recent successes (Owen et al., 1992; Tavladoraki ef al., 
1993; Artsaenko ef al., 1995) suggest that scFv antibodies, provided with the proper 
translocation signals, have these abilities and can even be expressed in the reducing 
environment of the cytosol. However, these scFv antibodies were never properly localized 
and cytosolic scFv expression in plants was mostly low or absent. We demonstrated 
previously that the expression level of an anti-cutinase scFv antibody targeted to the cytosol 
was significantly enhanced when carrying the KDEL sequence C-terminally (scFv-CK) 
(Schouten ef a/., 1996). Stabilizing scFv antibodies in the plant cytosol by adding this four 
amino acid sequence, known as ER retention signal (Denecke ef a/., 1992), would open new 
possibilities, but the actual subcellular location was uncertain. Noteworthy in this respect is 
that for a cytosolic scFv antibody in HeLa cells mistranslocation to the ER was suggested 
(Jiang ef a/., 1995). Furthermore, alternative translocation pathways to the ER of proteins 
lacking a signal sequence have been described (Muesch ef a/., 1990; Rubartelli ef a/., 1990 
and 1992). 
In this paper we located unambiguously the scFv-CK in the cytosol, excluding possible 
mistranslocation or alternative translocation events to the ER. This was proven using re-
linked glycosylation as a biochemical marker and immunoelectron microscopy. N-linked 
glycosylation is a post-translational modification of proteins and confined to the ER (Czichi 
and Lennarz, 1977). Transient expression assays in tobacco protoplasts of the positive 
control, an scFv with ER translocation signal and KDEL extension carrying the glycosylation 
signal (scFvglyc-SK), clearly demonstrated that glycosylation occurred, indicating that this 
scFv antibody had been translocated into the ER. However, only 70% of the scFvglyc-SK 
became glycosylated. This could have been caused by the fact that the ER translocation 
signal was inefficient, and the scFvslyc-SK was only partially translocated into the ER, or that 
N-linked glycosylation in the ER was incomplete. The first reason is most unlikely since 
immunoelectron microscopy showed no scFv-SK outside the ER of the plant cells. 
Incomplete glycosylation in the ER is more likely. Competition between protein folding and 
N-linked glycosylation has been described extensively (Allen et al., 1995; Chen ef a/., 1995; 
Hoist ef al., 1996) and, apart from the X as a determinant in glycosylation efficiency (Shakin-
Eshleman ef al., 1996), not all the Asn-X-Ser/Thr sequons in a protein become glycosylated 
(Gavel and Von-Heijne, 1990). Since the VL domain can fold independently into a stable 
domain (Bergman and Kuehl, 1979; Freund ef al., 1996) the nascent VL domain may rapidly 
begin with the formation of the proper domain structure the moment it is translocated into the 
ER, making it difficult for glycosyl transferase to attain the glycosylation signal in the linker 
peptide. 
As reported before, the anti-cutinase scFv designed to be located in the cytosol could only 
be detected when the tetrapeptide KDEL was added C-terminally (Schouten ef al., 1996). 
We postulated that stabilization may have been caused by mistranslocation into the ER. In 
this case, all the scFv-CK antibody present would be located in the ER. However, the results 
showed that scFvglyc-CK was not glycosylated, demonstrating that no mistranslocation into 
the ER had occurred. The actual subcellular location was confirmed by immunoelectron 
microscopy of tobacco leaf sections. The scFv-SK was detected in the ER and the scFv-CK 
49 
in the cytosol. No labeling was found in any other subcellular compartment. When two plants 
with similar expression levels are analyzed the scFv-CK antibody obviously becomes more 
diluted, since the cytosol, compared to the ER, is rather large in size. However, the 
immunodetection on the untransformed control plant showed no labeling. It can therefore be 
concluded that the four amino acid extension KDEL enhances the anti-cutinase scFv 
antibody expression levels in the cytosol. 
Other scFv antibodies were constructed to investigate a broad applicability of the KDEL 
extension for stabilizing scFv antibodies expressed in the cytosol. Expression levels were 
not improved for one anti-p-1,4-endoglucanase scFv (scFv49-CK) and the anti-(3-
glucuronidase scFv (SCFVGUS-CK). However, the other two anti-p-1,4-endoglucanase scFvs 
(scFv48-CK and scFv59-CK) showed a significantly enhanced protein expression level. This 
was found in both transient expression assays and stable transformants. As was already 
demonstrated previously (Schouten et al., 1996) for cytosolic scFvs, the protein expression 
levels in transient expression assays with tobacco protoplasts are positively correlated with 
the levels obtained in transformed plants, even if this is a different species. Furthermore, the 
scFv48-CK protein expression level in the transgenic plants, reaching 0.3% of total soluble 
protein, is very similar to what was found for the anti-cutinase scFv-CK (Schouten et al., 
1996). 
How this four amino acid extension is capable of stabilizing the scFv antibody still remains 
elusive. An interaction with the transmembrane KDEL receptor is unlikely since the binding 
site of the receptor is exclusively located at the lumenal side of the ER membrane (Singh et 
al, 1993). In addition, cytosolic scFv expression could also be improved when the 
tetrapeptide KDEI was added (scFv48-CI). It was demonstrated before that the substitution of 
leucine into isoleucine disrupted the tetrapeptide to act as an ER retention signal (Denecke 
ef al., 1992). It may therefore well be that C-terminal protein degradation is prevented or that 
the tetrapeptide sterically protects a part of the scFv antibody susceptible for proteolysis. 
Although different linker peptides were used to connect the variable domains of the different 
scFvs this seemed not to be crucial. The scFv48, SCFVGUS and the 21C5 scFv-CK (Schouten 
et al., 1996) and scFvA9lyc-CK all carried almost identical linker peptides. Yet, only the protein 
expression of the SCFVGUS was not improved when the KDEL extension was added. 
Furthermore, the expression protein level of scFv59-CK was considerably improved when 
compared to scFv59-C. These scFvs both carried the Gly2Ser(Gly4Ser)3 linker. Susceptibilty 
to proteolytic degradation may therefore depend on the amino acid sequence of the variable 
heavy and light domains. Since scFv antibodies lack the heavy and light chain constant 
domains some residues at the former variable and constant domain interface become 
solvent exposed. Depending on the amino acid sequence in this region proper folding and 
subsequent overall stability may be affected, thus increasing susceptibility to proteolytic 
degradation. Noteworthy in this respect is the recent report in which in COS-1 cells the 
cytosolic stability of an scFv antibody was greatly improved when the entire CK domain was 
added C-terminally (Mhashilkar ef al., 1995). Considering'the negative results with scFv49-
CK and SCFVGUS-CK, apparently not all possible proteolytic sensitive sites are protected by 
the tetrapeptide extension. 
As demonstrated with the cytosolic scFv expression in potato, the positive effect of the KDEL 
extension on the expression levels does not seem to depend on the choice of the plant 
species. The processes involved in stabilizing scFv antibodies in the cytosol of different 
species may be similar and is therefore not a factor determining the success of stable scFv 
expression. 
50 
Chapter 4 
It can be concluded that the tetrapeptide KDEL or KDEI can have a beneficial effect on the 
cytosolic expression levels of scFv antibodies in plants. Addition of this four amino acid 
extension may be a simple and effective solution for cytosolic scFv antibody expression and 
therefore is worth to try with scFvs which show great promise with respect to their binding 
affinity but can not be expressed at a sufficient level in the plant cytosol. 
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CHAPTER 5 
Disulfide bridge formation within and between single-chain Fv 
antibodies in the reducing ectopic environment of the plant 
cytosol 
Abstract 
Disulfide bridge formation in the reducing environment of the cytosol is considered a 
rare event and is mostly linked to inactivation of protein activity. In this report the in 
vivo redox state of an scFv antibody fragment in the plant cytosol was investigated. 
The functionality of antibodies, which are normally secreted via the oxidizing 
environment of the ER, depends on the formation of disulfide bridges. We 
demonstrate that an scFv can form intramolecular disulfide bridges and is 
functionally expressed in the cytosol of stably transformed plants. In addition, the 
formation of intermolecular disulfide bridges through a cysteine present in the linker 
peptide was observed. However, transient expression in tobacco protoplasts resulted 
in an scFv antibody lacking disulfide bridges which had a substantially reduced 
affinity for the antigen. This indicates that functionality rather than stability is 
determined by the presence of disulfide bridges in the expressed scFv antibody in 
plants. The controversial role of disulfide bond formation in the cytosol is discussed. 
Introduction 
Disulfide bond formation and disulfide rearrangements are reversible processes, and are 
kinetically and thermodynamically affected by the redox state of the environment (Ziegler, 
1985; Gilbert, 1990; Hwang ef a/., 1992). In eukaryotic cells, subcellular compartmentation 
plays an important role in the regulation of these reversible thiol-disulfide exchange 
reactions. Glutathione is the most abundant nonprotein thiol in eukaryotic cells and the 
preferential transport of the disulfide form (GSSG) compared to the reduced form (GSH) into 
the ER lumen is thought to be responsible in maintaining redox compartmentation between 
the ER and cytosol. For mammalian cells, it has been shown that the ratio of reduced 
glutathione to the disulfide form (GSH/GSSG) ratio ranged from 1:1 to 3:1, whereas the 
overall cellular GSH/GSSG ratio ranged from 30:1 to 100:1 (Hwang ef a/., 1992). In vitro 
studies have shown that the redox environment of the ER corresponds with the optimum for 
refolding of disulfide-bonded proteins (Hwang ef a/., 1992). In the ER, disulfide formation 
and rearrangements are further enhanced by protein disulfide isomerase (PDI) (Gething and 
Sambrook, 1992). 
As soon as the N-terminal part of a nascent polypeptide chain enters the oxidizing 
environment of the ER, folding starts with the aid of a full array of molecular chaperones and 
folding catalysts. Failure of disulphide formation has an adverse effect on various processes 
ranging from protein folding, oligomerization, intracellular transport to secretion (Alberini ef 
a/., 1990; Braakman ef a/., 1992; Tatu, ef a/., 1993; Chanat ef a/., 1993; Jamsa ef a/., 1994; 
de Vries ef a/., 1995). In extracellular proteins, containing cysteine residues, there is rarely 
more than one free thiol group (Thornton ef a/., 1981). Free thiols are considered extremely 
reactive in the oxidizing extracellular environment and may lead to disastrous polymerization 
or make folding more complex. 
The general idea is that the typical glutathione redox state of the cytosol in eukaryotic cells 
does not favour the formation of protein disulfide bonds (Thornton, 1981, Gilbert ef a/., 
1990). Also in prokaryotic organisms, intracellular disulfide bond formation seems to be 
hindered by the redox potential. Many recombinant proteins with disulfide bonds cannot fold 
properly in E. coli, where the intracellular GSH-GSSG redox state ranges from 50:1 to 200:1 
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(Hwang et al., 1992). On the other hand, it has been suggested that the redox state of the 
cytosol in eukaryotes is not constant and may change in response to e.g. physiological and 
metabolic stimuli. Also specialized intracelluJar compartmentation may provide localized 
environments within the cell where the thiol-disulfide redox state may be very different than 
that of the bulk cytoplasm. However, apart from the comparison of the redox state of the ER 
with the intracellular environment as a whole, techniques to monitor changes or subtle 
subcellular redox compartmentation are nonexistent. Nevertheless, various lines of evidence 
indicate that redox modulation for some specific cytosolic proteins is an important regulatory 
mechanism in eukaryotic organisms (Herouart et al., 1993; Parks et al., 1997). In vitro 
studies have demonstrated that various cytosolic enzymes are reversibly activated or 
inactivated upon incubation with disulfides or thiols (Abate et al., 1990; Staal et al., 1990). 
Disulfide bridges are often associated with an inactivated protein (Ziegler, 1985; Anderson ef 
al., 1995). These observations are consistent with metabolic changes in cell cultures, 
perfused organs and whole animals induced by manipulating the cellular thiol to disulfide 
balance by applying reducing agents (Rennenberg and Filner, 1982; Lodish and Kong, 1993; 
Tatu et al., 1993; Garaci et al., 1997). Although the biological significance of reversible thiol-
disulfide exchange reactions for the cytosol remains controversial, in chloroplasts there is 
little question about the role of redox modulation in regulating the activity of key enzymes 
(Cseke and Buchanan, 1986; Gilbert, 1990). Also for nuclei evidence has been obtained that 
redox modulation influences the activity of transcription factors (Gilbert, 1990). 
In this report we compared the redox state of an scFv antibody located in the ER and cytosol 
of tobacco (Nicotiana tabacum). We establish that in transgenic plants intramolecular 
disulfide bridges are present in both the cytosolic scFv and the scFv located in the ER. The 
cytosolic scFvs have binding properties which are similar to the scFv located in the ER. 
Furthermore, the scFvs present in the cytosol are, like the scFv in the ER, capable to form 
intermolecular disulfides through a cysteine present in the linker petide. Transient expression 
of the scFv in the ER of tobacco protoplasts also shows intramolecular and intermolecular 
disulfide bridges. However, no disulfide bridges are present when the scFv gene is 
expressed transiently in the cytosol. Although the expression levels are comparable to 
transgenic plants the binding properties of this cytosolic scFv are very poor. The 
relationships between transformation system, subcellular location, redox potential and 
disulfide bridge formation of heterologous proteins in the plant cytosol and the possible 
consequences are discussed. 
Materials and methods 
Cell lines, strains and cloning vectors. 
A scFv directed against a fungal cutinase was derived from immunoglobulin cDNA of the 
hybridoma cell line 21C5 (Schouten et al., 1996). Cloning procedures were according to 
Sambrook et al., (1989) using the Escherichia coli strains DH5a ,TG1 and 190 and the scFv 
cloning vectors pNEM5 and pNEM5K (Schouten et al., 1996) For construction of the various 
21C5 anti-cutinase scFv genes the pNEM-scFv-K (Schouten et a/., 1996) was used. 
Transgenic tobacco plants expressing scFv-SK and scFv-CK (Schouten et al., 1996, 1997) 
were used for analysis. As a control we used untransformed tobacco (A/, tabacum cv. 
Samsun NN) or a transgenic tobacco plant which was transformed with the empty 
transformation vector pCP033T (Schouten et al., 1996). 
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For transient expression assays pRAP-scFv-SK, pRAP-scFv-CK (Schouten et al., 1997) and, 
as a control, the empty transient expression vector pUCAP35S (van Engelen et al., 1995) 
were used. 
ScFv modifications. 
In order to replace the Cys in the linker of the anti-cutinase scFv 21C5 by Ser, the XhoMPvuW 
fragment in pNEM-scFv was replaced by a suitable adapter (5'-TCGAGTCTGAGGTCCAG-3' 
and 5'-CTGGACCTCAGAC-3') resulting in the pNEM-scFvser (Fig. 1). The scFv constructs 
were cloned as Sa/l/A/ofl fragments from pNEM-scFvser into pRAP-scFv-SK, creating and 
pNEM-scFvser-SK. All modifications were checked by sequencing (Sanger et al., 1977). 
scFv-SK REGKSSGSQSESKLEC 
soFw , e r - SK S 
scFv tagKDEL 
"L I I VH 
scFv-CK REQKSSQSQSESKLEC 
Fig. 1. Diagram of the scFv-SK and scFvser-SK constructs. In the scFvser-SK construct the cysteine 
present in the linker peptide was replaced by serine. The N-terminal signal peptide (SP), the single 
chain antibody construct (scFv) with the variable the variable light (VL) and heavy (VH) chain domain 
connected by the linker peptide, the C-terminal c-myc tag (tag) followed by the KDEL peptide 
sequence are indicated. 
Preparation of protoplasts and transient gene expression. 
Protolasts were obtained from transformed tobacco plants expressing scFv antibodies in the 
ER and cytosol at a level of 1% and 0.2 % of total soluble protein (Schouten et al., 1996) by 
the method described by (Denecke et al., 1989). As a control protoplasts were isolated from 
untransformed tobacco leaves (N. tabacum cv. Samsun NN) 
For transient expression assays the same procedure was used to obtain protoplasts from 
tobacco leaves (A/, tabacum cv. Samsun NN). Then plasmid DNA was introduced into the 
protoplasts according to the polyethylene glycol procedure as described by (Denecke et al., 
1989). 
Analysis ofintrachain disulfide bonds. 
The protoplasts from stable transformants or from a transient expression assay, expressing 
both scFv-SK and scFv-CK proteins, were separated from the incubation medium and lysed 
by adding an equal volume of 10 mM Tris-HCI, pH 8.0, 1 mM EDTA, 1 mM Pefabloc, 80 mM 
N-ethylmaleimide (NEM) and subsequent vortexing. The suspension was kept at 0°C for 5' 
and at room temperature for 10'. The chloroplasts were pelleted by centrifugation and to the 
the supernatant was split into two portions. The first portion received one forth volume 
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4xSDS-PAGE sample buffer, containing 244 mM Tris-HCI, pH 6.8, 8% (w/v) SDS, 50% (w/v) 
glycerol, and the second portion received 4xSDS-PAGE sample buffer and dithiothreitol 
(DTT) to a final concentration of 55 mM. Both samples were boiled for 5'. To the DTT 
containing portion NEM was added to a final concentration of 200 mM and incubated 15' at 
room temperature. The proteins were pelleted by ethanol precipitation and subsequent 
centrifugation. After drying the pellet was resuspended in 1xSDS-PAGE sample buffer with 
0.008% (w/v) bromophenolblue. Protein samples were loaded on a 13% SDS-
polyacrylamide gel (Leammli, 1970) (Bio-Rad mini protean system). After electrophoresis the 
proteins were transferred to a PVDF membrane (Millipore) by electroblotting. For 
immunodetection the membranes were incubated with 1:1000 diluted 9E10 monoclonal 
antibody (Munro and Pelham, 1986), followed by a 1:5000 diluted rat-anti-mouse alkaline 
phosphatase conjugate (Jackson Immuno Research). The blots were stained in 0.1 M 
ethanolamine-HCI pH 9.6, supplemented with 4 mM MgCI2, 5-bromo-4-chloro-3-indolyl 
phosphate (0.06 mg/ml) and nitro blue tetrazolium (0.1 mg/ml). The relative molecular 
weights of the proteins were estimated with pre-stained low range molecular weight markers 
(Bio-Rad). 
Analysis of interchain disulphide bonds. 
Protoplasts transiently expressing scFv-SK and scFvser-SK were separated from the 
incubation medium. The protoplasts were separated from the incubation medium and lysed 
by adding an equal volume of 10 mM Tris-HCI, pH 8.0, 1 mM EDTA and 1 mM Pefabloc SC 
(Boehringer), and subsequent vortexing. The chloroplasts were pelleted by centrifugation at 
13000xg for 2'. For western analysis one third volume 4xSDS-PAGE sample buffer was 
added to an aliquot of the supernatant, equaling 3x10" protoplasts. DTT and 
bromophenolblue were added to final concentrations of 40 mM and 0.008% (w/v), 
respectively, and the samples were boiled at 100°C for 5 minutes. For non-reducing gel 
electrophoresis DTT was omitted during sample preparation. The protein samples were 
analyzed by SDS-polyacrylamide gel followed by electroblotting and immunodetection as 
described. 
Affinity of oxidized and reduced anti-cutinase scFv for its antigen. 
The affinity of the oxidized and reduced scFv for cutinase was determined by both 
quantitative ELISA. To prevent disulfide bridge formation during sample preparation 
alkylated protein samples were prepared as followed. The proteins were extracted by 
grinding 0.2-0.4 g tobacco leaves in liquid nitrogen to a fine powder. The powder was 
transferred to an eppendorf tube and mixed 1:2 (w/v) with 10mM Tris-HCI, pH8.0, 5mM 
EDTA, 60mM NEM, 1mM Pefabloc SC (Boehringer) and subsequent vortexing. As a control 
extracts were prepared in the presence of 4% ethanol (the solvent of NEM) instead of NEM. 
The suspension was kept at 0°C for 5' and at room temperature for 10'. Insoluble material 
was removed by centrifugation at 13.000xg. To the supernatant 25% (v/v) 5xPBS, 0.5% 
(v/v) Tween, 5% (w/v) skimmed milk powder was added. Serial dilutions were made in 
1xPBS-0.1% (v/v) Tween (PBST), 1% (w/v) skimmed milk powder, and loaded on an ELISA 
plate. 
After a transient expression assay the protoplasts, transfected with pRAP-scFv-CK, pRAP-
scFv-SK and pUCAP35S, were separated from the incubation medium and lysed by adding 
an equal volume of 10 mM Tris-HCI, pH 8.0, 1 mM EDTA and 1 mM Pefabloc SC 
(Boehringer), and subsequent vortexing. The suspension was kept at 0°C for 5' and at room 
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temperature for 10' and the chloroplasts were pelleted by centrifugation at 13000xg for 2'. 
The supernatant was diluted with 5 volumes of PBST-1.25 % (w/v) skimmed milk powder 
and loaded on a 96-well ELISA plate which had been coated overnight with 2.5 ng/ml 
cutinase in 50 mM sodium carbonate, pH 9.6 (100 |il/well). After blocking for 30 minutes with 
200 |J PBST-5% skimmed milk powder per well the plates were washed and 100 JLXI protein 
extract per well was added. The plate was incubated for 2 hours. After washing with PBST 
each well was incubated for another two hours with 100 nl anti c-myc tag antibody 9E10 (1 
ng/(xl) in PBST-1% skimmed milk powder. Then, after washing three times with PBST, the 
wells were incubated for 1 hour with alkaline phosphatase conjugated rat-anti-mouse 
antibody (Jackson Immuno Research), diluted 1:5000 in PBST-1% skimmed milk powder. 
Finally the wells were washed five times with PBST. 100 JLXI Substrate (0.75 mg/ml p-
nitrophenylphosphate in 1M diethanolamine, pH 9.8) was added and the OD405 was 
monitored. All incubations were carried out at 37°C. 
Results 
Presence of disulphide bonds in the scFvs located in the ER and cytosol. 
We previously generated transgenic tobacco plants expressing functional scFv-CK and 
scFv-SK antibodies which were located in the cytosol and ER, respectively (Schouten et al., 
1996, 1997). Therefore, the scFv-SK antibody contains a signal sequence, for translocation 
into the ER, combined with the ER retention signal KDEL (Pelham, 1989). The scFv-CK, 
located in the cytosol, lacks the ER translocation signal. All scFv antibodies carry the c-myc 
tag sequence for detection purposes. 
To compare the in vivo redox state of the disulfide bridges in the cytosolic scFv-CK and ER 
located scFv-SK synthesized in the transgenics and in a transient expression assay we 
isolated protoplasts from transgenic tobacco leaves according to the procedure used for a 
transient expression assay. The protoplasts were cooled and immediately lysed in the 
presence of the sulphydryl alkylating agent N-ethylmaleimide (NEM), to block free thiols and 
prevent rearrangements of disulfide bonds. The scFv proteins were analyzed by SDS-PAGE 
followed by western blotting and immuno-detection using the anti-c-myc antibody, 9E10 (Fig. 
2). The transgenic tobacco protoplasts showed under non-reducing conditions for both scFv-
CK and scFv-SK a protein band at 32 kDa, the estimated molecular weight of the scFv 
antibodies, and at approximately 65 kDa (Fig. 2A, lanes 1 and 3). In the presence of the 
reducing agent DTT only a protein band at 33 kDa was detected (Fig. 2A, lanes 2 and 4). No 
protein bands were detected in protoplasts obtained from the plants transformed with the 
empty transformation vector pCP033T (Fig. 2A, lane 5). Apparently, as reported before 
(Biocca et al., 1995), the reduction of the two intramolecular disulfide bridges in an scFv 
antibody results in the shift in migration from 32 to 33 kDa. The 65 kDa band present in both 
the scFv-CK and scFv-SK is only present under oxidizing conditions (i.e. in the absence of 
DTT) and, as reported before (Schouten et al., 1996), shows antigen binding capabilities. 
This suggests it to be an scFv dimer, formed through intermolecular disulfide brigde 
formation by the cysteine residue present in the linker peptide (Fig. 1). Thus in transgenic 
tobacco both the cytosolic scFv-CK and ER located scFv-SK are present in a oxidized state. 
The protoplasts from the transient expression assay synthesizing scFv-SK also showed the 
32 kDa and 65 kDa protein bands under non-reducing conditions and the 32.5 kDa band 
under reducing conditions (Fig 2B, lanes 3 and 4). Both under non-reducing and reducing 
58 
Chapter 5 
(kDa) 
80 
red. 
ox. 
DTT -
B 
dimer ^ 
redv 
ox." 
-50 
-32 
-28 
-80 
-50 
-32 
-28 
1 
Fig. 2. Determining the redox state of cysteine residues present in scFv-SK and scFv-CK proteins 
expressed by stably transformed plants and in a transient expression assay. Panel A: Western blot of 
total protein from stably transformed tobacco plants expressing scFv-CK and scFv-SK, in the absence 
(-) or presence (+) of the reducing agent dithiothreitol (DTT). The scFv proteins were detected with 
the anti-c-myc antibody 9E10. The reduced (red.) and oxidized (ox.) scFv proteins and the presumed 
scFv dimer (dimer) are indicated. As control a tobacco plant stably transformed with the empty 
transformation vector pCP033T was used (Control). Panel B: Western blot of total protein from 
protoplasts, transfected with the vectors containing the scFv-CK and scFv-SK gene cassettes, in the 
absence (-) or presence (+) of the reducing agent DTT. The scFv proteins were detected with the anti-
c-myc antibody 9E10. The reduced (red.) and oxidized (ox.) scFv proteins and the presumed scFv 
dimer (dimer) are indicated. As a control a vector without scFv gene cassette was used (Control). 
conditions the protoplasts from the transient expression assay synthesizing scFv-CK showed 
the 32.5 kDa (Fig 2B, lanes 1 and 2). Only a weak background was detected in the transient 
expression assay when the empty expression vector pUCAP35S was expressed (Fig. 2B, 
lane 5). Therefore, in contrast to scFv-SK, the transiently expressed scFv-CK lacks the 
intramolecular and intermolecular disulfide bridges and thus is present in a reduced state. 
This situation differs from the oxidized scFv-CK present in stable transformed plants. 
Analysis of the scFv dimer formation. 
To ascertain that the 65 kDa protein observed in the transgenic plants is formed through 
disulfide bridge formation using the cysteine present in the linker we modified the linker 
region in the scFv-SK gene (Fig. 1). The cysteine coding triplet (TGT) was changed into a 
serine coding triplet (TCT), creating the scFvser-SK gene. We anticipated that, if the cysteine 
residue in the linker peptide was involved in dimer formation, scFvser-SK expression would 
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not result in the formation of the disulfide band under non reducing conditions. We only 
modified the scFv-SK gene since we wanted to analyze the 65 kDa band through a transient 
expression assay. Since, as mentioned before, the scFv-CK synthesized in a transient 
expression assay does not form disulfide bridges a transient expression assay with a 
modified scFv-CK would be useless to obtain the required information. 
The scFv-SK and scFvser-SK genes were both expressed transiently in tobacco protoplasts 
and the synthesized scFv proteins were analyzed by western blotting and immuno-detection, 
using the anti-c-myc antibody, 9E10 (Fig. 3). Under non-reducing conditions scFv-SK 
expression resulted in a weak 32 kDa and relatively strong 65 kDa protein band and the 
scFvser-SK expression resulted only in a 32 kDa protein band (Fig. 3, lanes 1 and 2). Under 
reducing conditions both scFv-SK and scFvser-SK expression resulted in 32 kDa protein 
bands (Fig. 3, lanes 4 and 5). Under both conditions, only a weak background was detected 
in the transient expression assay with the empty expression vector pUCAP35S (Fig. 3, lanes 
3 and 6). The 65 kDa band is only formed under non-reducing conditions when the cysteine 
is present in the linker peptide, indicating that the 65 kDa protein represents a dimerized 
scFv. 
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Fig. 3. Determining the role of the cysteine residue present in the linker peptide of scFv-SK in dimer 
formation. Western blot of total protein from protoplasts, transfected with the vectors containing the 
scFv-SK and scFvser-SK gene cassettes, in the absence (-DTT) or presence (+DTT) of the reducing 
agent dithiothreitol. The scFv proteins were detected with the anti-c-myc antibody 9E10. The scFv 
monomer and dimer proteins are indicated. As a control a vector without scFv gene cassette was used 
(Control). 
Redox state influences binding properties ofscFv-CK. 
We are very interested if the redox state of the 21C5 anti-cutinase scFv affected binding to 
the antigen cutinase. To determine the affinity by ELISA, we first prepared samples from 
transgenic tobacco leaves expressing scFv-CK, scFv-SK and, as a control, untransformed 
tobacco (N. tabacum cv. Samsun NN) in the presence of NEM. To exclude possible negative 
effects on the affinity by NEM (Goto and Hamaguchi, 1979) we also prepared samples in the 
absence of NEM. The concentration of the scFv in these crude protein homogenates (Fig. 
4A, insert) was calculated by comparison with different concentrations of purified Ec-scFv. 
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Fig. 4. Antigen-binding activity of scFv antibodies present in crude protein homogenates from leafs of 
stably transformed tobacco plants, assayed by ELISA using the anti-c-myc antibody. A western blot to 
detect scFv-CK and scFv-SK (Fig. 4A, insert) with the anti-c-myc antibody 9E10 was used for 
calculating scFv concentrations by comparison with different concentrations of purified scFv from 
E.coli. Serial dilutions of the scFv-CK (A)and scFv-SK (o) protein homogenates and purified scFv from 
E.coli (Ec-scFv) (x, -NEM; • , +NEM) were incubated in wells coated with 250 ng cutinase. Individual 
points represent mean values of duplicate trials with standard deviations (error bars). Protein samples 
were prepared in the presence (Panel A; +NEM) and in the absence (Panel B; -NEM) of the sulphydryl 
alkylating agent N-ethylmaleimide. 
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the 21C5 anti-cutinase scFv expressed in the periplasm of E. coli (Schouten et al., 1996), on 
SDS-PAGE followed by western blotting and immuno-detection using the anti-c-myc 
antibody, 9E10. 
Serial dilutions, in duplicate, of the scFv-SK and scFv-CK and untransformed tobacco 
samples were loaded on an ELISA plate coated with cutinase. As a reference duplicate 
serial dilutions of NEM treated purified Ec-scFv were included in the assay. Fig. 4A shows 
the comparison of the antigen-binding activity of scFv-CK, scFv-SK, both in the crude 
trangenic plant exctracts, and purified Ec-scFv. Apparently, the binding properties are very 
similar. The plant proteins in the crude homogenates did not affect the OD405 values, as was 
deteremined for the control samples, prepared from untransformed plants (not shown). 
Treatment with NEM does not affect the antigen binding properties of the anti-cutinase scFv 
since the samples prepared in the absence of NEM also show no significant difference in 
antigen-binding activity in the same experiment (Fig. 4B). 
Next NEM treated samples were prepared from the protoplasts transfected with the scFv-CK 
and scFv-SK expression vectors and the empty vector pUCAP35S as described before. As 
shown the migration rate and the presence of the 65 kDa protein band indicates the redox 
state of the scFv antibody. Western analysis of the protoplasts showed for scFv-SK the 32 
and 65 kDa band, indicating the oxidized nature, and for scFv-CK the 33 kDa protein band 
indicating the reduced nature (Fig. 5A). The concentration of the scFv in these crude protein 
homogenates was calculated at 8 ng/jul for both scFv-SK and scFv-CK by comparison with 
different concentrations of Ec-scFv on SDS-PAGE followed by western blotting and immuno-
SK CK MW (kDa) 
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Fig. 5. Binding of transiently expressed scFv-SK and scFV-CK antibodies to cutinase. Panel A: 
Western blot of total protein homogenates prepared in the presence of NEM from protoplasts, 
transfected with the vectors containing the scFv-CK and scFv-SK gene cassettes in the absenceof the 
reducing agent DTT was used for calculating scFv concentrations by comparison with different 
concentrations of purified scFv from E.coli. The scFv proteins were detected with the anti-c-myc 
antibody (9E10). Panel B: Protein homogenates containing 150 ng of the scFv-CK and scFv-SK and 
serial dilutions of scFv purified from E.coli were incubated in wells coated with 250 ng cutinase in 
triplicate. The serial dilutions were used to calculate the amount of bound scFv-SK and scFV-CK to 
cutinase. The bars represent the mean values of bound scFv-SK and scFV-CK with standard 
deviations (error bars), corrected for the protoplast homogenate transfected with the epmty vector 
pUCAP35S. The antibodies were detected with the anti-c-myc antibody (9E10). 
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detection using the anti-c-myc antibody, 9E10. ELISA samples were prepared and an ELISA 
binding assay was performed in triplicate using 150 ng scFv-CK and scFv-SK. To calculate 
binding serial dilutions of NEM treated Ec-scFv was included, in duplicate, in the assay. Fig. 
5 shows the comparison of the antigen-binding activity of scFv-CK and scFv-SK, both in the 
crude trangenic plant exctracts, and Ec-scFv. Since the antigen-binding activity of the Ec-
scFv was similar to oxidized scFv-SK and scFv-CK we calculated from the Ec-scFv 
reference that the OD405 value correlated to a concentration of 130.8±5.1 ng scFv-SK per 
well, after correcting for the background caused by aspecific binding of plant proteins from 
the crude homogenate (Fig. 5B). The scFv-CK OD405 correlated to 8.0+0.8 ng per well. It can 
therefore be concluded that in comparison to the oxidized scFv-SK less than 10% of the 
scFv-CK remained bound to cutinase. The alkylation of the cysteines by NEM did not cause 
the reduction in binding strength of the reduced scFv-CK as was determined by sample 
preparation in the absence of NEM (not shown). This indicates that the reduced scFv-CK 
antibody has a considerable reduced binding strength when compared to the oxidized scFv-
SK and scFv-CK. Apparently, the absence of intramolecular disulfide bridges has a 
considerable negative effect on the binding strength of the anti-cutinase scFv. 
Discussion 
The capability of an scFv antibody to form disulfide bridges in the cytosol is remarkable. 
Protein disulfide isomerase (PDI), a catalyst in the oxidative folding, is not present in the 
cytosol and the GSH/GSSG ratios of 30:1 to 100:1 (Hwang ef a/., 1992) do not favor 
disulfide bridge formation. It was calculated that RNase A, which efficiently refold at a 
GSH/GSSG ratio of 2:1 in the presence of PDI, would not be able to refold at the cytosolic 
GSH/GSSG ratios, both in the presence and absence of PDI (Hwang ef a/., 1992). This 
demonstrates that disulfide bridge formation in proteins is very much dependent on the 
GSH/GSSG ratio of the subcellular compartment. Cell-free translation assays in the 
presence of PDI and added bacterial chaperones showed that an scFv antibody fragment 
folds better at mildly reducing conditions, i.e. a GSH/GSSG ratio of 10:1 at 1.1 mM total 
glutathione, then at oxidizing conditions (Ryabova er a/., 1997). The bacterial chaperones did 
not promote the proper disulfide bridge formation and it was suggested that PDI merely 
served in disulfide rearrangements rather than in disulfide formation. Our results indicate that 
in vivo disulfide bridge formation in scFvs is possible at GSH/GSSG ratios found in the plant 
cytosol. Consequently, if these ratios correspond to the ratios found in the cytosol of cultured 
CRL-1606 hybridoma cells (Hwang ef a/., 1992) the scFv antibody is capable of forming 
disulfide bridges at GSH/GSSG ratios of 30:1 or higher. However, it is possible that in plants 
this ratio deviates or that the GSH concentration is relatively low. The total GSH/GSSG ratio 
of the phloem exudates of Cucurbita (Alosi ef a/., 1988) and Ricinus (Szerderkenyi ef a/., 
1997) was calculated at 13:1 and 3:1, respectively. Since phloem exudates represents the 
cytosol of a plant cell this total GSH/GSSG ratio represents the cytosolic ratio. In addition, in 
pumpkin leaves low concentrations of total GSH were measured (Rennenberg and Filner, 
1982). The concentration of GSH also has great influence on disulfide bridge formation in 
proteins (Gilbert, 1990) 
The presence of certain eukaryotic cytosolic chaperones (Ruddon and Beddows, 1997) may 
facilitate the efficient folding of the V|_ and VH domains and prevent aggregation through 
erroneous disulfide bridge formation. Once folded into the native structure, the disulfide 
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bridges are inaccessible for reduced glutathion due to a tight surrounding structure 
(Glockshuber ef al., 1992; Goto and Hamaguchi, 1979). That folding is accurate is 
emphasized by the 202' linker derivative with the cysteine residue. Even this extra cysteine 
does not result in an abberant disulfide bridge formation and results in a partial but rather 
organized dimerization. 
As demonstrated by the transient expression experiments, the plant cytosol can also be 
reducing enough to prevent disulfide bridge formation. This confirms that the redox state of 
the plant cytosol is not fixed and that redox modulation may play an important role in the 
physiology of the plant cell as suggested before. Why the cytosol of protoplasts is more 
reducing remains a question. Incubation of the protoplasts after transfection occurs in the 
dark and therefore the cytosol is presumed to be more oxidized when compared to 
illuminated protoplasts (Cseke and Buchanan, 1986). This should favor disulfide bridge 
formation. It may well be that the protoplasts, which are kept under non-natural conditions, 
protect themselves against an oxidative stress situation. The levels of GSH in foliar tissues 
has been shown to increase under various oxidative stress conditions (Alscher, 1989). 
Furthermore, extracellular added GSH was also shown to act as an activator of the 
transcription of genes encoding the cell wall hydroxyproline-rich glycoproteins and phenyl 
propanoid biosynthetic enzymes in cultured suspension cells or protoplasts of bean, 
soybean, and alfalfa (Wingate era/., 1988; Choudhary etal., 1990). 
Our results also raise the question whether such oxidative stress reactions also apply for 
other eukaryotic cell types. In other words, is the GSH/GSSG ratio in the cytosol of cultured 
animal cells higher than the ratio in the cytosol of the tissue from which the cells are 
derived? If in all cases the scFv functionality is indeed a marker for the presence of disulfide 
bridges, the reported successes with respect to cytosolic expression of scFvs for introducing 
resistance against pathogens, like viruses (Tavladoraki et al., 1993; Duan ef a/., 1994; Jiang 
ef al., 1995; Mhasilkar et al., 1995; Shaheen ef a/., 1996), or modifying phenotypic traits 
(Owen et al., 1992; Biocca ef al., 1993 and 1994; Werge ef al., 1994; Fecker ef a/., 1997) 
would imply the presence of disulfide bridges. However, Biocca ef al. (1995a) reported that a 
functional cytosolic anti-p21ras scFv, expressed in Xenopus oocytes, lacked disulfide bridges. 
To date, nothing is known about disulfide bridge formation in scFv antibodies in the cytosol 
of other eukaryotic cell types. 
As the results show, scFv antibodies can also form intermolecular disulfide bridges in the 
plant cytosol. Maciejewski ef al. (1995) reported the functional expression of an anti-HIV1 
reverse transcriptase Fab fragment in the cytosol of lymphoid cell lines, leading to a 
blockade of virus replication. Although it was demonstrated that uninfected cells expressed 
unassembled Fab fragments, i.e. without intermolecular disulfide bridges, it may have been 
that assembly may have occured during infection since HIV infection strongly reduces the 
intracellular reduced glutathion concentration (Garaci ef al., 1997). 
Our results also demonstrate that scFv antibodies without disulfide bridges can be found as 
a soluble protein in the plant cytosol and its stability does not seem to be affected. This is in 
contrast to heterologous scFv expression in £. coli (Glockshuber ef al., 1992) where the 
formation of the intramolecular disulfide bonds in both the variable heavy and light domains 
are considered crucial for stability. Apparently, next to the redox potential, the environment 
of the plant cytosol differs in other aspects from the £. coli cytosol. It was demonstrated by 
Freund ef al. (1997) that in vitro an scFv antibody folds through an early and fast folding 
intermediate followed by a slow folding proces into the final structure. As mentioned, certain 
chaperones, not present in the cytosol of E. coli, may play an important role in stabilizing and 
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maintaining a folding intermediate of the scFv antibody. It may therefore be that the disulfide 
bridge formation required for the final folding steps to acquire the fully folded structure is 
prevented due to the reducing environment. 
This report illustrates that it is impossible to predict a priori to what extent a given protein 
sulphydryl will remain reduced in the cytosol. This was also suggested by Pineiro et a/. 
(1994). Bacterial genes coding for the cytosolic enzymes phoshotransferase II (NPTII) and 
p-glucuronidase (GUS) were transiently expressed in the cytosol of tobacco protoplasts. 
Since the typical GSH/GSSG ratio in Escherichia coli ranges from 50:1 to 300:1 they 
reasoned that the GSH/GSSG ratio of 30:1 to 100:1 in the plant cytosol was not reducing 
enough to prevent disulfide bridge formation in these enzymes, resulting in a reduced 
stability. Thus, in cases disulfide bridges determine functionality and/or stability of a protein, 
the result of heterologous expression of the coding gene may be difficult to foresee. 
Expression in plant cytosol of functional scFvs has proven to be feasible and 
therefore offers good perspective with respect to their use in intracellular 
immunization and immuno modulation approaches. However, the choice of the 
expression system should be made carefully and guarantee a redox state of the 
heterologously expressed protein which represents the situation in the natural tissue. 
Transient expression assays may therefore be only representative for protein 
expression levels and not for functionality in the cytosol. 
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ScFv stability in the secretory pathway of plant cells: Influence 
of linker peptides, the scFv architecture, CH1 residues and the 
addition of camel hinges and IgM CH4 domains 
Abstract 
Single-chain antibody fragments (scFvs) are often poorly secreted by plants. This 
may be caused by the primary amino acid sequence of the Fv domains, the 
orientation of the VL and VH domains in the scFv construct, the choice of the linker 
peptide and the amino acids present at the C-terminal ends. It was investigated 
whether scFvs could be secreted more efficiently by modifying the elements 
necessary for constructing an scFv, without changing the Fv domains. Different 
linker peptides were compared. Amino acids potentially susceptible to degradation in 
one linker were replaced. ScFvs were constructed in VL- VH and VH -VL orientation, 
relative to the N- and C-terminus of the protein. Residual CH1 fragments were 
removed. Although, some of these modifications did increase intracellular 
accumulation of partially degraded scFv, secretion was not improved. However, 
addition of an IgM CH4 domain and camel long or short hinges, for the purpose of 
multimerizing scFv fragments, did improve both the intracellular accumulation and 
the secretion of non-degraded scFv fragments. Quality control mechanisms involved 
in proper folding and processing of antibody fragments in the secretory pathway are 
discussed. 
Introduction 
ScFv expression in the secretory pathway of plants is generally poor (Bruyns et al., 1996; 
Fecker et al., 1996; Whitelam and Cockburn, 1996), unless the scFv was retained in the 
endoplasmic reticulum (ER) using a C-terminal KDEL sequence (Artsaenko et al., 1995; 
Schouten et al., 1996 and 1997; Phillips et al., 1997). Only Firek et al. (1994) obtained 
substantial secretion of an scFv antibody in tobacco leafs and Fiedler and Conrad (1995) 
reported expression of a secretory scFv in tobacco seeds when using a seed specific 
promoter. 
So far, analysis of the expression pattern of chimeric scFv genes showed that the 
transcription levels obtained were in general normal, indicating that bottlenecks are 
predominated by (post-)translational processes. 
Expression in mammalian cells showed that different scFvs were secreted at various rates 
and that secretion could be improved by changing specific amino acids (Jost et al., 1994). 
Studies with scFv molecules, produced in Escherichia coli, have shown that the linker 
connecting the variable domains may have an impact on scFv stability. The number of amino 
acid residues (Pantaliano et al., 1991; Whitlow ef al., 1993; Desplancq et al., 1994) and the 
residues used (Glockshuber et al., 1990; Yasui et al., 1994) influence scFv folding, 
aggregation and its sensitivity to proteolytic degradation. Also, the scFv architecture (VL-VH 
versus VH-VL) has been shown to influence expression not only in £ coli (Anand et al., 1991; 
Tsumoto et al., 1994) but also in mammalian cells (Dorai et al., 1994). Some scFvs often 
include residues from the constant domains for cloning purposes. The stability of such scFv-
constructs might be affected by these amino acid sequences. Also, the addition of whole 
antibody domains, for the purpose of dimerizing scFvs and generating a F(ab')2-like 
molecules, has been reported to stabilize scFvs in vivo (Hu et al., 1996). 
elements by introducing them into the model scFv 21C5, which is poorly secreted in 
transgenic tobacco (Schouten et al., 1996). The 202' derived peptide linker (Bird et al.. 
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1988), present in the initial 21C5 scFv (see: Chapter 3), was modified as well as replaced by 
the frequently employed (Gly4Ser)3 linker (Huston et a/., 1988). The scFv was constructed in 
both VL-VH and VH-VL architecture. Furthermore, the first five amino acids of the CH1 domain, 
initially present in scFv 21C5, were deleted. Finally, to monitor the efficiency of 
multimerization and its influence on expression we added the camel long hinge or short 
hinge (Hamers-Casterman, et al., 1993) and/or the IgM CH4 domain (Smith and Morrison, 
1994) to the scFv antibodies. Using transient assays in tobacco leaf protoplasts and stably 
transformed tobacco plants we monitored the influence of these modifications on the intra-
and extracellular scFv accumulation of a secretory version of scFv 21C5. Possible quality 
control mechanisms involved in retention of secretory scFvs in the ER are discussed. 
Materials and methods 
Cell lines, strains and cloning vectors. 
Cloning procedures were according to Sambrook ef a/., (1989) using the Escherichia coli 
strains DH5oc, TG1 and 190 and the scFv cloning vectors pNEM5 and pNEM5K (Schouten et 
a/., 1996). 
To obtain vectors for transient expression assays in tobacco the expression cassette from 
pCP031 (van Engelen ef a/., 1994), containing the doubled CaMV 35S promoter, Almv 
untranslated leader, and Tnos terminator, was cloned into pUCAP (Engelen et al., 1995). 
The resulting vector pUCAP35S was provided with a kappa signal peptide (van Engelen et 
al., 1994). Standard scFv cassettes with and without carboxy terminal KDEL extensions, 
obtained from inserts in the vector pNEM5 and pNEM5K, were inserted in pUCAP35S. In the 
thus obtained vectors pRAP35-S (Secretory) and pRAP35-SK (Secretory KDEL) scFv 
encoding regions can be cloned as Sa/I/Smal or Sal\INot\ fragments between the kappa 
signal peptide and the c-myc tag or c-myc tag plus C-terminal KDEL extension. 
For transformation into tobacco (N. tabacum cv. Samsun NN) the system based on the 
binary vector pBINPLUS (van Engelen et al., 1995) was used. 
ScFv modifications. 
To modify the 202' derived peptide linker of the scFv21C5 anti-cutinase the VL domain was 
reamplified using the primers L5d (5'-GGTGTCGACGGTGATGTTKTGATGACCCAAA-3') and 
Vkqlvc(5'-AGCCGGATCCGTTGGATTTACCCTCGAGTTTTATTTCCARCTTKGTSCC-3'). 
Restriction sites in the primers, used in the cloning procedure, are underlined. PCR 
conditions were used as described by Schouten et al., (1996). The amplified fragment was 
inserted into the Sa/l/BamHI restricted vector pNEM5. The resulting scFvLNC (Fig. 1A, 
superscript refers to the modified linker residues at positions 1, 6 and 16 in single amino acid 
code) contains a linker flanked by Xho\ sites. With respect to the original scFv (scFvRSC) the 
Arg at position 1 of the linker is replaced by Leu. The Ser at position 6 by Asn, thereby 
creating a consensus site for N-linked glycosylation (Kornfeld and Kornfeld, 1985). A control 
scFv construct in which the Asn is replaced by Ser, but the Leu at position 1 retained, was 
obtained by inserting an Xho\IBamH\ adapter fragment (5'-TCGAGGGTAAATCCTCCG-3' and 5'-
GATCCGGAGGATTTACCC-3'). This scFv is referred to as scFvLSC (Fig. 1A). 
In order to replace the Cys in the linker of the scFvRSC by Ser, the Xho\ site Pwvll fragment 
was replaced by a suitable adapter (5'-TCGAGTCTGAGGTCCAG-3' and 5'-CTGGACCTC-
69 
AGAC-3') resulting in the scFvRSS. The scFvLNS and scFvLSS were constructed by exchanging 
Sa/l/SamHI fragment of scFvRSS with the same fragments of scFvLNC and scFvLSC (Fig. 1 A). 
To delete the five amino acids of the CH1 domain the scFvRSS was reamplified with the 
primers L5d and 3FvH (5'-CTCCCCGGGTGARGAGACDGTGAS-3l and cloned as Sa/I/Smal 
fragment in pNEM5 resulting in the scFvACH1 (Fig. 1A). 
To construct a scFv 21C5 with (Gly4Ser)3 peptide linker in the VL-VH and VH-VL architecture 
the original scFv construct (scFvRSC) was reamplified with a suitable set of primers. For the 
scFvL(gs)H the VL domain was amplified by the primers L5d and 3KGS (5'-ACCGGATCC-
TCCACCTCCAGAACCACCACCCCCTTTTATTTCCARCTTKGTSCC-3,). For the VH domain the 
combination of primers 5HGS (5'-GGTGGAGGATCCGGTGGAGGAGGTTCTGAGGTYCAGCTG-
CARSA-3') and VH33b (5'-GCACGTTAACCCCGGGTGTTGTTTTGGCTGCAGAGACAG-3") was 
used. Fragments were cloned jointly into pNEM5 and the plant cloning vectors pRAP35-S 
and pRAP35-SK (Fig. 1B). 
The scFvH(9S)L was cloned similarly from amplification products of the VH domain reamplified 
with primers H5c (5'-CGGTGTCGACTCCGAGGTCCAGCTGCAACARTC-3') and 3HGS (5'-
ACCGGATCCACCACCACCAGATCCCCCTCCGCCTGARGAGACDGTGAS-3•) and the VL domain 
reamplified with primers 5Lgs (5'-GGTGGTGGATCCGGTGGAGGTGGTTCTGATGTTGTGATG-
ACCCAAACT-3') and 3K (S'-TCCCCCGGGTTTTATTTCCARCTTKGTSCC-S') (Fig. 1B). 
To obtain an scFv antibody fragment with short hinge the scFvL(9S)H gene construct was 
reamplified using L5d as 5'-end primer and 3HSH (5'-TCCCCCGGGGCACTTTGGGCACT-
TGCAGACCTCGTTAGTTCCTGA(G/A)GAGAC(T/A/G)GTGA(C/G)-3') as 3'-end primer. This 
scFvL(gs>H-SH gene construct (Fig. 1C) was cloned as Sa/I/Smal fragment in Sa/I/Smal 
digested pRAP35-S and pRAP35-SK. 
To obtain an scFv antibody fragment with long hinge the scFvL(gs)H gene construct was 
reamplified using L5d as 5'-end primer and 3HLH (5'-TCCCCCGGGGAATCTTTGGCTCT-
GA(A/G)GAGAC(T/A/G)GTGA(G/C)-3') as 3'-primer. This fragment was Sa/I/Smal digested and 
ligated to the blunt/Wofl long hinge fragment (LH1-4), resulting in the scFvL(9S)H-LH gene 
construct. The LH1-4 fragment was constructed out of four oligonucleotides, LH1 (5'-AAC-
CACAACCTAAGCCACAACCACAACCTCAACCACAACCTAAG-3') and LH2 (5'-pCCACAA-
CCTAAGCCAGAGCCTGAGTGCACTTGCCCTAAGTGCCCAGC-3') for the plus strand, and LH3 
(5'-GGCCGCTGGGCACTTAGGGCAAGTGCACTCAGGCTCTGGCT-3') and LH4 (5'-pTAGGTTGT-
GGCTTAGGTTGTGGTTGAGGTTGTGGTTGTGGCTTAGGTTGTGGTT-3,) for the minus strand. 
The scFvL(gs)H-LH gene construct (Fig. 1C) was cloned as in Sa/l/A/ofl digested pRAP35-S 
and pRAP35-SK. 
To construct the scFvL(9S)H, scFvL(9S)H-SH and scFvL(gs)H-LH genes with CH4 domain poly(A)+ 
RNA from an IgM producing hybridoma cells was isolated using the QuickPrep Micro mRNA 
purification kit (Pharmacia) and cDNA was synthesized using the Pharmacia First Strand 
cDNA Kit. The CH4 domain was amplified using the 5CH4 (5'-CCCAGCGGCCGCACCCAG-
GAATGAGGTGCACAAACATCCA-3') as 5'-end primer and H3M (5'-GTGCGTTAACCCCGG-
GTTAATAGCAGGTGCCGCCTGTGTC-3') as 3'-end primer. This CH4 domain was subcloned as 
Not\IHpa\ fragment in /Vofl/EcoRV digested pNEM5, resulting in pNEM5-CH4. Next the CH4 
domain was isolated as Not\IXba\ from pNEM5-CH4 and cloned into NotllXbal digested 
pRAP35, resulting in pRAP-CH4 (Fig. 1C). The scFvL(gs)H, scFvL(gs)H-SH and scFvL(gs)H-LH 
gene constructs cloned in pRAP35 were isolated as Sa/I/Nofl fragments and each cloned in 
Sa/l/A/ofl digested pRAP-CH4 (Fig. 1C). 
All constructs were checked by sequencing (Sanger er a/., 1977). 
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Fig. 1. Schematic representation of the various 21C5 scFv constructs. A, modifications in the 202'-
derived linker peptide; B, scFvs with (Gly4Ser)3 linker peptide; C, scFvs with extra domains for the 
formation of F(ab')2-like fragments. The amino acid sequences (single letter code) of the linker 
peptide, the long and short hinges and both the N- and C-terminus of the variable domains are 
indicated. The different 202' linker variants are named according to the amino acids present at position 
1, 6 and 16 in peptide linker. In RSSACH1 five amino acids of the CH1 region are removed. The 
constructs with (Gly4Ser)3 linker (gs) are named according to the orientation of the VL (L) and VH (H) 
domain. All fragments in panels A and B and the scFv <0S)HLH fragments were constructed in the 
absence (-S) and presence (-SK) of the ER retention signal of KDEL. Abbreviations: SP, signal 
peptide; VL, variable domain of the light chain; VH, variable domain of the heavy chain; CH1, first 
constant domain of the heavy chain; LH, camel lgG2 long hinge; SH, camel lgG3 short hinge; CH4, 
mouse IgM CH4 domain; tag, c-myc tag. 
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Tobacco transformation and protein analysis. 
The scFvL(9S)H-S and -SK and scFvL(9S)H-LH-S and -SK expression cassettes, cloned in 
pRAP35-S and pRAP35-SK, and the scFvL(9S)H-CH4-S and scFvL(8S)H-LH-CH4-S, cloned in 
pRAP35-S, were isolated as Pac\-Asc\ fragments and transferred to the binary vector 
pBINPLUS as described by van Engelen et al. (1995). The resulting plasmids were 
introduced into Agrobacterium tumefaciens strain LBA4404 (Hoekema et al., 1983). Tobacco 
transformation was conducted according to Horsch et al. (1985). Kanamycin resistant 
transformants were regenerated and total soluble proteins were extracted by grinding leafs 
essentially as described by Schouten et al. (1996). The proteins were analyzed by loading 
30 |xg total soluble protein homogenate on an SDS-polyacrylamide gel followed by electro 
blotting and immundetection as described. 
Preparation of protoplasts and transient gene expression. 
Protoplasts were obtained from leafs of untransformed and transformed tobacco plants (A/. 
tabacum cv. Samsun) by the method described by Denecke et al. (1989). 
For transient expression assays DNA was introduced into untransformed tobacco 
protoplasts according to the polyethylene glycol procedure (Denecke et al., 1989). To study 
the scFv glycosylation in vivo the transfected protoplasts were incubated in TEX medium 
supplemented with 10 ng/ml tunicamycin (Iturriaga ef al., 1989). 
The protoplasts were separated from the incubation medium and lysed by adding an equal 
volume of 10 mM Tris-HCI, pH 8.0, 1 mM EDTA and 1 mM Pefabloc SC (Boehringer), and 
subsequent vortexing. The chloroplasts were pelleted by centrifugation at 13000xg for 2 min 
and the supernatant was used for further analysis. 
For the secretion experiments the protoplasts from individual stable transformants 
expressing scFvL(gs)H-LH-SK, scFvL(9S)H-CH4-S, scFvL(9$)H-LH-CH4-S proteins were isolated 
and resuspended in TEX medium to a concentration of 2x106 protoplasts/ml. 500nl 
protoplast suspension expressing scFvL(9S)H-LH-SK was mixed with 500^1 protoplasts 
expressing scFvL<gs)H-CH4-S or scFvL(gs)H-LH-CH4-S and incubated at 25°C for 72 hours. 
Where indicated the TEX medium contained 10 ng/ml tunicamycin, 4 mM (3-mercaptoethanol 
(2-ME), or 10 mM dithiothreitol (DTT). 
The protoplasts were separated from the incubation medium and lysed by adding an equal 
volume of 10 mM Tris-HCI, pH 8.0, 1 mM EDTA, 1 mM Pefabloc, 80 mM N-ethylmaleimide 
(NEM) and subsequent vortexing. The suspension was kept at 0°C for 5' and at room 
temperature for 10'. The chloroplasts were pelleted by centrifugation and the supernatant 
was isolated. For western analysis to the medium samples NEM was added to a final 
concentration of 40 mM. The solution was kept at 0°C for 5 min and at room temperature for 
10 min. 
Protein analysis. 
For western analysis one third volume of 4xSDS-PAGE sample buffer, containing 244 mM 
Tris-HCI, pH 6.8, 8% (w/v) SDS, 50% (w/v) glycerol and 1 mM Pefabloc SC (Boehringer), 
was added to an aliquot of the supernatant, equalling 3x10" to 5x10" protoplasts. The 
secreted proteins were precipitated by adding 3 volumes ethanol to the TEX medium, 
equalling 3x10" to 5x104 protoplasts, 30 min incubation at -80°C, and centrifugation at 
13000xg for 15 min. The protein pellets were dissolved in 1xSDS-PAGE sample buffer. The 
samples were incubated at 100°C for 5 min and bromophenolblue was added to a final 
concentration of 0.008% (w/v). 
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For deglycosylation samples from protoplasts or medium, equalling 3x10" to 5x10" were 
denatured by adding SDS and p-mercaptoethanol to final concentrations of 0.5% (w/v) and 
0.2% (v/v), respectively, and incubation at 100°C for 5 minutes. The proteins were 
deglycosylated using PNGase F (500 units/fxl, New England Biolabs) or endo Hf (1000 
units/|il, New England Biolabs) according to the manufacturer's protocol. As a control a 
mock treated sample, in which water replaced the enzyme, was included in the assay. The 
samples were incubated at 37°C for 2 hrs and bromophenolblue was added to a final 
concentration of 0.008% (w/v). 
Aliquots equalling 3x104 to 5x10" protoplasts were loaded on a 13% SDS-polyacrylamide gel 
(Leammli, 1970; Bio-Rad mini protean system). After electrophoresis the proteins were 
transferred to a PVDF membrane (Millipore) by electro blotting. For immunodetection the 
membranes were incubated with 9E10 monoclonal antibody (1 (ig/ml) (Munro and Pelham, 
1986), followed by rat-anti-mouse alkaline phosphatase conjugate (0.2 |ig/ml, Jackson 
Immuno Research). Alternatively, the scFv proteins were detected using a rabbit polyclonal 
anti-21C5 serum, precleared from antibodies reacting to the constant domains, followed by a 
goat-anti-rabbit alkaline phosphate conjugate (0.2 (xg/ml, Jackson Immuno Research).CH4 
domains were detected using a anti IgM alkaline phosphate conjugate (0.2 ng/ml, Southern 
Biotechnology Associates Inc.). The blots were stained in 0.1 M ethanolamine-HCI pH 9.6, 
supplemented with 4 mM MgCI2, 5-bromo-4-chloro-3-indolyl phosphate (0.06 mg/ml) and 
nitro blue tetrazolium (0.1 mg/ml). The relative molecular weights of the proteins were 
estimated with pre-stained low or broad range molecular weight markers (Bio-Rad). 
Quantification ofscFv. 
To analyze the functional binding of the different scFv versions, an ELISA was carried out as 
described previously (Schouten et a/., 1996). To enable the quantification of the ELISA 
readings a dilution series of known amounts of purified bacterially expressed scFvRSC was 
loaded in the same experiment. After correction for background, the ELISA readings were 
converted to nanograms by interpolation. 
The expression levels of the different constructs were compared by statistical analysis using 
the Mann-Whitney test or the Wilcoxon matched-pairs test. 
Results. 
Modifications in the 202'-derived linker peptide. 
If poor expression of scFv molecules is a consequence of the amino acid sequences 
introduced in the cloning procedure, modifications of these features might allow us to find 
factors that could improve expression. The modifications were introduced into a model scFv 
construct (Fig. 1, A and B). Replacing the Cys by a Ser is expected to prevent the formation 
of dimers. Introduction of the LNS motif is expected to result in N-linked glycosylation. 
Substitution of the Arg by Leu may prevent proteolysis in the endoplasmic reticulum (ER). 
Both secretory versions as well as KDEL versions were constructed. The latter allow 
retention in the ER and were used as controls since addition of the C-terminal KDEL 
sequence results in high intracellular accumulation (Schouten et al., 1996 and 1997). All 
constructs were tested in transient expression assays. The effect of the different 
modifications was assayed by SDS-PAGE followed by immunoblotting using the anti-c-myc 
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Fig. 2. Western blot analysis of non-reduced protein extracts of tobacco protoplasts transfected with 
the different 202'-derived linker constructs with (+) and without (-) C-terminal KDEL extension. For 
detection the anti-c-myc antibody was used. C, mock transfected protoplasts. 
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Fig. 3. Analysis of glycosylation state of scFv molecules in protoplasts, transiently expressing scFv-
SK constructs with modified 202'-derived linkers. Panel A: Western blot analysis after incubation in the 
presence (+) or absence (-) of tunicamycine. C, mock transfected protoplasts. Panel B: Western blot 
analysis after treatment (+) or mock treatment (-) of the protein samples with N-glycosidase F 
(GlycoF). Proteins were detected using the anti-c-myc antibody. 
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tag antibody 9E10 as probe to visualize expressed proteins. A typical western blot of the 
intracellular accumulation of the different scFv molecules is shown in Figure 2. The different 
SK-versions clearly accumulate intracellularly. In contrast, the S-versions are hardly 
detectable. For both the scFv-SK and the scFv-S versions the amounts present in the 
medium fall below the detection limit for western blot analysis. This lack of secretion is not a 
property of the tobacco protoplasts since transfection with full size antibody constructs 
resulted in secretion (not shown). 
Modified single chain antibody fragments targeted to the secretory pathway. 
To address the question where in the secretory pathway breakdown takes place we studied 
the expression of the scFv-SK constructs having the Asn-X-Ser consensus sequence for re-
linked glycosylation in the linker, as depicted in Fig. 1A. The presence of this sequence 
caused both scFvLNS-SK and scFvLNC-SK molecules to migrate as 33 and 32 kDa bands (Fig. 
2A, lanes 2 and 6). Upon treatment with N-glycosidase F these molecules migrated solely as 
a 32 kDa product, whereas the mobility of scFvLSS-SK was not affected (Fig. 3A). Similar 
observations were made after endoglycosidase H treatment (results not shown). Results, 
congruent with these findings were obtained in vivo using the glycosylation inhibitor 
tunicamycin (Fig. 3B). The presence of this compound only induced a shift in migration in the 
scFvLNS-SK and scFvLNC-SK (not shown), thus confirming that the asparagine in the linker 
was indeed glycosylated. Since N-linked glycosylation takes place exclusively in the ER, the 
experiments also prove that the scFv-SK molecules are translocated to this compartment. In 
addition, the Endo H sensitivity indicates that these fragments do not reach the medial Golgi 
or later parts of the secretory pathway. 
Intermolecular linker peptide disulfide bonds. 
Previously, we concluded that formation of the 65kDa protein is dependent on the presence 
of the cysteine in the linker and that the product represents a true scFv dimer (see Chapter 
5). The state of this cysteine in the linker can therefore be considered as a free cysteine until 
dimerization occurs. Again, analysis of protoplasts expressing scFvLSC-SK and scFvRSC-SK 
showed that the molecule is predominantly migrating at the dimeric position (Fig. 2 lanes 4 
and 10) in the absence of the reducing agent DTT. Remarkably, the scFvLNC-SK molecules 
showed no dimerization (Fig. 2, lane 2). Apparently, glycosylation prevents dimerization. 
Since the four cysteines, supposed to be participating in the intra domain disulfide bonds, 
are still present in all different linker constructs, this indicates that these cysteines are not 
involved in the intermolecular disulfide bond. 
The scFv constructs with 202' linker variations are functional. 
In order to determine the amounts of scFv expressed and to establish functionality an ELISA 
was carried out using anti-c-myc and anti-Fv antibodies for detection. Assuming that 
differences in the peptide linker do not substantially influence scFv affinity, comparisons can 
be made between the different constructs. Statistical analysis showed some significant 
differences (Table 1). The amount of scFv present in the medium does not differ significantly 
between the scFv-S and scFv-SK constructs (p>0.05; Mann-Whitney) independent of the 
variations in the linker. The use of an anti-Fv antiserum did not change this figure. 
Apparently, these results are not influenced by the possible loss of the c-myc tag. This 
exposed tag is potentially sensitive to digestion by several proteases. Thus, the low apparent 
secretion levels could be caused by degradation of the scFv in the culture medium. However 
this is rather unlikely since purified scFvRSC incubated in spent medium is stable during the 
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Table 1. Expression levels based on functional binding of the scFv molecules carrying 
different 202' derived linker modifications, (n) is number of experiments 
A. Intra (c) and extracellular (m) scFv accumulation of the 
202'-derived linker variants represented as ng/3x104 
protoplasts or equivalent part of the medium. 
-SER- -CYS-
RS* 
LS* 
LN* 
RS*-KDEL 
LS*-KDEL 
LN*-KDEL 
c 
m 
c 
m 
c 
m 
c 
m 
c 
m 
c 
m 
7.9 ± 9.4 (6) 
0.7 ± 1.1 (6) 
1.5 ± 1.2(4) 
0.47 ± 0.67 (4) 
9.8 ±11.9(5) 
1.5 ± 1.8(5) 
81.6 ± 102.7(7) 
3.0 ± 5.9 (7) 
39.4 ± 17.2(2) 
0.6 ± 0.1 (2) 
101.0 ± 114.0(6) 
2.8 ± 3.0 (6) 
5.8 ± 5.5 (7) 
1.0 ± 1.0(7) 
2.5 ± 1.8(3) 
0.1 ± 0.1 (3) 
3.5 ± 1.5(3) 
0.8 ± 0.3 (3) 
61.9 ±60.5 (9) 
0.9 ± 1.4(9) 
24.4 ± 24.8 (3) 
0.3 ± 0.4 (3) 
44.6 ± 32.4 (4) 
0.6 ± 0.3 (4) 
B. Ratio of intracellular scFv accumulation in absence and 
presence of KDEL (S/SK) 
1. RS* 
2. LS* 
3. LN* 
-SER-
0.129±0.090(9) 
0.025±0.009 (2) 
0.079±0.027 (4) 
-CYS-
0.117±0.062(6) 
0.083 (1) 
0.060±0.011 (2) 
76 
Chapter 6 
incubation periods used in the protoplast assays (Fig. 4). 
The intracellular scFv accumulation shows a strong effect of the C-terminal KDEL extension 
(Table 1.). Independent of the linker employed the intracellular accumulation of the scFv-SK 
molecules is much higher than of the scFv-S (p<0.001; Mann-Whitney). Since the variances 
are rather high it is difficult to establish the influence of the individual changes in the linker. 
The only difference with significance is the replacement of Cys by Ser, in the scFv-SK, which 
increases the intracellular scFv accumulation (0.025< p <0.05 ; Wilcoxon). This is in 
agreement with the results concerning scFv-SK accumulation when analyzed on a western 
blot (Fig. 2) and could indicate that also in plants a free thiol dependent quality control 
mechanism of protein assembly is acting. 
anti-tag anti-Fv 
hrs. 1 3 17 1 3 17 (kDa) 
-50 
-32 
-28 
-18 
Fig. 4. Western blot analysis to determine stability of purified scFvRSC, incubated for 1, 3 and 17 hours 
in spent protoplast culture medium. scFvRSC was detected using the anti-c-myc tag and anti-Fv 
antisera. 
Expression ofscFv 21C5 with (Gly4Ser)3 linker and deleted CH1 residues. 
The low intra- and extracellular accumulation of the scFv-S constructs prompted us to 
investigate whether the often used (Gly4Ser)3 linker as well as the scFv domain order (VL-VH 
versus VH-VL) would improve expression. Since the scFvH(gs)L does not carry the five amino 
acid residues of the CH1 region the influence of this change was also studied in a scFv with 
202' linker in the VL-VH architecture (scFvRSSACH1). For comparison the 202' linker construct 
(scFvRSS) was included. Medium samples from protoplasts transfected with the different 
constructs did not show any signal on western blots indicating that secretion of the scFv was 
not improved. Immunoblotting of the intracellular proteins using the anti-c-myc antibody 
revealed that, again, only the constructs with KDEL had detectable expression levels (Fig. 5, 
panel A). In contrast, after decorating the blot with the anti-Fv antiserum, the scFvLgsH-S was 
detectable at an expression level similar to that observed with scFv-SK (Fig. 5, panel B, lane 
3). This material migrated predominantly as a 30 kD product, indicating that the c-myc tag 
was cleaved off. It is noteworthy that this only applied for the VL-VH configuration. The 
increased intracellular accumulation indicates that the (Gly4Ser)3 linker improves the scFv 
stability. The absence of the five amino acids of the CH1 did not influence scFv expression 
since the amount observed were not different for the scFvRSS and scFvRSSACH1 (Fig. 5, lanes 5 
to 8). In all, this implies that the difference in expression between the VL-VH and VH-VL 
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Fig. 5. Western blot showing intracellular accumulation in transfected tobacco protoplasts of the 
secretory (-KDEL) and ER retained (+KDEL), scFv",gs,L (HgsL), scFvL,9S,n (LgsH), scFvKoa (RSS) and 
scFvRssAcrii ( R S S A ) Ul 
Fv (panel B) antisera. 
scFvRSSA (RSSA) under non-reducing conditions, detected by the anti-c-myc tag (panel A) and anti 
configuration results from the domain orientation and not from the presence of the constant 
domain residues. 
The functional analysis of these constructs based on ELISA was well in agreement with the 
results observed on western blots (Table 2). Secretion did not differ for the scFv-S and scFv-
SK constructs (p >0.05; Mann-Whitney), independent of the antibody (anti-Fv or anti-c-myc) 
used for detection. However, as compared to the 202' linker constructs, the (Gly4Ser)3 linker 
had a significant effect on the intracellular accumulation of functional scFv in the scFv-S 
format (0.01 < p <0.025 ; Mann-Whitney). The amount of functional scFv in the VL-VH 
configuration does reach a level similar to that observed for the scFv-SK constructs. 
The reverse domain orientation resulted only in minute amounts of functional scFvH(gs)L in 
lower ELISA readings and deduced scFv amounts (Table 2.). 
Expressed scFvH(9S)L constructs with camel hinges and/or IgM CH4 domain can dimerize. 
The previous results showed that the choice of linker, the architecture and the residues 
present at the C-terminus do not improve scFv secretion. Apparently, the structural 
properties of the variable domains dominate in determining whether transport through the 
secretory pathway is attenuated. Quality control mechanisms for protein export present in 
the secretory pathway may be responsible for this. This might be overcome by the addition 
antibody constant domains and camel antibody hinges, which would also mediate 
dimerization. 
The IgM CH4 domain or the camel lgG2 long hinge (LH) were added C-terminally to scFvL(gs)H 
antibodies (Fig. 1C). In addition, we constructed scFvL(gs)H genes carrying a LH or camel 
lgG3 short hinge (SH) coding sequence combined with the CH4 coding sequence. The 
influence on both overall protein stability in the secretory pathway and secretion were 
studied. We chose the scFvL(9S)H since the transient assay indicated that this antibody 
fragment remained relatively stable intracellularly in the absence of the ER retention signal. 
The scFvL(gs)H with long hinge was constructed as both a secretory fragment (scFvL(gs)H-LH-
S) and ER retained fragment (scFvL(gs)H-LH-SK). 
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Table 2. Intra (c) and extracellular (m) scFv accmulation of the constructs with gly-ser linker and 
ACH1 (ng/3x10 protoplasts) 
LgsH 
LgsH-KDEL 
HgsL 
HgsL-KDEL 
RSS 
RSS-KDEL 
ACH1 
ACH1-KDEL 
c 
m 
c 
m 
c 
m 
c 
m 
c 
m 
c 
m 
c 
m 
c 
m 
a-Tag 
6.67 ± 9.73 (4) 
1.00 ± 1.08(3) 
66.1 ±72.2(6) 
1.76 ± 2.15(4) 
0.42 ± 0.49 (4) 
0.13 ±0.16 (4) 
28.9 ± 25.0 (5) 
0.37 ± 0.51 (4) 
2.39 ± 3.41 (5) 
0.68 ± 1.23(5) 
77.3 ± 139.8(6) 
4.32 ± 8.15(6) 
3.73 ± 5.95 (3) 
0.99 ± 1.68(3) 
114.8 ± 190.7(3) 
2.55 ± 3.42 (3) 
a-Fv 
32.7 ± 58.1 (4) 
1.52 ±2.32 (3) 
34.1 ± 52.2 (6) 
0.94 ± 1.43(4) 
1.93 ±2.66 (4) 
0.71 ± 1.26(4) 
8.35 ± 7.75 (5) 
0.29 ± 0.33 (4) 
2.37 ± 3.63 (5) 
0.72 ± 1.30(5) 
49.9 ± 102.0(6) 
2.49 ± 4.39 (6) 
4.64 ± 7.76 (3) 
0.35 ± 0.48 (3) 
45.4 ± 76.7 (3) 
0.61 ± 0.74 (3) 
In western blot analysis under non-reducing conditions of protoplasts transfected with both 
scFvL(9S)H-LH-S and scFvL(gs)H-LH-SK constructs two protein bands were detected 
intracellular^ with estimated sizes of 38 and 75 kDa when using anti-Fv antiserum (Fig. 6, 
lanes 4 and 5). The scFvL(9S,H-LH-SK protoplasts also showed a weaker band of 
approximately 57 kDa, which probably represents a degradation product of the 75 kDa 
band.No protein bands were observed when using anti-lgM. Using anti-Fv or anti-IgM 
antiserum for the scFvL(gs,H-CH4-S construct protein bands, estimated at 42, 45 and 90 kDa, 
were detected (Fig. 6, lane 6). For the scFvL(8S)H-LH-CH4-S protein bands estimated at 46, 50 
and 100 kDa and two distinct but faint bands in the range of 150 to 200 kDa (Fig. 6, lane 7) 
were found. Expressing scFvL(gs)H-SH-CH4-S resulted in the detection of 47 and 95 kDa 
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Fig 6. Western blot showing intracellular accumulation in transfected tobacco protoplasts of 
the secretory (-S) and ER retained (-SK) scFvL(9S)H (lanes 2 and 3), scFvL(9S)H-LH (lanes 4 and 
5) and the secretory scFvL(9S)H-CH4-S (lane 6), scFvl(9S>H-LH-CH4-S (lane 7) and scFvL(9S)H-SH-
CH4-S (lane 8) under non-reducing conditions, detected by the anti-c-myc tag (panel A) and 
anti-IgM (panel B) antisera. 
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bands. These results show that the secretory scFv constructs can accumulate intracellular^ 
as a non-degraded protein. 
Under reducing conditions only the 38 kDa (scFvL(gs)H-LH-SK), the 46 kDa (scFvL(9S)H-CH4-S), 
the 50 kDa (scFvL(ss)H-LH-CH4-S) and 47 kDa(scFvL(gs)H-SH-CH4-S) bands were detected 
(Fig. 7, lanes 5, 6 and 7). As shown previously, no scFvL(gs)H-S protein and the 32 kDa 
scFvL(9S)H-SK protein were detected when using the anti c-myc antibody (Fig. 7, lanes 1 and 
2). Apparently, although some protein degradation occurs the ER retained scFvL(9s)H-LH-SK 
and secretory scFvL(9S)H-LH-S, scFvL(gs)H-CH4, scFvL(gs)H-SH-CH4 and scFvL(gs)H-LH-CH4 are 
synthesized and a large fraction (up to approximately 70%) forms dimers. 
Since both the LH and the CH4 contain free cysteines for disulfide bridge formation it is, in 
theory, possible that the scFvL(gs)H-LH-CH4-S dimers themselves can form multimers, 
possibly even up to IgM-like pentamers. The results obtained with scFvL<gs>H-LH-CH4-S 
suggests that this is happening. Since the blotting efficiency of high molecular weight 
proteins is very poor, the results may give a significantly distorted impression of the 
percentage of these possible high molecular multimers. However, if these multimers are 
being formed the percentage is rather low since intensity of scFvL(9s)H-LH-CH4-S protein band 
under reducing conditions is not dramatically increased when compared to the intensity of 
the scFvL(g$)H-LH protein band (Fig. 7, lanes 5 and 6). 
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Fig. 7. Western blot showing intracellular accumulation in transfected tobacco protoplasts of the 
secretory (-S) and ER retained (-SK) scFvL(9S)H (LgsH), scFvL(gs)H-LH (LgsH-LH) and the secretory 
scFvL(gs) -CH4-S (LgsH-CH4-S), scFvL(gs)H-LH-CH4-S (LgsH-LH-CH4-S), scFvL(°s)H-SH-CH4-S (LgsH-SH-
CH4-S) under reducing conditions, detected by the anti-c-myc tag (panel A) and anti-IgM (panel B) 
antisera. 
81 
Expression ofscFvs in stable transformed tobacco plants. 
The transient expression experiments reported in the previous section suggested that the 
modified scFvL(9S)H constructs were promising with respect to protein expression level and 
stability. Therefore, stable tobacco transformants were generated expressing the scFvL(gs)H-
S, scFvL(9S)H-SK, scFvL(9S)H-LH-S, scFvL(8S)H-LH-SK, scFvL(9S)H-CH4-S and scFvL(gs)H-LH-CH4-S, 
and analyzed. 
The presence of the scFv proteins in the individual transgenics was determined by western 
blot analysis of leaf extracts under non-reducing conditions. Using anti-Fv antiserum in 50% 
of the screened scFvL(9S,H-S transgenics, a protein band of 30 kDa was observed, whereas in 
all of the screened scFvL(gs)H-SK transgenics a protein band of 32 kDa was found (Fig. 8, 
lanes 1 and 2). Like in the transient expression assay, the 30 kDa band could not be 
detected with anti-c-myc antiserum (results not shown) indicating that the c-myc tag is 
cleaved off. 
In 33% of the scFvL(gs)H-LH-S transgenics screened two weak protein bands of 75 and 65 
kDa could be observed, which were undetectable with anti-c-myc (not shown), whereas all of 
the scFvL(9S)H-LH-SK transgenics showed a strong protein band of 75 kDa and a weaker 
protein band of 38 kDa (Fig. 8, lanes 3 and 4), which both were also detectable with anti-c-
myc (not shown). 
In all of the scFvL(gs)H-CH4-S and scFvL(9S)H-LH-CH4-S transgenics screened, protein bands of 
45 and 90 kDa and of 50 and 100 kDa were detected, respectively (Fig. 8, lanes 5 and 6). 
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blot analysis of leaf homogenates from sta 
secretory (-S) and ER retained (-SK) scFvL(9S)H (LgsH), scFvLl9S'"-LH (LgsH-LH) and the secretory 
scFvL(9S)-CH4-S (L(gs)H-CH4-S), scFvL<gs)H-LH-CH4-S (L(gs)H-LH-CH4-S) under non-reducing 
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conditions, detected by the anti-Fv antiserum. 
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The same bands were detected with anti-IgM antiserum (not shown). The highest expression 
level for both scFv constructs was estimated at 0.2% of total soluble protein. 
All these results are congruent with those obtained with the transient expression assays, 
although the intracellular degradation of scFvL(gs)H-LH-S is more distinct in stable 
transformants. 
ScFvL<9S>H-LH-CH4 constructs are secreted. 
Next, the efficiency of scFvL(9S)H-CH4-S and scFvL(9s,H-LH-CH4-S secretion by the transformed 
plants was analyzed. To determine secretion protoplasts were prepared from the scFvMgs>H-
CH4-S, scFvL(gs>H-LH-CH4-S and scFvL(gs)H-LH-SK synthesizing transgenics (Fig. 8, lanes 6, 7 
and 4 , respectively). Since scFvL(ss)H-LH-SK is retained in the ER, it can be used as a 
control to determine whether all protein detected in the medium was actually secreted by 
living protoplasts or released by cell disruption and degradation. The scFvL(gs)H-LH-SK 
contains the c-myc tag, whereas both the scFvL(gs,H-CH4-S and scFvL(gs)H-LH-CH4-S lack the 
c-myc tag but contain the CH4 domain. By using the proper antibodies for detection, anti-c-
myc or anti-IgM, it is possible to discriminate between the different scFv constructs. 
Protoplasts expressing scFvL(9S)H-LH-SK were mixed in equal numbers with those expressing 
scFvL(9S)H-CH4-S or scFvL(gs)H-LH-CH4-S and incubated for 72 hrs. Anti-IgM detection on 
western blot of the protoplasts from the scFvL(9S)H-CH4-S/scFvL(9S)H-LH-SK mix showed the 45 
kDa scFvL(9S)H-CH4-S monomer (Fig. 9, panel A, lane 1). An additional 32 kDa was found, 
probably representing a degradation product of scFvL(9S)H-CH4-S. In the same mix a clear 75 
kDa band and faint 55kDa band was visible when anti-c-myc detection was used (Fig. 9, 
panel B, lane 1). With both antisera no proteins were observed in the medium (Fig. 9, lane 4, 
panel A and B). Thus, during the assay the protoplasts remained intact and no detectable 
levels of scFvL(gs)H-CH4-S were secreted into the medium. 
In protoplasts of the scFvL(gs)H-LH-CH4-S/scFvL(9S)H-LH-SK mix the scFvL(9S)H-LH-CH4-S 50 
kDa monomer and 100 kDa dimer were detected with anti-IgM (Fig. 9, panel A, lane 2) and 
the 75 kDa scFvL(gs)H-LH-SK dimer together with a faint 55kDa protein band were detected 
with anti-c-myc (Fig. 9, panel B, lane 2). In the medium the 50 and 100 kDa scFvL(gs)H-LH-
CH4-S were detected with anti-IgM (Fig. 9, panel A, lane 5) and no scFvL(9S)H-LH-SK protein 
bands were observed with the anti-c-myc antiserum (Fig. 9, panel A, lane 5). This shows that 
both the monomeric and dimeric scFvL(gs)H-LH-CH4-S fragments are secreted at detectable 
levels into the medium. 
Intracellular scF\/-<9S>H-LH-CH4-S fragments are glycosylated and located in the ER. 
As demonstrated, the scFvL(9S)H-LH-CH4-S fragments also accumulated intracellular^. These 
fragments may be retained early in the secretory pathway. This can be analyzed by 
establishing the maturation of the N-linked glycosylation of the CH4 domain. ScFvL(gs)H-LH-
CH4-S expressing protoplasts were incubated for 72 hrs and total protein homogenates from 
protoplasts and medium was treated with N-glycosidase F or endoglycosidase H. The 
relative migration on western blot of the scFvL<gs)H-LH-CH4-S fragments is indicative for 
glycosylation. In the mock treated protoplast samples 50 kDa scFvL<gs)H-LH-CH4-S protein 
was detected using anti-IgM antiserum (Fig. 10, lane 1). In both the glycosidase F and 
endoglycosidase H treated protoplast homogenates the size was reduced to 48 kDa (Fig. 10, 
lanes 3 and 2, respectively). In the control, which were protoplasts from transformants stably 
transformed with the empty expression vector pRAP35, a relatively weak band was visible at 
50 kDa in the mock treated sample (Fig. 10, lanes 7). This band was not sensitive to N-
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Fig. 9. Location of scFvL(9S)H-LH-SK (-LH-SK), scFvL(ss)H-CH4-S (-CH4-S) and scFvL(°s)H-LH-CH4-S (-LH-
CH4-S), analyzed by western blotting. Equal numbers of protoplasts expressing scFvL(gs,H-LH-SK and 
scFvL(9S)H-CH4-S (lanes 1 and 4), and scFvL(9S)H-LH-SK and scFvL(gs)H-LH-CH4-S (lanes 2 and 5) from 
stable tobacco transformants were mixed and incubated in medium for 72 hrs. As a control protoplasts 
from transgenic tobacco, stably transformed with the empty expression vector pRAP35, were used 
(lanes 3 and 6). Protein samples (lanes 1 to 3) and medium (lanes 4 to 6), equaling 5x104 protoplasts, 
were separately analyzed, under non-reducing conditions, for the presence of antibody fragments. For 
detection the anti-IgM (panel A) or anti-c-myc (panel B) antiserum was used. 
84 
Chapter 6 
glycosidase F or endoglycosidase H treatment (Fig. 10, lanes 8 and 9) and was therefore 
considered to be aspecific. In the medium sample no significant differences in relative 
migration of the detected proteins could be found. In the mock treated and enzyme treated 
samples a protein smear of 50-51 kDa was present. The insensitivity of the scFvL<gs)H-LH-
CH4-S present in the medium for N-glycosidase F is unexpected. 
These results demonstrate that the scFvL(9S>H-LH-CH4-S fragments are translocated into the 
secretory pathway and are glycosylated. The Endo H sensitivity indicates that the 
intracellular scFvL(9S)H-LH-CH4-S fragments are retained in the ER or cis-Golgi prior to 
secretion. 
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Fig. 10. The glycosylation state of the intracellular (cells) and secreted (medium) scFvL(9S)H-LH-CH4-S 
expressed by a stable tobacco transformant. Western blot analysis of the protein samples after mock 
treatment (-) or treatment with endoglycosidase H (H) or N-glycosidase F (F). As a control protoplasts 
from transgenic tobacco, stably transformed with the empty expression vector pRAP35 were used. 
Proteins were detected using the anti-IgM antibody. 
Secretion of scF\/-<9S>H-LH-CH4-S is not primarily regulated by thiol mediated retention. 
Secretion of monomeric scFvL(9S)H-LH-CH4-S suggests that these fragments are not retained 
by thiol mediated quality control mechanism in the ER, which normally prevents the 
secretion of IgM molecules with free thiols in mammalian cells (Alberini et al., 1990). To 
determine whether this mechnism still plays some role in the secretion efficiency of 
monomers and dimers the scFvL<gs)H-LH-CH4-S/scFvL<9S)H-LH-SK protoplast mix was 
incubated in the presence of dithiothreitol (DTT) and p-mercaptoethanol (2-ME), which are 
known to interfere with this quality control mechanism (Valetti and Sitia, 1994). Analysis of 
protoplasts and incubation medium on western blot showed, in the presence of 2-ME, no 
significant reduction in the intracellular and extracellular accumulation of scFvL(9S,H-LH-CH4-S 
(Fig. 11, panel A, lanes 5 and 6) compared to the control (Fig. 11, panel A, lanes 1 and 2). 
ScFvL(gs)H-LH-SK accumulated only intracellular^ and to a slightly higher level, preferentially 
in the monomeric form (Fig. 11, panel B, lanes 1, 2, 5 and 6). Furthermore, the intensities of 
the detected protein bands indicate that for both scFvL<gs)H-LH-CH4 and scFvL(9S)H-LH-KDEL 2-
ME only slightly affects the formation of dimers. 
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In the presence of DTT accumulation levels of both intracellular and extracellular scFvL(gs)H-
LH-CH4-S were significantly reduced (Fig. 11, panel A, lanes 3 and 4). However, the 
intracellular accumulation level of scFvL(3S)H-LH-SK was slightly increased. For both 
fragments no or little dimer formation was detected. Apparently, DTT induces reduction and 
partial disassembly of scFvL(9S)H-LH-CH4-S, leading to a reduced stability when passing 
through the secretory pathway. 
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Fig. 11. Influence of reducing agents on the secretion of scFvL(9S)H-LH-CH4-S expressed by protoplasts 
derived from a stable tobacco transformant, analyzed by western blotting. Equal numbers of 
protoplasts expressing scFvL(9S)H-LH-SK and scFvL(gs'H-LH-CH4-S were mixed and incubated in TEX 
medium (untr.), or TEX medium supplemented with dithiothreitol (DTT) or p-mercaptoethanol (2-ME), 
for 72 hrs. As a control protoplasts from transgenic tobacco, stably transformed with the empty 
expression vector pRAP35, were used (lane 7). The protein samples from cells (C) and medium (M), 
equaling 5x104 protoplasts, were separately analyzed, under non-reducing conditions, for the 
presence of antibody fragments. For detection the anti-IgM (panel A) or anti-c-myc (panel B) antiserum 
was used. 
Tunicamycin increases scF^^-LH-C^-S secretion. 
To establish whether the efficiency in secretion of the scFvL(9S)H-LH-CH4-S fragments is 
influenced by the degree of glycosylate a scFvL(9S)H-LH-CH4-S/scFvL(9S)H-LH-SK protoplast 
mix was incubated in the presence tunicamycin for 72 hrs. Analysis of protoplasts and 
medium on western blot showed that in the presence of tunicamycin no scFvL(gs)H-LH-SK had 
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come into the medium (Fig. 12, panel B, lane 4) indicating that, like in the control (Fig. 12, 
panel B, lane 2), no cell disruption had occurred. 
Both incomplete disulfide bridge formation and incomplete glycosylation influences migration 
into the gel. Therefore, to exclude that possible incomplete disulfide bridge formation caused 
the differences in migration the scFvL(9S)H-LH-CH4-S fragments were analyzed on western 
blot under reducing conditions. This showed a reduction in intracellular accumulation and an 
increase in extracellular accumulation in the presence of tunicamycin when compared to the 
control (Fig. 12, panel A). The total amount of synthesized scFvL(9S)H-LH-CH4-S was not 
significantly influenced. Furthermore, the 50 kDa protein band was reduced in intensity 
whereas the 48 kDa protein band had increased in intensity, both in protoplasts and 
medium. Apparently, glycosylation of scFvL(gs)H-LH-CH4-S was not completely inhibited by 
tunicamycin. Although scFvL(9S)H-LH-SK contains no sites for N-linked glycosylation 
intracellular accumulation of this fragment was significantly reduced in the presence of 
tunicamycin (Fig. 12, panel B). Apparently, tunicamaycin inhibits scFvL(9S)H-LH-SK protein 
synthesis in tobacco protoplasts (Elbein, 1987). In all, the results indicate that the 
glycosylation process in the ER attenuates scFvL(9S)H-LH-CH4-S transport through the 
secretory pathway. 
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Fig. 12. Influence tunicamycin on the secretion of scFv lg -LH-CH4-S expressed by protoplasts 
derived from a stable tobacco transformant, analyzed by western blotting. Equal numbers of 
protoplasts expressing scFvL(9S)H-LH-SK and scFvL(9S'H-LH-CH4-S were mixed and incubated in TEX 
medium (untr.) or TEX medium supplemented with tunicamycin (tun.) for 72 hrs. As a control 
protoplasts from transgenic tobacco, stably transformed with the empty expression vector pRAP35, 
were used (lane 7). Protein samples from cells (C) and medium (M), equaling 5x104 protoplasts, were 
separately analyzed, under non-reducing conditions, for the presence of antibody fragments. For 
detection the anti-IgM (panel A) or anti-c-myc (panel B) antiserum was used. 
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Discussion 
The expression in plants of secretory single-chain Fv antibody molecules has been less 
straight forward as could have been expected on the basis of the expression levels obtained 
with full size antibodies, F(ab')2 and Fab fragments. Apparently the contributions of the 
constant domains play an important role in obtaining a stable export competent antibody 
structure. Therefore, with the lack of these contributions expression of secretory scFv 
molecules could be dominated by the primary amino acid sequence of the variable domains 
and their compatibility in the final structure (Glockshuber ef al., 1990; Rees et al., 1994). 
However, the final structure of the scFv can also be influenced by the introduced elements 
needed for scFv construction, like the orientation of the domains, the degree in which they 
still contain constant region residues and the length and amino acid sequence of the peptide 
linker used. Since these elements are more amenable to modification than the primary 
amino acid sequence we have evaluated these factors for the secretory format of the scFv 
21C5 (Schouten era/., 1996) 
The concept behind the amino acid changes in the 202' derived peptide linker was to 
decrease its potentially proteolytic sensitivity thereby preventing domain dissociation and 
degradation (Glockshuber et al., 1990). Removal of the dibasic amino acid sequence Lys-
Arg which is recognized by KEX-like proteases in the ER (Julius et al., 1984; Hein et al., 
1991) did not influence the accumulation and secretion of the scFv. The same was observed 
for the expression of individual light and heavy chains of full size antibodies (Hiatt et al., 
1993). Apparently, these sites are, even in the scFv format, buried in the folded structure 
before these proteases are encountered. 
Like the effect of N-linked glycosylation on the overall final structure of other proteins 
(Machamer and Rose, 1988) it could also help the scFv in folding or protecting its linker 
peptide by steric effects from cleavage by proteases (Dullis et al., 1982; Elbein, 1987). This 
modification did not improve the expression deficit of the secretory scFv. The amount of 
scFv-S expressed was too low to determine unambiguously whether it was indeed 
glycosylated. However the ER retained control constructs (scFvLNC-SK and scFvLNS-SK) were 
glycosylated indicating that the recognition sequence should also be accessible in the scFv-
S molecules. The glycosylation status of both scFvLNC-SK and scFvLNS-SK was only partial, 
probably as a result of the context of the recognition site (Machamer and Rose, 1988; 
Shakin-Eshleman et al., 1996). The fact that the glycosylated fraction is sensitive to endo H 
indicates that these molecules are present in the ER and/or cis-Golgi compartment (Pelham, 
1988), which is in agreement with the location of the KDEL receptor (Semenza et al., 1990; 
Lewis and Pelham, 1990). These results confirm the observations obtained with immunogold 
labeling (Artsaenko et al., 1995; Schouten et al., 1997). The fact that the accumulation 
cannot be increased is in contrast to what has been found for a different scFv molecule (Jost 
etal., 1994). 
The cysteine in the 202' derived linker could play a role in free thiol-mediated quality control 
of protein assembly (Fra ef al., 1993; Hammond and Helenius, 1994). The Cys to Ser 
mutation proved that the 65kDa product represents a dimer consisting of two scFv molecules 
connected by the cysteines in the peptide linker (see also: Chapter 5). The fact that we do 
not observe full dimerization could be caused by the acidic residue preceding the cysteine in 
the linker (Reddy et al., 1996). Therefore this residue could be of particular relevance in 
relation to quality control mechanisms. In agreement with this is the twofold higher 
accumulation in the scFv-SK constructs upon replacement of the cysteine. However this 
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modification had no beneficial effect on the accumulation of secretory scFv (scFv-S), both 
intra- and extracellularly. 
Despite the change of some of the apparent drawbacks in the amino acid sequence of the 
202' derived linker we never observed scFv secretion to a level found by Firek ef a/., (1994). 
Since they used a similar linker peptide these results might reflect differences in stability 
caused by the primary amino acid sequence of the variable domains. 
Surprising results were obtained with the (Gly4Ser)3 linker (Huston ef a/., 1988). This linker 
peptide has also been used in scFv antibodies expressed in planta (Tavladoraki ef a/., 1993, 
Fiedler ef a/., 1995 , Artsaenko ef a/., 1995; Bruyns ef a/., 1996). In these reports different 
architectures of the scFv have been employed. Therefore both scFvL(gs)H and scFvH(9s)L were 
created (Fig. 1B). These constructs showed the same expression results as the 202' linker 
constructs if the anti c-myc tag antibody was used for detection. However, using the anti-Fv 
antiserum it was found that the intracellular accumulation of the secretory scFv was 
increased, especially for the VL-VH architecture. The molecular weight of the expressed 
product was about 2 kDa smaller. This showed that the c-myc tag was removed since these 
molecules could not be detected with the anti c-myc tag antibody. 
The increased intracellular accumulation of scFv with the (Gly4Ser)3 linker, did not result in a 
concomitant improvement of secretion. The level of secretion was similar to that found for 
the 202' derived linker constructs. Experiments with full size antibody constructs 
(unpublished results) indicate that the protoplasts are export competent since large amounts 
of antibodies are found in the medium. Apparently the major part of the scFv molecules is 
retained in the cell. 
The (Gly4Ser)3 linker greatly improves the scFv stability, probably by decreasing proteolysis 
in the linker region. It thereby prevents the Fv regions to dissociate. However the removal of 
the c-myc tag indicates that the molecule still encounters proteases. Although we can 
exclude KEX-like proteases, it is unclear which proteases are responsible for this cleavage. 
As found for other scFv molecules the domain order influences protein yield and binding 
activity (Dorai ef a/., 1994, Tsumoto ef a/., 1994). The same was found for the 21C5 scFv 
with the (Gly4Ser)3 linker. The scFvH(gs)L constructs was expressed less efficiently than the 
construct with reversed configuration (scFvL(gs)H). Furthermore, the scFvH(9S)L constructs had 
a decreased affinity for the antigen or were more difficult to detect as a result of steric 
effects. 
The presence of peptide sequences from the CH1 region of the heavy chain in a scFv 
construct might influence its secretion as well as its stability. It has been shown that heavy 
chains were retained in the ER in the absence of the light chains. The CH1 domain is critical 
for this retention (Hendershot ef a/., 1987). In a scFv all residues on the former 
variable/constant domain interface become solvent exposed. On this interface the frequency 
of exposed hydrophobic residues is much higher than in the rest of the Fv fragment (Nieba 
ef a/., 1996). In our scFv 21C5 we left five CH1 residues at the C-terminus for cloning 
purposes. It follows that these residues could play an ambiguous role concerning the stability 
of the scFv. To study this feature these five amino acids were removed. However, the results 
obtained showed that this deletion was to no avail. 
Since secretion of full size antibodies and Fab fragments in plants is generally more 
successful, scFv constructs were made which could assemble into more full size antibody-
like molecules. There are many options to dimerize scFvs (Hoogenboom, 1997). We chose 
the IgM CH4 domain and the camel lgG2 long hinge and lgG3 short hinge. It was 
demonstrated previously that IgG antibodies could multimerize when the IgM CH4 domain 
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was added (Smith and Morrison, 1994). The use of the camel hinges for dimerization was a 
new approach. In camel the long and short hinges replace the CH1 domain. These hinges 
are of interest for multimerization purposes since they are normally stable in antibody 
molecules which lack light chains (Hamers-Casterman, et al., 1993) and do not arrest 
secretion by interaction with Bip, like the CH1 domain in murine IgG antibodies does 
(Hendershot et al., 1987). A combination of the two added to an scFv (scFvL(gs)H-LH-CH4-S 
fragments) may, in theory, not only form dimers but also multimeric forms of these dimers. 
About 50% of the scFvL(gs)H-LH-S, scFvL(9S)H-LH-SK and scFvL(gs,H-CH4-S fragments occurred 
as a dimer. Although in stable transformants, compared to scFvL(gs)H-S, slightly better 
scFvMgs)H-LH-S expression was obtained, degradation still occurred and expression levels 
were low. Relatively high scFvL(gs)H-CH4-S protein levels (estimated at 0.2% of the total 
soluble protein) were obtained without detection of significant degradation products. 
However, in contrast to what was expected, both monomeric and dimeric fragments were 
mainly detected intracellularly. Remarkably, when both domains were added (scFvL(gs)H-LH-
CH4-S) secretion was significantly improved. Since both monomers and dimers are secreted, 
intracellular transport competence and protein stability is not provided through dimer 
formation, as was found for IgM antibodies in animal cells (Alberini et al., 1990). 
The transient expression assays suggests that even polymeric scFvL<8s)H-LH-CH4-S 
fragments can be formed, although at a low percentage. In stable transformants however no 
polymeric fragments could be detected. The structural orientation of the cysteines may be 
such that they are preferentially involved in dimerization or the chaperones present may not 
be able to assemble scFvL(gs)H-LH-CH4-S fragments into polymers as efficiently as was found 
for chimeric lgG3-CH4 molecules in murine myeloma cells (Smith and Morrison, 1994). 
The predictability of these transient expression results for the scFv behaviour in transgenic 
plants is unclear. Transient expression assays with scFvL(gs)H-LH-S were promising and no 
intracellular degradation was visible. However, when stable transformants were analyzed 
one third expressed this fragment at a low protein level, whereas all of the scFvL(gs)H-SK 
transformants analyzed showed a relative high protein expression. Furthermore, scFvL(gs,H-
LH-S protein degradation was visible in all screened transformants. 
The analysis of the different scFv constructs allows us to follow part of the fate of scFv 
molecule in the secretory pathway. Previously, it was demonstrated that the scFvRSC-SK was 
translocated into the ER (Schouten et al., 1997). The deglycosylation experiments using the 
glycosylated scFv fragments confirm this. This is direct proof that the signal peptide exerts 
its function properly, like it did with the full size light and heavy chains (van Engelen et al., 
1994). The general consensus is that the immunoglobulin molecules are retained in the ER 
by interactions with GRP78 (BiP), GRP94 and calnexin (Bole et al., 1986; Melnick et al., 
1994; Degen and Williams, 1991) until they are properly processed and have attained their 
properly folded and assembled structure. Homologues for these accessory proteins have 
been found in plants (Fontes et al., 1991; Walther-Larsen er al., 1993; Huang et al., 1993) 
and it can therefore be assumed that the same mechanisms pertain in plant cells, although 
interactions with BiP are unlikely since scFvs lack the CH1 domain (Hendershot et al., 1987). 
From the ER onwards the pathway that scFv molecules follow diverges between the scFv-
SK and scFv-S versions. The scFv-SK molecules are recycled from the cis-Golgi back into 
the ER by their association with the KDEL receptor (Pelham 1992). The scFv-S protein is 
expected to leave the cell. However, despite its stability in the protoplast culture medium, it is 
only found in low amounts. Therefore, degradation may occur beyond the cis-Golgi. In 
mammalian cells some form of quality control mechanisms operates in post ER 
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compartments (Hammond and Helenius, 1995). Proteolytic processing of polypeptides 
occurs in the trans-Golgi compartment or later (Sambamurti ef a/., 1992; Lahiri, 1994; Deng 
et al., 1995; Cartwright and Higgins, 1996; Wilnow ef ai, 1996), indicating that specific 
proteases are located there 
Quality control mechanisms, present in the ER may be responsible for the arrest in 
intracellular transport. The same phenomenon has been reported for the behaviour of a 
single domain antibody in plants (Benvenuto et a/., 1991). In animal cells some scFvs 
(Marasco et a/., 1993; Jost et ai, 1994) and even individual light chains (Wu ef a/., 1983; Dul 
and Argon, 1990) show this lack of secretion. Based on our results for the scFvs with 
modified linker it is not possible to discriminate between impairment in exit from the ER or a 
later intracellular compartment. 
The results obtained with the secreting scFv fragment, scFvL(gs)H-LH-CH4-S, give a more 
detailed picture with respect to quality control mechanisms. The deglycosylation experiments 
demonstrate that these fragments have not passed the cis-Golgi, suggesting that a rate 
limiting step mediates the exit from the ER or cis-Golgi. This is probably not caused by the 
intermolecular disulfide bridge formation since both monomeric and dimeric fragments are 
secreted equally efficient into the medium. Due to the rigid rod shaped structure of the long 
hinge (Hamers-Casterman et al., 1993) and the positions of the cysteine residues it seems 
unlikely that intra molecular disulfide bridges within the long hinge and/or CH4 are present in 
the monomeric fragments. Furthermore, incubation with 2ME does not impair secretion, 
suggesting that the free cysteines are not involved in quality control of scFvL(gs)H-LH-CH4-S. 
2ME displays only positive effects on the secretion of IgM intermediates that are retained by 
disulfide interchange reactions involving the CH4 Cys575 reactions (Valetti and Sitia, 1994). 
Since DTT is more effective in reducing intra- and intermolecular disulfide bridges (Valetti 
and Sitia, 1994), the overall structure of scFvL(gs)H-LH-CH4-S is disrupted to a level that 
chaperones, involved in a correct folding, retain the fragment from being secreted. 
Additionally, this may indicate that, under natural conditions, the scFvL<g$)H-LH-CH4-S protein 
is correctly folded. 
Treatment with tunicamycin did result in a higher scFvL(8S)H-LH-CH4-S secretion level and 
lower intracellular accumulation, suggesting that the quality control mechanism with respect 
to glycosylation is the rate limiting step for secretion. Since tunicamycin prevents 
glycoproteins, and thus the CH4 domain, from being glycosylated, scFvL(gs)H-LH-CH4-S will 
not be bound to the chaperone calnexin (Hammond ef al., 1994). Normally, calnexin will 
retain only those glycoproteins which still carry glucose residues and, therefore, have not yet 
been properly trimmed. Noteworthy in this respect is that an IgM antibody which was 
designed to be secreted in tobacco was also found only intracellular^ (During et al., 1990). 
In all, this may suggest that the maturation of glycosylation of antibodies and antibody 
fragments in the ER in some cases proceeds relatively inefficient. Although the N-linked 
glycosylation process of proteins in plants is similar to that in mammals (Jones and 
Robinson, 1989), there are differences in added terminal residues (Sturm ef al., 1987). Hein 
et al. (1991) reported that an IgG antibody synthesized by plants differed from the same 
antibody synthesized by hybridoma cells with respect to glycosylation. This may explain why 
the secreted scFvL(gs)H-LH-CH4-S was not sensitive to GlycoF treatment. Glycosylation of the 
CH4 domain may also differ, resulting in a modification that is GlycoF resistant, as a 
consequence of the addition of a core a1-3 fucose (Tretter ef al., 1991). This kind of 
modification can be found frequently in plant glycoproteins (Sturm ef al., 1987). The nascent 
CH4 domain will rapidly begin with the formation of the proper domain structure the moment 
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it is translocated into the ER, which may make it difficult for modifying enzymes, not found in 
mammalian cells, to process the glycans. A chaperone involved in the quality control 
mechanism may therefore, similar to calnexin, prevent the partially processed protein from 
exiting the ER. 
Our results strongly suggest that the architecture and linker introduced in the scFv are not 
the main reason for a low secretion level. Apparently residues in the frameworks or 
complementarity-determining regions are responsible for this. In this respect it is interesting 
to note that in stable transformants we found relatively high amounts of non-degraded scFv, 
which was derived from a different antibody (unpublished results). Therefore, apart from the 
design, scFv secretion in plant cells probably depends also upon the primary amino acid 
sequence of the domains which influence the inherent stability of the combination of light 
and heavy chain variable domains, both of which can belong to considerable number of 
subtypes (Kabat ef a/., 1991). In full size antibodies probably the contributions of the variable 
regions to the total stability are low as compared to those of the constant domains 
(Glockshuber et a/., 1990) and therefore do not pose a strong selection against the use of 
certain combinations of subtypes. In a single-chain format and in an heterologous system 
however certain combinations of variable regions might highlight their less favourable 
association by a lowered expression and secretion level. The addition of extra constant 
domains C-terminally may therefore render the overall structural stability less dependent on 
the contributions of the variable domains and therefore may be beneficial for the secretion of 
otherwise poorly secreted scFvs. 
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CHAPTER 7 
Summary and Concluding Remarks 
A major challenge with respect to the expression of antibodies or antibody fragments in 
plants is to obtain large amounts of correctly folded and functional proteins at the proper 
subcellular location. In this thesis it is demonstrated that antibodies and single-chain Fv 
fragments (scFvs) can be efficiently expressed in plants, targeted to the proper subcellular 
location and the subcellular location influences expression levels and functionality. 
Coordinate expression of full size antibody coding genes. 
The most important condition for full size antibodies is that two genes must be expressed 
equally efficient to guarantee optimal antibody expression levels. In Chapter 2 an efficient 
transformation vector is described for integration of a single T-DNA, carrying both the heavy 
and light chain encoding genes, into the plant genome. Controlled by the CaMV 35S and the 
TR2' promoter both genes were efficiently expressed simultaneously, giving rise to a large 
proportion of transformants expressing a complete antibody at a relatively high level in roots 
and leafs (Wilmink et al., 1998). This approach avoids the time consuming method of 
crossing light chain expressing transgenics with heavy chain expressing transgenics (Hiatt et 
al., 1989) or the unreliable method of co-transformation, which suffers from a large 
proportion of low antibody expressors (De Neve et a/., 1993). Furthermore, segregation in 
the progeny is avoided. 
The secreted antibodies were to some extent sensitive to proteolytic processing, resulting in 
functional F(ab')2-like molecules. These results and the observations by others (Hein et a/., 
1991; Voss et al., 1995; de Wilde ef al., 1996) illustrate that antibodies of 150 kDa can pass 
the cell wall and accumulate in the apoplastic space. De Wilde et al. (1998) also 
demonstrated that antibodies can be transported apoplasticly through the plant. 
In this thesis cytosolic expression of complete antibodies was not studied. In animal cells the 
assembly of full size antibodies has been described (Biocca ef al., 1990). In plants, however, 
cytosolic expression resulted only in very low levels of unassembled light and heavy chains 
(Hiatt et al., 1989). Chaperones present in the cytosol may promote the correct folding of the 
individual peptide chains, but the reducing environment probably prevents the assembly into 
complete antibodies through disulfide bridge formation. 
Subcellular targeting of single-chain antibodies in plant cells. 
The unique characteristic of scFvs is that they can be modified in a relatively simple way to 
obtain optimal stability and functionality at various interesting subcellular locations in plants 
(Fig. 1). When carrying the signal peptide for translocation into the ER an anti-cutinase scFv 
can be secreted, although often poorly. It was efficiently retained to high levels of functional 
protein in the endoplasmic reticulum (ER) by adding the ER translocation signal and the four 
amino acid extension, Lys-Asp-Glu-Leu (or KDEL). Most intriguing, cytosolic expression of 
the scFv failed unless the KDEL extension was added C-terminally (Chapter 3). 
Immunoelectron microscopy and molecular markers confirmed that the cytosolic scFv with 
KDEL extension was located in the cytosol and not 'mistranslocated' to another subcellular 
compartment. Although the mode of action remains elusive, addition of this four amino acid 
extension, or a slightly modified one (KDEI), also improved cytosolic expression of several 
other scFv fragments (Chapter 4). Protein degradation commencing at the C-terminus may 
be prevented or the extension may sterically protect another part of the scFv fragment, 
which is susceptible to proteolysis. 
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Functional scFvs in the reducing cytosolic environment. 
Interestingly, further characterization of stable transformants revealed that the cytosolic scFv 
was present in an oxidized and functional state, like the ER retained fragment. The 
intramolecular disulfide bridges in the variable domains were present. Furthermore, cysteine 
residues present in the linker could, partially, form intermolecular disulfide bonds, resulting in 
scFv dimers. However, transient expression led to a non-functional cytosolic scFv, which 
lacked disulfide bridges (Chapter 5). This illustrates that the disulfide bridges in the variable 
domain are crucial for functionality (Fig. 2). 
/Nuc!eolus 
/ .Nucleus 
/ / Rough endoplasmic reticulum 
r' / Peroxisome 
/ ' ,' Smooth endoplasmic reticulum 
/ ' 
' / / / 
/ / / / / / 
*Cs£S<^' 
Plasmodesmata 
Chloroplast 
Ab 
scFv-S 
Mitochondrion 
-Golgi vesicles 
-Leukopiast 
• iai! membrane vesicle 
scFv-SK 
scFv-CK/scFv-C 
Fig. 1. Subcellular targeting of functional antibodies and scFv fragments in plant cells (Lodish ef a/., 
1995). Secreted complete antibodies (Ab) and scFvs (scFv-S) can traverse the cell wall. ScFv can 
be intracellularly expressed in the endoplasmic reticulum, by adding the ER retention signal KDEL 
(scFv-SK) to the secretory scFv, or in the cytosol by omitting the ER translocation signal (scFv-
C/scFv-CK). 
Disulfide bridge formation in the cytosol is remarkable. The cytosol and the secretory 
pathway of eukaryotic cells are two environments of grossly different thiol-disulfide redox 
states. In the oxidizing environment of the secretory pathway the formation of disulfide 
bridges is an important step in post translational processing. This is essential for folding, 
oligomerization and sorting of the assembled protein among different pathways. 
In contrast, in the reducing environment of the cytosol, formation of disulfide bonds is 
considered to be rare. The cysteine residues present in cytosolic proteins are often being 
used to bind ligands in Cys(S)-X bonds, where X= Fe, Zn, S, C or Cu. When present, 
disulfide bridges are often associated with an inactivated protein. However, evidence about 
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the in vivo redox state of cytosolic proteins is scarce and most has been deduced indirectly 
from in vitro experiments. Like in animal cells, the redox potential in the cytosol of plant cells 
is not static, but there is little information between which values it varies. In vitro experiments 
indicated that scFvs could fold efficiently at mildly reducing conditions (Ryabova et a/., 
1997). Apparently, the intrinsic properties of the protein determine the eventual redox state 
of the protein at a given redox potential in the cytosol. The fact that the transiently expressed 
scFv is present in a reduced and non-functional state can therefore probably be explained by 
the physiological conditions of the tobacco protoplasts. When put under oxidative stress 
conditions, the cytosol of plant cells becomes a more reducing environment, thus preventing 
scFvs from becoming oxidized. 
In conclusion, unlike the cytosol of bacteria, the plant cytosol may not be such a hostile 
environment for the expression of functional scFv. Formation of the proper intramolecular 
disulfide bonds to obtain functional scFvs is possible in stable transformants. This makes 
scFv fragments ideal to modulate protein activity in the plant cytosol and, as a consequence, 
to alter existing or design new metabolic pathways and to obtain resistance against 
pathogens. This approach is supported by the successful results of Tavadoraki et at. (1993) 
and Owen ef at. (1992). 
scFv antigen 
Fig. 2. Intramolecular disulfide bridges within the variable domains of the scFv fragment are crucial for 
antigen binding capabilities. 
ScFv secretion by plant cells. 
Secretion of scFv fragments proved to be more difficult than anticipated (Chapter 3). 
However, low expression could not be related to a poor transcription or translation. For the 
ER retained scFv expression levels of 1% were reached. Apparently, the scFv is susceptible 
to proteolytic degradation further down the secretory pathway. Since in the literature 
reported scFvs differed with respect to variable domains, architecture, linker peptide and C-
terminal residues it was difficult to determine which of the individual factors determine low 
scFv secretion. 
To elucidate the causes of this phenomenon a systematic study was set up to analyze 
whether scFv expression and secretion could be improved without changing the variable 
domains and thus the specificity. Several modifications in the linker peptide were introduced 
to reduce possible susceptibility to certain proteases. This was to no avail. However, 
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exchanging the 202' linker by the other frequently used (Gly4Ser)3 linker and maintaining the 
VL-VH architecture of the poorly secreting 21C5 scFv resulted in an elevated intracellular 
scFv expression level when expressed transiently in tobacco protoplasts comparable to the 
ER retained scFv. The expression levels were comparable to those of the ER retained scFv. 
Although functional, this protein was still badly secreted. Apparently, secretion is arrested 
somewhere in the secretory pathway, probably by a protein quality control mechanism. No 
stable transformants were found expressing this scFv fragment at detectable levels. This 
may emphasize that, as suggested before (Glockshuber et a/., 1990), the contribution of the 
variable domains to stabilize protein folds in an scFv are rather low, resulting in a structure in 
which proteolytic sensitive sites still can be reached. 
In an effort to reduce the overall contribution of the variable domains to stability extra 
constant domains were added C-terminally. These domains were also expected to cause 
dimerization through disulfide bridge formation (Fig. 3). The selected domains, the IgM CH4 
domain and the camel lgG2 long hinge, have interesting properties. The CH4 domain is 
involved in pentamer formation of IgM antibodies and has already been used successfully to 
VL linker V H (S") 
/ X^ 
GTNEVCKCPKCP 
VL linker Vy fl-H) 
V//y/yA^/yX^M/r//M^A-/^-
EPKIPOPQPKPQPQPQPQPKPQPKPEPECTCPKCP 
\^ _ linker V H C H 4 
Fig. 3. Construction of scFv fragments with extra domains for the purpose of mulimerization through 
disulfide bridge formation. Addition of the IgM CH4 (CH4) domain and the camel lgG2 long hinge (LH) 
and lgG3 short hinge (SH) leads to dimerization. Addition of both the LH and CH4 domain may lead to 
multimeric IgM like structures. 
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multimerize IgG antibodies (Smith and Morrison, 1994). The camel lgG2 long hinge and lgG3 
short hinge are rod shaped like domains which substitute the CH1 domain normally found in 
murine IgG antibodies. In addition, these camel lgG2 and lgG3 antibodies lack light chains. 
Consequently, the long and short hinges do not depend on an interaction with the CL domain 
for their stability. Adding these hinges to an scFv fragment would confront them with a 
similar situation. Both in transient expression assays and in stable transformants the addition 
of an IgM CH4 domain did increase intracellular expression levels. Again, no secretion was 
observed. Remarkably, when both the camel lgG2 long hinge and IgM CH4 domain were 
added, the scFv fragment was partially secreted both as monomer and dimer. In this case, 
the intracellular accumulation is probably caused by an inefficient glycosylation of the CH4 
domain, which caused a prolonged stay of the fragment in the ER. 
Transient expression suggested that scFv fragments carrying a long hinge combined with a 
CH4 domain were, next to dimers, capable of forming trimers and tertramers. However, IgM-
like multimers, as depicted in Fig. 3, were not observed. In addition, the trimers and 
tetramers were not found in stable transformants. Further optimization may eventually lead 
to an efficient assembly into IgM-like structures. 
The individual domains are capable of folding separately into stable structures, enabling the 
design and expression of many exotic antibody constructs (Hoogenboom, 1997). However, 
our results indicate that antibody domains have their limitations, at least in plants, and one 
should be careful to consider domains as individual building blocks, which can be assembled 
into antibody fragments with any predicted structure. 
In all, scFvs can be constructed which remain stable in the secretory pathway and become 
secreted more efficiently. By removing the glycosylation signal in the CH4 domain scFv-LH-
CH4 fragments may be obtained which are secreted even more efficiently. New scFv 
constructs may also solve the problem of low scFv secretion, like bivalent scFv antibodies 
(Fig. 4). In these antibody fragments, an additional peptide linker covalently connects two 
scFvs. Both scFv fragments do not necessarily have the same specificity and different scFv 
can be linked. The first results show that these constructs can be expressed in plants 
(unpublished data). 
VL linker V H CBHI linker VL linker V H 
Monospecific 
Bispecific 
Fig. 4. Mono- and bispecific bivalent scFvs 
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Future prospects of the plantibody technology. 
This thesis demonstrates that antibodies are flexible molecules, which facilitate obtaining 
transgenics expressing antigen-binding domains at high levels and at various subcellular 
locations. The first examples of modified plant traits and resistance against viruses show that 
plantibodies have an enormous potential. Once suitable antibodies are available, a rational 
approach can be devised to express the antibody at the appropriate subcellular location in 
the plant. Recently, promising target proteins in sedentary plant parasitic nematodes have 
been isolated and characterized (Smant ef a/., 1998). Resistance not only to viruses but also 
to more complex organisms like nematodes, fungi and even insects through plantibody 
technology seems within reach. 
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Samenvatting. 
Waardplantresistentie is een milieuvriendelijke methode voor de beheersing van ziekten en 
plagen, en is van oudsher een belangrijke eigenschap geweest waar veredelaars op 
selecteerden. Door de komst van de DNA technologie is het mogelijk geworden het arsenaal 
van resistente rassen drastisch uit te breiden en het gebruik van pesticiden verder terug te 
dringen. Deze technologie onderscheidt zich van de klassieke resistentieverdeling, doordat 
de soortsbarriere doorbroken wordt. Nieuwe eigenschappen kunnen worden ge'introduceerd 
die van origine niet in een plantensoort voorkomen. Introductie van natuurlijke 
resistentiegenen is te prefereren. Echter, hiervan is slechts een beperkt spectrum 
beschikbaar. Een alternatief is het ontwerpen van nieuwe genen. 
Een nieuwe ontwikkeling in de moleculaire resistentieveredeling is het transformeren van 
planten met genen die coderen voor antilichamen. Antilichamen kunnen diverse biologische 
functies blokkeren en zijn hierdoor uitermate geschikt voor het creeren van nieuwe vormen 
van resistentie. De idee is dat de door de plant gesynthetiseerde antilichamen 
('plantibodies') specifiek essentiele factoren (bijv. enzymen) van de parasiet of het 
pathogeen kunnen remmen. Bij deze benadering is het van cruciaal belang dat het 
antilichaam zich op dezelfde subcellulaire locatie bevindt als de te blokkeren 
pathogeniteitsfactor. 
In dit proefschrift zijn de mogelijkheden onderzocht met betrekking tot de in planta expressie 
van antilichamen en antilichaamfragmenten en het versturen van deze eiwitten naar de 
juiste subcellulaire locaties. 
Antilichamen, of immunoglobulinen, spelen een essentiele rol in het immuunsysteem van 
gewervelde dieren. Hun unieke functie is binding aan een schier eindeloze variatie van 
indringers (antigenen) met als doel om deze te neutraliseren en uiteindelijk te elimineren. 
Een antilichaam is een eiwit dat een Y-vormige structuur heeft en bestaat uit vier polypeptide 
ketens, twee identieke lichte ketens en twee identieke zware ketens (Fig. 1). Zowel de lichte 
als de zware keten hebben een duidelijk herkenbare domeinstructuur. Een lichte keten 
bestaat uit twee domeinen, een variabel en een constant domein. Een zware keten bestaat 
uit vier domeinen, een variabel domein en drie constante domeinen. De lichte keten is 
geassocieerd met het variabele domein en het eerste constante domein van de zware keten 
via een zwavelbrug en niet-covalente interacties. De twee zware ketens zijn, eveneens via 
zwavelbruggen en niet-covalente interacties, onderling geassocieerd via hun tweede en 
derde constante domeinen. De twee variabele domeinen van de lichte en zware keten 
vormen samen de bindingsplaats voor een antigeen. leder antilichaam is dus in staat twee 
antigenen te binden. Binding van een antilichaam heeft vaak tot gevolg dat het functioneren 
van het antigeen (bijv. een enzym) gedeeltelijk of volledig wordt geremd. 
In hoofdstuk 2 is een effectieve methode beschreven om de twee genen, coderend voor de 
lichte en zware keten van een model antilichaam, te introduceren in planten en evenredig tot 
expressie te brengen. Beide genen bevinden zich op een transformatievector en worden op 
deze wijze simultaan in het plantengenoom ge'introduceerd. Op deze wijze zijn tijdrovende 
kruisingsprocedures of de moeizame methode van co-transformatie te vermijden. is een Een 
bijkomend voordeel dat uitsplitsing van beide genen bij kruising tijdens verdere veredeling 
uitgesloten is omdat beide genen op dezelfde chromosomale positie zijn geincorporeerd. 
Om mogelijke 'silencing' effecten te vermijden zijn de twee genen onder controle gezet van 
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verschillende promoters. De resultaten tonen aan dat transgene planter) de genen coderend 
voor lichte en zware ketens evenredig en op een relatief hoog niveau tot expressie brengen. 
Zoals verwacht worden de antilichamen gesecreteerd omdat een signaal voor translocatie 
naar het endoplasmatisch reticulum (ER) is toegevoegd. 
Volledige antilichamen zijn dus uitermate geschikt om door plantencellen te worden 
uitgescheiden in de apoplast. Intracellular expressie van antilichamen is aanzienlijk 
gecompliceerder. In de reducerende omgeving van het cytosol is intramoleculaire 
zwavelbrugvorming, noodzakelijk voor de assemblage lichte en zware ketens, niet mogelijk. 
'Single-chain Fv' (scFv) antilichaamfragmenten (Fig. 1) kunnen voor dit probleem uitkomst 
bieden omdat deze fragmenten geen intramoleculaire zwavelbruggen nodig hebben voor 
assemblage. 
Antilichamen hebben een domeinstructuur die het mogelijk maakt om antilichamen op 
verschillende manieren te trimmen zonder dat dit de binding met het antigeen bei'nvloedt 
(Fig. 1). Genen coderend voor antilichaamfragmenten zijn niet alleen in dierlijke cellen tot 
expressie gebracht, alsmede in gist en bacterien. Een van de meest interessante 
antilichaamfragmenten is een zogenaamd 'single-chain Fv' (scFv). Dit is een Fv fragment 
waarbij de variabele domeinen van de lichte en zware keten covalent verbonden zijn via een 
peptide 'linker' (Fig. 1). Hierdoor is een scFv veel stabieler dan een Fv fragment. Een 
bijkomend voordeel is dat een scFv gecodeerd wordt door een gen. 
In hoofdstuk 3 is gekeken naar hoe efficient een scFv antilichaam zowel intra- als 
extracellulair tot expressie is te brengen in planten. Planten zijn getransformeerd met genen 
coderend voor een scFv antilichaam voorzien van signalen voor secretie, retentie in het 
Fig. 1. Schematische weergave van een compleet antilichaam (Ab) en afgeleide 
antilichaamfragmenten (F(ab')2, Fab, Fv en scFv). De variabele (VL an VH) en constante (CL, CH1, 
CH3 en CH3) domeinen binnen de lichte en zware keten, alsmede het hinge gebied (h), zijn 
weergegeven. Zwavelbruggen en niet covalente interacties houden de afeonderlijke peptiden ketens 
bij elkaar. F(ab')2 en Fab fragmenten kunnen zowel via enzymatisch klieving als genetische 
manipulatie gemaakt worden. 'Single-chain Fv' (scFv) fragmenten zijn afgeleid van Fv fragmenten. 
Voor extra stabiliteit zijn de VL an VH domeinen covalent verbonden via een peptide linker. Zowel Fv 
als scFv fragmenten kunnen alleen verkregen worden via genetische manipulatie. 
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endoplasmatisch reticulum (ER) en expressie in het cytosol. Teleurstellend is dat secretie 
van de scFv leidt tot een relatief laag eiwitniveau. Het accumulatieniveau is relatief hoog 
indien de scFv intracellular wordt vastgehouden in het endoplamatisch reticulum middels 
het ER retentie signaal, wat bestaat uit de vier aminozuren Lys-Asp-Glu-Leu ('KDEL'). Zeer 
opmerkelijk is dat de scFv, bestemd voor het cytosol, alleen detecteerbaar is wanneer een 
KDEL sequentie is toegevoegd. Dit is niet te verklaren door een verhoogd transcriptieniveau. 
In hoofdstuk 4 is de intracellular expressie van scFv antilichamen nader bestudeerd. De 
reden van het vehoogde eiwitexpressieniveau van het cytosolische scFv fragment met extra 
KDEL sequentie kan veschillende oorzaken hebben. Enerzijds is dit scFv fragment, middels 
de KDEL sequentie, minder gevoelig voor proteases. Anderzijds kan de KDEL sequentie op 
zichzelf als signaal voor een onjuiste translocatie naar het ER hebben gefunctioneerd. 
Localisatiestudies met behulp van immunoelectronenmicroscopie en biochemische markers 
sluiten deze laatste mogelijkheid echter uit. De cytosolische scFv met KDEL sequentie is 
inderdaad in het beoogde subcellulaire compartiment aanwezig. Klaarblijkelijk heeft de 
KDEL extensie een positief effect op de stabiliteit van het scFv fragment in het cytosol. Dit is 
verder bevestigd door aan te tonen dat deze extensie ook positief werkt op de cytosolische 
expressie van enkele andere scFv fragmenten. 
In hoofstuk 5 is bij zowel de cytosolische als de ER gelocaliseerde scFvs de aanwezigheid 
van intramoleculaire zwavelbruggen onderzocht. Deze zwavelbruggen zijn belangrijk voor de 
functionaliteit van het molecuul. Zoals verwacht zijn in het ER de zwavelbruggen inderdaad 
aanwezig. Opmerkelijk is dat ook in het cytosol zwavelbrugvorming plaatsvindt in stabiele 
transformanten. Bovendien zijn scFvs in beide compartimenten gedeeltelijk gedimeriseerd 
middels intermoleculaire zwavelbrugvorming tussen de cysteineresiduen in de linker. 
Zwavelbrugvorming in het cytosol is opvallend. Tot nu toe werd aangenomen dat, in 
tegenstelling tot de 'secretory pathway', dit subcellulaire compartiment te reducerend is voor 
de vorming van zwavelbruggen. 
In hoofstuk 6 is het model scFv fragment op verschillende manieren gemodificeerd met als 
doel de secretie te verbeteren, zonder de functionaliteit te beinvloeden. In transients assays 
brengt het modificeren van proteolytisch gevoelige plaatsen in de linker geen verbetering in 
stabiliteit en secretie. Het gebruik van de (Gly4Ser)3-linker, in combinatie met de VL-VH 
architectuur, resulteert wel in een verhoogde intracellulaire accumulatie, echter niet in een 
verbetering van de secretie. Waarschijnlijk wordt het transport ergens in de 'secretory 
pathway' tegen gehouden, mogelijk door een kwaliteitscontrole mechanisme m.b.t. 
eiwitvouwing. Stabiele introductie van dit scFv-construct in transgene tabaksplanten 
resulteert echter niet in een hogere expressie en dus ook niet in een tegenomen secretie. 
Een mogelijke verklaring voor deze resultaten is dat de variabele domeinen de stabiliteit van 
het scFv fragment bepalen. Indien de vouwing van deze domeinen onvoldoende stabiel is 
kunnen proteasen bepaalde gevoelige plaatsen nog steeds bereiken. Het C-terminaal 
toevoegen van constante domeinen kan mogelijk gevoelige plaatsen afschermen. Hiervoor 
zijn het CH4 domein van een IgM antilichaam en de 'long hinge' (LH) en 'short hinge' (SH) 
van verschillende kamelenantilichamen gebruikt (Fig. 2). Beide hinges zijn staafvormig en 
vervangen het eerste constante domein van een normaal antilichaam. Bovendien ontbreken 
bij deze type kamelenantilichamen de lichte ketens en hebben beide hinges geen interactie 
met een ander domein nodig voor stabiliteit. Gekoppeld aan een scFv bevinden deze 
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domeinen zich dan ook in een vergelijkbare situatie als in kamelenantilichamen. Het CH4 
domein en beide hinges zouden bovendien kunnen zorgen voor efficiente multimerisatie 
(Fig. 2) wat een bijkomende verhoging van de schijnbare affiniteit (aviditeit) tot gevolg heeft. 
In stabiele transformanten blijkt alleen het toevoegen van het CH4 domein de scFv expressie 
te verhogen. Dit resulteert weer in een verhoogde intracellulaire accumulatie zonder een 
verbetering van de secretie. Opmerkelijk is dat het toevoegen van een combinatie van de LH 
en het CH4 domein wel leidt tot een verbeterde secretie. Deze scFv wordt zowel in 
monomere als dimere vorm gesecreteerd. De resterende intracellulaire accumulatie is in dit 
geval vermoedelijk veroorzaakt door een inefficiente glycosylering van het CH4 domein, 
hetgeen resulteert in een langer verblijf in het ER. Dit scFv construct heeft de potentie om 
naast dimeren ook complexere multimeren te vormen. In stabiele transformanten zijn deze 
echter niet aangetroffen. 
long-hinge 
short 
lgG2 
Fig. 2. Bij lgG2 en lgG3 antilichamen van kameel zijn de eerste constante domeinen (CH1) vervangen 
door respectievelijk de 'long hinge' en 'short hinge'. Daarnaast zijn de lichte ketens in hun geheel 
afwezig. 
Verdere optimalisatie zou uiteindelijk kunnen leiden tot een nog efficientere secretie van, 
scFv fragmenten, al of niet in multimere vorm. Hierbij kan ook nog gedacht worden aan 
alternatieve constructen zoals zogenaamde bivalente scFv fragmenten. Hierbij zijn twee 
scFv fragmenten covalent verbonden door een additionele linker. De eerste nog niet 
gepubliceerde resultaten tonen aan dat planten ook deze constructen tot expressie kunnen 
brengen. 
Dit proefschrift toont aan dat antilichaamgenen redelijk eenvoudig gemodificeerd kunnen 
worden om een zo optimaal mogelijke intra- en extracellulaire expressie in planten te 
bereiken. Het potentieel van de plantibody-benadering is reeds aangetoond door de eerste 
voorbeelden van resistentie tegen tabaksmozaiekvirus (TMV) 'artichoke mottled crinkle 
virus' (ACMV) en 'beet necrotic yellow vein virus' (BNYW). Van groot belang is het vinden 
van de geschikte 'target'-eiwitten. Indien deze voorhanden zijn dan lijkt het ontwerpen van 
resistente rassen met behulp van de plantibody-technologie niet alleen tegen virusen maar 
ook tegen nematoden, schimmels en insecten heel goed mogelijk. 
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